https://rjrindex.com/articles/cutaneous-diffuse-large-b-cell-lymphoma-induce-a-macrophage-immunosuppressive-phenotype-through-il-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-from-dreamm-7-and-dreamm-8-using-the-eq-5d-3l-patient-global-impression-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ras-mutations-are-frequent-in-extramedullary-aml-and-drive-the-tissue-infiltration-of-leukemic-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-30mgkg-atlg-in-preventing-gvhd-after-haploidentical-hematopoietic-stem-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modeling-disability-reduction-through-low-dose-prophylaxis-versus-on-demand-therapy-in-hemophilia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-disease-presentation-and-clinical-outcomes-of-chronic-myelomonocytic-leukemia-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-disease-progression-and-vascular-events-in-essential-thrombocythemia-a-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chidamide-based-epigenetic-therapy-for-relapsedrefractory-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-time-limited-treatment-with-orelabrutinib-plus-bendamustine-and-obinutuzumab-ob 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-after-relapse-for-adolescent-and-young-adult-patients-with-all-results-from-the-childrens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-car-hematotox-score-in-patients-with-refractory-relapsed-multiple-myeloma-treated-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-reliability-and-accuracy-of-point-of-care-measurements-of-fetal-hemoglobin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-spectrum-of-alpha-thalassemia-an-unrecognised-blood-disorder-in-nepal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/can-the-development-of-drug-induced-rash-after-mogamulizumab-administration-predict-survival-in-myco 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sex-based-disparities-in-mpn-treatment-patterns-a-study-of-1167-patients-from-the-quebec-mpn-regist 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-analysis-compared-with-efficacy-shows-iron-dextran-surpassing-other-intravenous-iron-formulatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-efficacy-and-safety-of-hydroxyurea-and-thalidomide-for-beta-thalassemia-a-systematic-rev 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-mortality-involving-ischemic-heart-disease-andanemia-in-the-unite 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimal-infection-prophylaxis-strategy-for-relapsedrefractory-multiple-myeloma-patients-undergoing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-cooperation-between-progranulin-and-jak2stat3-signaling-determines-definitive-myeloid-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-brain-initiative-bettering-radiology-access-to-improve-neuro-outcomes-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tracking-fellowship-competitiveness-in-hematology-oncology-insights-from-nrmp-match-data-2014-2025 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-multiomics-dissection-of-in-vivo-immune-modulation-and-reconstitution-induced-by-bruton 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-rw-treatment-tx-patterns-factors-associated-with-discontinuation-and-toxicity-across 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-and-clinical-study-of-olverembatinib-in-patients-with-myeloidlymphoid-neoplasms-with-fg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delivering-car-t-and-bites-outpatient-a-safe-and-resource-conscious-model-for-t-cell-redirecting-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prmt5-is-a-therapeutic-vulnerability-in-cutaneous-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discovery-of-the-transcription-factor-znf683hobit-as-a-central-regulator-of-pathogenic-t-cell-proli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-mrd-the-importance-of-weight-recovery-in-adults-with-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd48-as-an-additional-marker-for-measurable-residual-disease-assessment-in-pediatric-acute-myeloid-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-genomic-landscape-and-prognostic-impact-of-trisomy-8-on-contemporary-outcomes-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differential-expression-of-coagulation-and-inflammation-genes-in-itp-patients-before-and-after-treat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etiology-of-anemia-in-a-murine-model-of-myelodysplastic-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-placebo-controlled-study-to-assess-the-safety-tolerability-pharmacokin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-daratumumab-carfilzomib-based-therapy-in-newly-diagnosed-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-isolation-and-patient-reported-and-healthcare-utilization-in-adults-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-among-warm-autoimmune-hemolytic-anemia-patients-receiving-rituximab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-sema4a-directed-car-t-cells-to-overcome-low-bcma-antigen-density-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/total-marrow-irradiation-based-intensified-reduced-intensity-conditioning-regimen-for-hematopoietic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-von-willebrand-factor-targeting-thrombolytic-tgd001-is-safe-and-well-tolerated-in-a-phase-1-fi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inpatient-vs-outpatient-treatment-management-with-teclistamab-in-relapsed-and-refractory-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/apolipoproteins-from-the-microenvironment-promote-aggressive-myeloid-leukemia-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pretargeted-glycoengineered-nk-cell-pg-nk-therapy-a-universal-off-the-shelf-platform-redefining-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-cd33car-nk-cell-therapy-for-acute-myeloid-leukemia-through-tgfv-imprinting-and-nktr-255 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-costs-associated-with-hematopoietic-cell-transplant-for-sickle-cell-disease-in-the-united 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vte-risk-in-transgender-women-on-estrogen-therapy-a-review-of-formulation-specific-risks-managemen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-omic-single-cell-sequencing-reveals-discordant-mrd-and-mechanisms-of-relapse-in-pediatric-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-tp53-mutations-on-survival-outcomes-in-the-car-t-era-of-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vysion-vyxeos-liposomal-italian-observational-study-in-the-real-practice-study-design-and-baseli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rondecabtagene-autoleucel-an-autologous-dual-targeting-cd19cd20-car-t-cell-candidate-manufactured 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-mosunetuzumab-use-in-indolent-and-aggressive-lymphomas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-sls009-in-combination-with-azacitidine-and-venetoclax-for-relapsedrefractory-aml-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-efficacy-of-azacitidine-combined-with-lenalidomide-in-tp53-mutation-positive-and-other-high-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bi-allelic-tet2-alterations-are-frequently-found-in-npm1-mutated-aml-and-constitute-a-distinct-subgr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-the-mutant-calreticulin-specific-monoclonal-antibody-inca033989-as-monotherap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-role-of-ep300-in-maintaining-the-enhancer-landscape-and-lineage-specific-epigenetic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-procoagulant-activity-of-phosphatidylserine-positive-platelets-in-antiphospholipid-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-randomized-phase-2-rosewood-study-of-zanubrutinib-obinutuzumab-vs-obinutuzum 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inotuzumab-ozogamicin-then-blinatumomab-for-older-adults-with-newly-diagnosed-ph-negative-cd22-pos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-pan-car-therapy-utilizing-circular-rna-for-treatment-of-autoimmune-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inotuzumab-ozogamicin-as-salvage-therapy-for-refractoryrelapsed-b-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combination-therapy-with-methotrexate-ifosfamide-cytarabine-dexamethasone-and-rituximab-r-miad 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploration-of-optimal-high-dose-methotrexate-based-therapy-for-patients-with-primary-cns-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polatuzumab-vedotin-plus-r-chp-demonstrates-high-efficacy-with-manageable-toxicity-in-treatment-naiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-stem-cell-transplantation-in-myelodysplastic-syndrome-using-machine-learnin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-optimized-msc-product-promotes-gvhd-prophylaxis-through-exosome-mediated-regulatory-t-cell-induct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-il-10-incorporated-predictive-model-for-late-immune-effector-cell-associated-hematotoxicity-follo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-concurrent-antiplateletnsaid-use-on-the-safety-and-efficacy-of-thromboprophylaxis-with-ap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golidocitinib-combined-with-chop-in-treatment-naive-monomorphic-epitheliotropic-intestinal-t-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/icam-2-mediates-adhesion-of-acute-myeloid-leukemia-cells-to-bone-marrow-microenvironment-and-promote 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-growth-development-and-endocrine-function-in-children-with-primary-immunodeficiency-dis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-clinical-observation-of-treating-autoimmune-cytopenias-after-allogeneic-hematopoietic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-post-transplant-cyclophosphamide-ptcy-peripheral-blood-hematopoietic-cell-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-of-abbreviated-dose-escalation-in-patients-pts-receiving-glofitamab-glofit-or-epcoritamab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-t-cellhistiocyte-rich-large-b-cell-lymphoma-insights-from-the-largest-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-cd135-expression-in-pediatric-aml-is-associated-with-specific-disease-characteristics-and-wor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/telomere-attrition-is-common-in-patients-with-germline-runx1-pathogenic-variants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-medical-provider-practice-patterns-in-the-assessment-and-management-in-heavy-menstrual 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-evaluation-of-the-safety-and-efficacy-of-intensive-chemotherapy-with-or-without 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-slim-crab-criteria-on-treatment-initiation-in-newly-diagnosed-multiple-myeloma-in-the-vete 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-transplant-associated-thrombotic-microangiopathy-in-pediatric-patients-undergoing-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-p300-mediated-histone-acetylation-inhibits-neutrophilic-proteinase-3-and-prevents-the-deve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-demographic-patterns-in-hodgkin-and-non-hodgkin-lymphoma-mortality-among-us-ad 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-petct-scan-in-differentiating-malignant-and-bland-thrombi-in-cancer-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-regional-variations-in-survivorship-care-plan-delivery-among-hematologic-cancer-survivors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-death-from-multiple-myeloma-with-concomitant-diabetes-mellitus-in-the-usa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-efficacy-and-safety-of-givinostat-versus-hydroxyurea-in-patients-with-polycythemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emergence-of-new-somatic-mutations-in-cml-patients-optimally-responding-to-tyrosine-kinase-inhibitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-study-on-the-efficacy-and-safety-of-pegylated-recombinant-human-granulocyte-colony-stimulat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-and-characterization-of-a-potent-and-selective-blimp1-protac-as-a-novel-first-in-class 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-12-multi-center-open-label-clinical-study-to-evaluate-the-safety-pharmacokinetics-and-eff-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nemtabrutinib-in-participants-with-relapsed-or-refractory-follicular-lymphoma-updated-efficacy-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exposure-to-epcoritamab-is-associated-with-improved-t-cell-functionality-and-dynamic-changes-in-cd8 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-first-integrated-proteomic-and-lipidomic-profiling-reveals-immune-metabolic-and-membrane-remod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd49d-expression-is-epigenetically-regulated-in-chronic-lymphocytic-leukemia-insights-from-cd49d-bi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombocytopenia-at-diagnosis-adversely-affects-overall-and-leukemia-free-survival-in-lower-risk-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-cerebrospinal-fluid-pleocytosis-and-cell-subsets-during-blinatumomab-therapy-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/siglec-15-dependent-alteration-of-the-leukemia-immune-microenvironment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-geographic-variation-in-mortality-from-hypertensive-diseases-with-coexisting-apl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-hpb-092-a-novel-dual-kinase-inhibitor-targeting-flt3-and-irak4-for-the-treatment-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fludarabine-pharmacokinetics-and-dynamic-immune-monitoring-as-predictive-biomarkers-for-cd19-and-bcm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-following-lower-intensity-therapy-with-venetoclax-in-patients-with-npm1-mutated-acute-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-targeting-of-sphingosine-1-phosphate-receptor-1-s1pr1-in-angioimmunoblastic-t-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hospital-bed-size-and-sepsis-related-complications-in-patients-with-myelodysplastic-syndromes-insig 2026-08-17 monthly 0.7 https://rjrindex.com/articles/timing-of-tyrosine-kinase-inhibitor-switching-and-long-term-outcomes-in-chronic-myeloid-leukemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-response-relapse-and-survival-of-hospitalized-adult-primary-warm-autoimmune-hemolytic-ane 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-dose-methotrexate-consolidation-prior-to-autologous-hsct-in-b-all-a-decade-long-retrospective 2026-08-17 monthly 0.7 https://rjrindex.com/articles/radiotherapy-consolidation-post-autologous-stem-cell-transplant-in-relapsedrefractory-aggressive-no 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-hematological-malignancies-among-diabetic-patients-aged-25-and-older-in-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-selective-pi3kd-inhibitor-roginolisib-synergizes-with-ruxolitinib-against-progenitor-cells-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odronextamab-treatment-for-patients-with-rare-subtypes-of-relapsedrefractory-rr-aggressive-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-in-house-hit-screening-testing-in-community-based-hospital 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-toxicity-of-cyclophosphamide-etoposide-and-prednisone-as-an-outpatient-oral-chem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/st6galnac4-promotes-dlbcl-progression-by-regulating-ldha-sialylation-to-enhance-glycolysis-and-lacta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transformer-neural-network-using-dna-methylation-for-sensitive-and-specific-diagnosis-of-acute-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-evaluation-of-guideline-adherence-for-the-timeliness-of-pain-medication-for-acute-sickle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-provides-equivalent-survival-benefits-in-first-line-and-second-line-treatment-of-transpl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expanding-the-boundaries-of-car-t-cell-therapy-implementation-of-an-outpatient-at-home-oath-model 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-hematopoietic-stem-cell-transplantation-followed-by-cd19cd22-dual-target-car-t-therapy-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-chidamide-and-bruton-tyrosine-kinase-inhibitors-combination-therapy-in-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mefv-e148q-p369s-r408q-germ-line-variant-identified-from-the-adolescent-imcd-tafro-family-conferred 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-between-protocol-and-practice-a-quality-improvement-initiative-to-optimize-platele 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-clinical-utility-of-soluble-interleukin-2-receptor-testing-in-diagnosing-adult-hlh-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-kinase-related-gene-signature-predicts-the-survival-and-therapeutic-responses-of-acute-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-independence-of-double-hit-multiple-myeloma-based-on-mayo-definition-and-nomogram-was-es 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-the-role-of-second-allogeneic-hct-for-post-transplant-relapse-in-acute-lymphoblastic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vitamin-k3-metabolic-fate-determines-pro-survival-or-ferroptotic-outcomes-in-multiple-myeloma-via-ub 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-step-up-dosing-of-patients-receiving-elranatamab-for-multiple-myeloma-in-japan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-donor-age-on-transplant-outcomes-in-unrelated-allogeneic-hematopoietic-stem-cell-transplan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-efficacy-and-prognostic-factors-in-transfusion-dependent-thalassemia-following-allogenei 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multifunctional-nanoplatform-for-ferroptosis-inducingchemophotothermal-therapy-enhances-therape 2026-08-17 monthly 0.7 https://rjrindex.com/articles/causes-of-death-in-ddx41-mutated-myeloid-neoplasms-a-retrospective-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-in-treatment-of-shwachman-diamond-syndrome-a-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-decrease-and-efficacy-of-platelet-rich-plasma-return-for-car-t-lymphocyte-apheresis-in-low 2026-08-17 monthly 0.7 https://rjrindex.com/articles/triple-negative-myeloproliferative-neoplasms-tn-mpn-a-meta-analysis-of-clinical-and-molecular-cha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-myelofibrosis-patients-with-mpl-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upfront-comprehensive-donor-search-overcomes-the-impact-of-poor-search-prognosis-irrespective-of-ra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-replicates-and-extends-clinician-informed-disease-severity-grading-classification-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ex-vivo-treatment-by-mitapivat-an-allosteric-pyruvate-kinase-activator-reduced-oxidative-stress-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/st2-as-a-biomarker-of-cytokine-release-syndrome-following-cd19-targeted-chimeric-antigen-receptor-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-results-of-the-methoglu-trial-a-phase-1-trial-from-the-loc-network-evaluating-the-reduction-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-based-regimens-in-newly-diagnosed-mayo-2004-stage-3b-al-amyloidosis-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-tyrosine-kinase-inhibitors-on-estimated-glomerular-filtration-rate-in-chronic-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-golidocitinib-in-relapsedrefractory-t-cell-and-nk-cell-large-gra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-interleukin-10-at-diagnosis-and-during-treatment-independently-predicts-adverse-outcomes-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/day-7-mount-sinai-acute-gvhd-international-consortium-magic-algorithm-probability-predicts-gvhd-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-return-to-school-after-pain-related-hospitalizations-and-hospital-re-admission-risk-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cmv-reactivation-under-foscarnet-prophylaxis-in-cord-blood-transplantation-increased-nrm-without-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-dkk1-a2-car-t-cell-therpy-for-hematologic-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-roles-of-hematopoietic-notch-signaling-in-extramedullary-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-allogeneic-hematopoietic-cell-transplant-hct-in-patients-with-tp53-altered-acute-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modeling-germline-ddx41-andor-chek2-mutations-using-patient-derived-bone-marrow-organoids 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-g-csf-in-aml-patients-treated-with-venetoclax-and-azacitidine-a-dataml-registry-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-pilot-study-integrating-health-care-coaching-into-va-hematologic-cancer-care-a-va-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-echocardiography-and-ferritin-based-screening-model-to-optimise-cardiac-t2-mri-use-for-detecting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-immune-profiling-reveals-enhanced-immune-fitness-of-endogenous-and-engineered-t-cells-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-novel-druggable-targets-via-npm1a-turboid-fusion-and-mass-spectrometry-to-overcome-gen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1b-safety-run-in-study-followed-by-phase-2-study-of-ficlatuzumab-azacitidine-and-venetoclax-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatial-biomarkers-of-car-t-treatment-response-in-relapsed-refractory-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expanding-access-in-pediatrics-outcomes-of-haploidentical-transplantation-with-reduced-intensity-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-carfilzomib-based-combination-regimens-in-patients-with-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-profile-of-obecabtagene-autoleucel-as-a-car-t-cell-therapeutic-agent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spontaneous-remissions-in-paroxysmal-nocturnal-hemoglobinuria-true-remission-or-clonal-evolution-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-liposome-plus-cytarabine-and-azacitidine-for-newly-diagnosed-acute-myeloid-leukemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interrelationship-between-endothelial-dysfunction-and-inflammation-and-outcomes-in-pulmonary-embolis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prothrombin-complex-concentrate-in-managing-direct-oral-anticoagulant-doac-associated-bleeding-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/double-burden-bleeding-disorders-and-their-impact-on-cardiovascular-mortality-across-demographics-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-flt3-inhibitors-and-hypomethylating-agents-as-post-transplant-prophylaxis-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-and-prospective-validation-of-a-prognostic-model-for-diffuse-alveolar-hemorrhage-after-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-prognostic-factors-in-older-adults-with-early-stage-classic-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-asparaginase-discontinuation-on-outcomes-in-pediatric-b-cell-precursor-acute-lymphoblastic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-relapsedrefractory-multiple-myeloma-retreatment-versus-no-retreatment-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-no-bolus-versus-bolus-unfractionated-heparin-nomograms-in-the-management-of-pulmonary-em 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-parameters-and-outcomes-associated-with-genetic-alterations-in-patients-diagnosed-with-comp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-series-of-pediatric-patients-with-congenital-thrombotic-thrombocytopenia-purpura-cttp-treat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-the-sickle-cell-outcome-grading-system-scogs-a-novel-classification-system-for-sic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/economic-burden-of-relapse-in-patients-with-acute-lymphoblastic-leukemia-a-retrospective-claims-bas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bleed-versus-clot-paradox-under-immune-checkpoint-inhibition-a-decade-long-us-faers-analysis-reveal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-risk-stratification-in-patients-aged-80-years-with-large-b-cell-lymphoma-comparison-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-treatment-responses-to-methotrexate-and-cyclophosphamide-among-t-lgl-patients-with-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/initial-performance-of-pirtobrutinib-real-world-outcomes-among-cll-patients-after-prior-covalent-bt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-survival-outcomes-among-adolescent-and-young-adults-vs-adult-populations-with-hodgkin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expert-consensus-on-the-clinical-management-of-congenital-thrombotic-thrombocytopenic-purpura-in-asi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/end-of-study-results-from-the-icon3-pines-trial-a-phase-3-randomized-trial-of-eltrombopag-vs-stan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cpx-351-is-a-feasible-bridge-to-allogeneic-hematopoietic-stem-cell-transplantation-in-tp53-mutated-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-characteristics-and-outcomes-of-patients-with-myelodysplastic-syndrome-with-tp53 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bispecific-antibody-therapy-in-multiple-myeloma-is-impaired-by-tumor-associated-macrophages-through 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-morphological-features-of-malignant-cells-in-large-b-cell-lymphoma-identified-by-soft-segme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vaccination-targeting-azacytidine-induced-neoantigens-in-the-c1498-murine-aml-model 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gold-salt-phospholipid-inhibits-glutathione-peroxidase-4-gpx4-and-causes-cell-death-in-mantle-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-single-cell-profiling-in-canine-dlbcl-reveals-regulatory-networks-driving-chemotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/late-onset-and-long-lasting-neutropenia-amp-primary-immune-dysregulation-early-signals-amp-gen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-prolyl-trna-synthetase-sensitizes-acute-myeloid-leukemia-to-venetoclax-through-bmf-med 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-in-pediatric-patients-with-hsct-tma-treated-with-ravulizumab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-dimensional-transcriptomic-profiling-reveals-novel-tumor-microenvironment-landscape-and-subtyp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/erythroblastic-sarcoma-transformation-from-chronic-myeloid-leukaemia-a-case-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-decitabine-cedazuridine-versus-parenteral-hypomethylating-agents-in-treatment-naive-tp53-mutate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/center-effect-on-large-b-cell-lymphoma-outcome-in-frontline-prospective-phase-ii-and-iii-trials-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-a-14-day-venetoclax-regimen-in-combination-with-a-hypomethylating-agent-for-acute-myeloi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eb2023-primes-mitochondria-for-bcl2-dependence-and-induces-pyroptotic-cell-death-via-ampk-signaling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-zanubrutinib-monotherapy-for-cllsll-focusing-on-treatment-discontinuation-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rehabilitation-needs-and-clinical-associations-post-car-t-cell-therapy-a-retrospective-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematologic-toxicities-associated-with-parp-inhibitors-real-world-pharmacovigilance-updated-study-u 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fbxo3-mediated-dusp9-ubiquitination-reprograms-mapk-signaling-to-eradicate-tyrosine-kinase-inhibitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prime-editing-mediated-bcl-2-hematopoietic-stem-cell-shielding-as-a-strategy-for-leukemia-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hdac-inhibitors-potentiate-the-efficacy-of-antineoplastic-agents-in-acute-megakaryoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapy-induced-senescence-reprograms-non-m3-aml-into-a-drug-exploitable-apl-like-state 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-chronic-myeloid-leukemia-in-the-united-states-a-population-based-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mezigdomide-overcomes-crbn-mutations-emerging-post-imid-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-genomics-studies-identify-determinants-of-response-vs-resistance-to-pharmacological-inhi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pediatric-inspired-regimens-for-all-are-not-associated-with-improved-overall-survival-in-us-hispanic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-haploidentical-transplantation-with-umbilical-cord-blood-co-infusion-in-aplastic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adaptive-rebalancing-of-ros-composition-averts-lsd1-inhibitor-induced-oxidative-stress-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-randomized-placebo-controlled-phase-1-trial-in-healthy-volunteers-investigating-safety-pharmacoki 2026-08-17 monthly 0.7 https://rjrindex.com/articles/navigating-the-complement-cascade-a-multicenter-journey-from-pegcetacoplan-to-iptacopan-in-paroxysm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-differentiation-stage-drives-mechanisms-of-apoptosis-evasion-in-waldenstrom-macroglobulinemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiologic-clues-current-management-and-diagnostic-trends-in-idiopathic-budd-chiari-syndrome-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-ing-study-a-prospective-evaluation-of-geriatric-patient-reported-and-frailty-assessments-to-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-incidence-of-delayed-methotrexate-elimination-in-pediatric-patients-with-philadelphia-chro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ai-based-characterization-of-terminal-erythroid-differentiation-as-a-prognostic-biomarker-in-myelody 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-fludarabine-the-impact-of-fludarabine-renal-dose-adjustment-during-lymphodepletion-prior 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevation-of-fetal-hemoglobin-is-a-biomarker-for-response-to-decitabine-in-aml-results-of-the-aml21 2026-08-17 monthly 0.7 https://rjrindex.com/articles/short-survival-with-bcma-and-gprc5d-dual-antigen-exposed-relapsed-myeloma-an-international-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intratumoral-b-cell-diversity-in-follicular-lymphoma-revealed-by-single-cell-paired-transcriptome-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flp-r-a-clinical-prediction-model-for-follicular-lymphoma-prognosis-in-the-relapsedrefractory-sett 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genoprime-perturb-seq-functional-dissection-of-gata2-variants-via-simultaneous-genotyping-coupled-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-clonal-hematopoiesis-and-braf-mutation-status-on-clinical-outcomes-in-melanoma-patients-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-patient-characteristics-of-venetoclax-combination-time-limited-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-academic-center-effect-better-outcomes-for-patients-with-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-standard-and-modified-daratumumab-based-therapy-in-al-amyloidosis-a-cohort-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/infection-risk-factors-and-burden-in-patients-treated-with-t-cell-engaging-bispecific-antibodies-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/race-agnostic-models-maintain-accuracy-in-predicting-m-protein-levels-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/profile-of-ndmm-patients-who-remain-progression-free-at-10-years-treated-with-rvd-induction-and-risk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-for-infections-in-the-real-world-setting-in-newly-diagnosed-myeloma-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concizumab-plasma-concentration-measurements-for-personalized-dose-adjustment-in-patients-with-hemop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characterization-of-the-rare-g6pd-pawnee-variant-a-five-patient-case-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-nk-cells-in-immune-escape-in-patients-with-classical-paroxysmal-nocturnal-hemoglobinuria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-donor-cell-engraftment-in-prenatal-hematopoietic-stem-cell-transplantation-with-novel-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tim3-galectin9-axis-drives-csf-1r-independent-senescent-macrophage-and-tscm-crosstalk-in-chronic-gra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/innovative-sdab-based-car-t-cells-targeting-bcma-outperform-current-car-t-therapies-for-multiple-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-antibiotic-exposure-on-car-t-cell-therapy-outcomes-analysis-in-multiple-myeloma-and-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-versus-second-generation-tki-in-newly-diagnosed-chronic-phase-chronic-myeloid-leukemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polatuzumab-vedotin-zanubrutinib-rituximab-lenalidomide-and-prednisone-pola-zr2p-as-frontline 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammatory-waldenstrom-macroglobulinemia-is-associated-with-monocyte-dysregulation-and-il-1v-produ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-zanubrutinib-combined-with-anti-cd20-monoclonal-antibody-based-regimens-as-fi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/caplacizumab-as-a-pre-emptive-therapy-in-thrombotic-thrombocytopenic-purpura-a-proactive-strategy-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-with-luspatersept-exerts-a-pleiotropic-effect-on-the-molecular-signatures-of-bone-marrow-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-stx-0712-a-ccr2-cytotoxicity-targeting-chimera-cytac-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glofitamab-and-obinutuzumab-globin-as-first-line-therapy-for-patients-with-high-tumor-burden-folli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-3-study-inmind-of-tafasitamab-plus-lenalidomide-and-rituximab-for-relapsed-or-refractory-fol-2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/erythrocyte-membrane-camouflaged-jak1-inhibitor-for-the-treatment-of-hemophagocytic-lymphohistiocyto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idh12-mutations-predict-a-distinct-high-risk-subset-in-philadelphia-chromosome-negative-b-cell-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/only-young-age-and-genetics-retain-prognostic-value-for-2-year-relapse-free-survival-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-disparities-on-incidence-and-survival-in-mantle-cell-lymphoma-a-surveillance-epidemiology-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phylogenetic-reconstruction-reveals-early-divergence-and-late-expansion-of-focal-lesions-in-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-treatment-patterns-and-outcomes-in-primary-cns-lymphoma-of-t-cell-origin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ending-the-undetermined-significance-of-monoclonal-gammopathies-mgus-first-results-of-the-nomorem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-multidisciplinary-quality-improvement-project-standardizing-an-approach-to-scree 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cpg-level-dna-methylation-analysis-identifies-molecular-events-that-are-definitive-of-progressive-li 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complement-induced-procoagulant-platelets-in-patients-with-antiphospholipid-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-pathogenic-alloantibody-generation-using-a-chimeric-hpa-1a-containing-fc-fusion-protein-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cxxc1-is-required-for-irf4-chromatin-binding-and-expression-and-regulates-cellular-fitness-in-lenali 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quantifying-the-impact-of-vancomycin-on-short-and-long-term-renal-function-in-a-contemporary-real-wo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergizing-sickle-cell-extending-healthcare-dollars-through-a-specialized-sickle-cell-program 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-genetic-loci-regulating-plasma-and-platelet-factor-v-expression-in-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-genomic-and-tumor-microenvironment-subtyping-refines-risk-stratification-in-primary-centr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatially-resolved-profiling-reveals-the-perifollicular-border-zone-as-a-key-immunologic-hub-in-foll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-and-outcomes-of-patients-diagnosed-with-chronic-myeloid-leukemia-in-blast-phase-a-multic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcome-of-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-a-15 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mitapivat-in-pediatric-patients-with-pyruvate-kinase-deficiency-who-are-not-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delayed-neurotoxicity-enterocolitis-and-bcma-cart-associated-immune-related-adverse-events-cirae 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparable-survival-with-transplant-free-approach-versus-autologous-stem-cell-transplantation-in-adu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineered-ipsc-derived-nk-cells-targeting-the-siglec7-glyco-immune-checkpoint-improves-anti-tumor-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-data-from-the-phase-iii-study-of-nuvisertib-an-oral-investigational-selective-pim1-inh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-iii-clinical-trial-of-bortezomib-in-combination-with-cpx-351-for-the-treatment-of-newly-diagn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iii-study-admyre-of-plitidepsin-in-combination-with-dexamethasone-vs-dexamethaso 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemotherapy-free-ponatinib-asciminib-achieves-optimal-disease-controlpreallohsct-in-advanced-cm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/soundtrack-b-a-phase-2-single-arm-study-to-evaluate-the-efficacy-and-safety-of-surovatamig-azd0486 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-hematotoxic-tim-3cd70-dual-targeting-car-t-cells-promote-potent-anti-leukemia-activity-against 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prophylactic-dexamethasone-to-reduce-risk-of-cilta-cel-associated-immune-effector-cell-delayed-neuro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-data-from-the-ongoing-phase-1-study-of-the-menin-mll-inhibitor-enzomenib-dsp-5336-in-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revumenib-for-patients-with-relapsed-or-refractory-rr-nucleophosmin-1-mutated-npm1m-acute-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cac-mm-001-anti-bcma-car-t-therapy-followed-by-autologous-stem-cell-transplantation-and-second-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-outcomes-by-age-comorbidities-and-frailty-among-relapsed-or-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-nk-cell-therapy-in-hematologic-malignancies-2019-2025-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-romiplostim-n01-with-or-without-tpo-ra-for-cancer-therapy-induced-thromb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functionally-high-risk-disease-is-associated-with-inferior-outcomes-after-chimeric-antigen-receptor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-progression-free-survival-benefit-with-ciltacabtagene-autoleucel-in-standard-risk-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-efficacy-analysis-of-phase-ii-study-investigating-tyrosine-kinase-inhibitor-tki-and-inotuz 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-with-rituximab-lenalidomide-r2-and-epcoritamab-maintenance-deliver-deep-and-durable 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-intravenous-mosunetuzumab-plus-polatuzumab-vedotin-combination-therapy-continues-to-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-maintenance-with-revumenib-in-children-with-hox-driven-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/durable-efficacy-and-long-term-safety-with-pelabresib-plus-ruxolitinib-in-jak-inhibitor-naive-myelof 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-of-therapies-in-primary-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-golidocitinib-based-first-line-regimen-in-peripheral-t-cell-lymphoma-a-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-sequencing-of-cart-vs-bi-specific-antibody-on-survival-in-relapsedrefractory-large-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/realworld-experience-with-antitfpi-agent-marstacimab-in-severe-and-nonsevere-hemophilia-first 2026-08-17 monthly 0.7 https://rjrindex.com/articles/olverembatinib-hqp1351-demonstrates-efficacy-vs-best-available-therapy-bat-in-patients-pts-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/is-functional-cure-possible-in-follicular-lymphoma-analysis-and-development-of-a-predictive-model-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/precision-in-vivo-car-t-generation-via-clamp-enabled-mrna-delivery-toward-scalable-and-translatable 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-evaluation-methods-and-prognostic-impact-of-flt3-itd-microclones-in-acute-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-prognostic-scoring-system-incorporating-xpo1-for-primary-central-nervous-system-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/grip-strength-predicts-overall-survival-of-patients-with-myelodysplastic-syndrome-in-a-multivariable 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-following-single-unrelated-cord-blood-transplantation-with-atg-conditioning-regime 2026-08-17 monthly 0.7 https://rjrindex.com/articles/model-based-evaluation-of-clinical-outcomes-for-ponatinib-versus-2g-tkis-in-third-line-chronic-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-guided-outcome-analysis-of-ponatinib-plus-hyper-cvad-versus-historical-imatinib-in-ph-positive-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/osteonecrosis-risk-in-adult-all-insights-from-real-world-clinical-laboratory-data-in-eighty-seven-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tracing-malignant-precursor-mutations-and-their-cellular-origins-in-blood-and-bone-marrow-of-primary 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-older-adults-with-triple-class-exposed-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tropomyosin-1-promotes-platelet-adhesion-and-clot-contraction-to-inhibit-thrombosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/qhrd107-cdk9-inhibitor-venetoclax-and-azacitidine-combination-therapy-107va-regimen-in-relapse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-tet2-mutant-clonal-hematopoiesis-in-solid-tumor-immunology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-post-transplant-gilteritinib-maintenance-in-mrd-positive-flt3-itd-acute-myeloi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-adar1-mediated-rna-editing-disrupts-lineage-fidelity-in-human-t-cell-development-by-inducing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-mayo-clinic-enterprise-experience-and-outcomes-of-perioperative-utilization-of-recombinant-facto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relationship-between-salvage-strategy-and-outcomes-in-patients-with-cbf-or-npm1-mutated-aml-and-firs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pediatric-inspired-usc-all-regimen-vs-hyper-cvad-in-adults-with-ph-negative-all-real-world-outcomes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-setting-matters-academic-cancer-centers-deliver-superior-survival-in-malt-lymphoma-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emicizumab-levels-in-patients-with-acquired-and-congenital-hemophilia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-massive-overdose-of-6600mg-enoxaparin-and-its-treatment-with-protamine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplantation-cyclophosphamide-ptcy-combination-with-low-dose-anti-thymocyte-globulin-atg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mavs-mediates-inflammatory-memory-in-hematopoietic-stem-cells-and-promotes-ineffective-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-thrombotic-and-bleeding-events-in-patients-with-mpns-does-ssri-use-have-an-impact 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-adult-acute-lymphoblastic-leukemia-a-multicenter-cohort-stu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-brentuximab-vedotin-versus-standard-therapy-for-cutaneous-t-cell-lymphoma-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-and-safe-administration-of-g-csf-in-aml-patients-treated-with-venetoclax-based-therpy-clinica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-impact-of-non-traumatic-intracranial-hemorrhage-on-outcomes-in-chimeric-antigen-recept 2026-08-17 monthly 0.7 https://rjrindex.com/articles/belumosudil-is-effective-in-patients-with-chronic-graft-versus-host-disease-lasting-more-than-two-ye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-transplantation-and-frontline-therapy-shape-survival-outcomes-in-secondary-aml-real-worl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-immune-thrombocytopenia-on-oral-health-lets-talk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-double-negative-t-cell-therapy-in-aml-patients-with-relapse-post-allo-hsct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maternal-and-fetal-risks-in-patients-with-sickle-cell-disease-results-of-the-retrospective-drepamom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blood-microbial-dna-as-a-non-invasive-diagnostic-surrogate-for-pneumonia-pathogens-in-immunocompromi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-leukemogenic-transmission-via-blood-transfusion-from-genetically-modified-leukemic-mice-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-c-kit-and-flt3-mutations-on-survival-outcomes-in-core-binding-factor-acute-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-analysis-of-salvage-allogeneic-hct-in-acute-leukemia-patients-relapsing-after-autologous 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-universally-accessible-residual-network-assisted-diagnostic-and-analytic-tool-radiant-for-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quantitative-ex-vivo-synergy-profiling-uncovers-heterogeneous-combination-responses-in-aml-primary-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-serum-igg-at-apheresis-predicts-delayed-humoral-immune-reconstitution-and-increased-risk-of-infe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-polatuzumab-based-regimens-among-elderly-patients-with-previously-untreated-diffuse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-the-manufacturing-and-delivery-of-lv2019-car-t-cells-for-relapsed-refractory-dlbcl-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-10-minute-targeted-geriatric-assessment-10-taga-a-10-domain-to-one-score-tool-predicts-early 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-immunodynamic-landscape-of-blinatumomab-therapy-in-pediatric-bcp-all-through-full-spec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-anemia-and-cardiac-arrest-related-mortality-in-adults-aged-25-years-in-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-analyses-of-patient-reported-outcomes-from-the-phase-3-verify-study-of-rusfertide-or-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementation-and-utility-of-measurable-residual-disease-mrd-testing-for-multiple-myeloma-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-pts-with-relapsedrefractory-rr-large-b-cell-lymphoma-lbcl-progressing-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyp3a4-inhibitors-cyp3a4i-and-myelosuppression-in-patients-pts-with-newly-diagnosed-mutant-isoci 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-free-car-therapy-bcma-car-t-cell-derived-exosomes-exhibit-potent-anti-myeloma-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-itacitinib-prophylaxis-for-cytokine-release-syndrome-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-mortality-and-prognostic-factors-in-diffuse-large-b-cell-lymphoma-presenting-with-hemophagocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-transition-readiness-for-sickle-cell-disease-a-high-and-low-income-comparative-analysi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-patients-with-acute-lymphoblastic-leukemia-in-the-aya-population-treated-with-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/persistent-racial-disparities-in-sezary-syndrome-outcomes-despite-use-of-modern-therapies-a-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cdcp1-mesenchymal-stem-cells-preferentially-inhibit-acute-graft-versus-host-diseaseagvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-transplant-atrec-diversity-reflects-thymic-function-and-independently-predicts-mortality-followi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/co-mutation-of-bcor-and-bcorl1-was-associated-with-favorable-outcome-in-the-adverse-risk-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-after-post-transplant-relapse-of-adult-t-cell-leukemia-lymphoma-and-trends-of-salv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-efficacy-of-the-synergistic-ruxolitinib-homoharringtonine-combination-in-tp53-mutated-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advanced-myelofibrosis-is-marked-by-loss-of-nkg2d-and-dnam-1-nk-activating-signaling-and-increased-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hetrombopag-in-the-treatment-of-pediatric-immune-thrombocytopenia-a-real-wor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tbi-based-vs-chemotherapy-based-myeloablative-conditioning-in-t-cell-replete-haploidentical-transpla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inotuzumab-ozogamicin-leads-to-high-rates-of-measurable-residual-disease-negativity-for-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/simplified-frailty-score-for-patients-with-multiple-myeloma-undergoing-autologous-stem-cell-transpla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-plus-rituximab-leads-to-superior-progression-free-and-overall-survival-to-fcr-in-previousl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-broad-spectrum-antibiotic-exposure-on-outcomes-following-autologous-stem-cell-transplantat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-us-real-world-analysis-of-demographics-transplant-patterns-and-survival-outcomes-in-posttranspla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-combination-strategy-of-inotuzumab-ozogamicin-ino-and-bcl-2-family-inhibitors-prevents-the-emerg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changes-in-body-composition-during-early-phases-of-treatment-and-subsequent-risk-of-relapse-in-child 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-antitumor-effects-and-mechanisms-of-kpt-330-combined-with-venetoclax-in-acute-myeloid-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-population-based-outcome-analysis-of-small-lymphocytic-lymphoma-sll-in-british-columbia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/erythroid-specific-inducible-cdan1-mouse-model-phenocopies-congenital-dyserythropoietic-anemia-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/conversion-from-calcineurin-inhibitor-to-ruxolitinib-as-gvhd-prophylaxis-during-patients-with-transp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/microbiota-derived-15-pentanediamine-attenuates-cd19-car-t-function 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-risk-factors-and-survival-impact-of-secondary-myelofibrosis-in-patients-with-myeloprolif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-real-world-experience-of-belumosudil-treatment-in-heavily-pretreated-patients-with-stero 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-ctcs-improve-risk-stratification-according-to-the-second-revision-of-the-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changing-patterns-and-comparative-outcomes-of-watch-and-wait-versus-immediate-therapy-in-cll-a-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dna-methylation-markers-assessed-at-birth-are-associated-with-future-development-of-pediatric-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/user-experience-with-pegcetacoplan-on-body-injector-in-patients-with-paroxysmal-nocturnal-hemoglobin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zap-trial-mrd-guided-chemotherapy-and-maintenance-de-escalation-with-zanubrutinib-g-chop-in-high-ri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-between-efficacy-clonal-dynamics-evolution-and-development-of-bone-marrow-failure-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacological-mechanism-of-action-and-therapeutic-potential-of-a-quantitative-and-qualitative-rbc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/afatinib-boosts-car-t-cell-antitumor-therapeutic-efficacy-via-metabolism-and-fate-reprogramming 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relationship-between-changes-in-quality-of-life-and-social-function-and-treatment-response-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cadance-302-a-phase-3-open-label-randomized-study-of-bgb-16673-compared-with-idelalisib-rituxim 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-long-term-tolerability-with-asciminib-asc-vs-investigator-selected-is-tyrosine-kinase-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-consolidation-phase-blinatumomab-in-newly-diagnosed-b-cell-acute-lymphoblasti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mean-corpuscular-hemoglobin-modulates-hbf-distribution-and-sub-phenotypes-of-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implicating-a-functional-domain-spoc-of-rbm15-in-the-pathogenesis-of-rbm15mkl1-fusion-protein-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/building-healthcare-professional-capacity-in-sickle-cell-disease-through-a-global-case-based-discuss 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-clinical-and-systemic-response-with-combination-radiation-therapy-and-topical-imiquimod-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dna-methylation-episignature-as-a-novel-diagnostic-tool-for-diamond-blackfan-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enteral-supplementation-with-a-tgf-v-enriched-polymeric-diet-mitigates-gastrointestinal-acute-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-extracorporeal-membrane-oxygenation-on-survival-in-critically-ill-adults-with-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-fusions-in-amlmds-an-experience-from-first-400-patients-enrolled-into-myelomatch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transplant-outcomes-for-children-and-adolescents-with-severe-aplastic-anemia-comparing-matched-sibli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-comparison-between-subcutaneous-isa-vrd-from-the-isasocut-study-and-intravenous-isa-vrd-from-the-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2a-study-of-cto1681-for-the-prevention-of-cytokine-release-syndrome-in-patients-with-diff 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-flag-and-clag-regimens-replacing-cyclophosphamide-in-conditioning-for-allog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanisms-of-acute-pain-involve-spinal-il17-tnf-ail-6-p38-mapk-activation-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-teclistamab-plus-daratumumab-combination-therapy-for-high-risk-smoldering-multipl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mettl14-overexpression-identifies-a-biologically-aggressive-subgroup-and-correlates-with-adverse-cli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ktx-1001-a-potent-selective-mmsetnsd2-inhibitor-enhances-immunomodulatory-and-immune-directed-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-in-malignancy-associated-hemophagocytic-lymphohistiocytosis-m-hlh-a-systematic-litera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-overall-survival-in-patients-with-advanced-systemic-mastocytosis-treated-with-avapritinib-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-patterns-due-to-aplastic-anemia-in-the-united-states-a-retrospective-analysis-from-1999-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-individualized-care-plans-on-management-of-acute-pain-in-the-emergency-department 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-spectrum-of-non-malignant-complications-in-germline-ddx41-associated-hematologic-disor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-luspatercept-in-reducing-transfusion-burden-and-its-impact-on-liver-iron-concentration-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-and-risk-of-mortality-after-incident-ischemic-stroke-the-reasons-for-geographi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-donor-engraftment-and-clinical-remission-after-hematopoietic-cell-transplantation-for-vexa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2a-study-of-weekly-decitabine-and-venetoclax-treatment-as-maintenance-therapy-in-high-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-stem-cell-transplantation-versus-consolidation-chemotherapy-as-post-remission-treatment-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-before-and-after-allogeneic-hematopoietic-stem-cell-transplantation-in-adult-patients-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-epidemiological-analysis-of-hematological-malignancies-in-adolescents-and-young-adults 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monoclonal-gammopathy-in-patients-with-type-i-gaucher-disease-data-from-the-russian-gaucher-registr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-the-stromal-microenvironment-on-the-extrinsic-apoptotic-pathway-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intermediate-dose-04-gkg-per-dose-versus-standard-high-dose-10-gkg-per-dose-intravenous-immu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-discontinuation-of-cbtki-based-treatments-in-patients-with-cllsll-in-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dna-based-mrd-monitoring-enhances-risk-stratification-during-tki-dose-reduction-in-cml-evidence-fro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacologic-overactivation-of-alk-activity-by-ptpn2ptpn1-inhibition-induces-a-combination-of-tumo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/home-monitoring-of-neutrophil-counts-by-patients-with-cyclic-and-congenital-neutropenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bispecific-antibody-vs-non-bispecific-antibody-systemic-therapy-as-immediate-next-line-treatment-aft 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-omic-analysis-reveals-metabolic-fitness-of-the-ari0002h-bcma-car-t-cell-infusion-product-as-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-thrombopoietin-tpo-in-stem-cell-mobilization-for-multiple-myeloma-and-lymphoma-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimated-total-cost-of-care-and-patient-out-of-pocket-cost-savings-with-first-line-fixed-duration-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanistic-study-of-the-cullin3-crl3keap1-nrf2-neddylation-axis-in-chemotherapy-resistance-of-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-cell-of-origin-gene-expression-profiles-and-frontline-therapy-in-predic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-haploidentical-hematopoietic-stem-cell-transplantation-in-low-and-middle-income-countri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/second-autologous-transplantation-remains-a-valid-consolidation-option-in-patients-with-relapsed-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fk506-improves-b-cell-reconstitution-after-allo-hsct-compared-to-csa-a-real-world-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-autoimmune-hemolytic-anemia-related-mortality-in-the-us-mexico-border-region-1999 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-exhaustion-limits-cd19-car-t-efficacy-in-richters-transformation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/axicabtagene-ciloleucel-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma-in-chinese-populatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gene-expression-profiles-of-the-nephron-by-urine-mrna-a-liquid-biopsy-to-investigate-molecular-chan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-clinical-and-laboratory-predictor-of-thrombosis-and-bleeding-complicatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/easix-a-new-tool-to-predict-response-and-refractoriness-in-immune-mediated-thrombotic-thrombocytope 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-minimal-residual-disease-and-next-generation-sequencing-discordance-in-aml-following-induc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/srsf2-mutation-induces-bh3-mimetics-sensitivity-via-bcl2l2-mis-splicing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tbi-atg-based-conditioning-regimen-is-a-promising-approach-for-adult-patients-with-refractory-and-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-serum-erythropoietin-level-is-associated-with-unique-clinical-and-genomic-features-respons 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-model-to-predict-risk-of-infection-in-patients-receiving-bispecific-antibody-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-clinical-utility-of-maldi-tof-ms-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dexamethasone-dose-intensity-does-not-improve-6-month-responses-in-newly-diagnosed-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-management-of-severe-anemia-in-the-emergency-department-a-single-center-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hereditary-predisposition-genes-to-hematologic-malignancies-on-transplant-outcomes-and-don 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-associated-with-intraparenchymal-hemorrhage-in-patients-with-acute-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/generation-of-faithful-autochthonous-mouse-models-of-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/methionine-promotes-glycolysis-and-tumor-progression-in-multiple-myeloma-by-enhancing-pou2af1-expres 2026-08-17 monthly 0.7 https://rjrindex.com/articles/germline-predisposition-in-pediatric-malignancies-insights-from-a-retrospective-study-at-dana-farbe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitochondrial-dysfunction-as-a-key-factor-in-the-predisposition-to-14q32-related-myeloid-hematologic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-manufacturing-cd8-central-memory-type-2-t-cells-predict-axicabtagene-ciloleucel-failure-in-larg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/icans-mitigation-in-high-risk-elderly-patients-treated-with-cd28-co-stimulatory-anti-cd19-car-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/absolute-lymphocyte-count-is-predictive-of-response-to-salvage-therapies-for-post-car-t-failure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-hydrochloride-liposome-gemcitabine-vinorelbine-with-or-without-anti-cd20-antibody-gv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-analysis-of-the-role-of-magnesium-in-transplant-associated-thrombotic-microangiopathy-vi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mesenchymal-stromal-cells-in-the-prophylaxis-of-graft-vs-host-disease-a-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/umbilical-cord-blood-microtransplantation-improves-the-prognosis-of-patients-with-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/uncovering-survival-linked-genes-in-dlbcl-a-transcriptomic-analysis-of-1311-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-ropeginterferon-alfa-2b-under-its-hidat-regimen-for-the-treatment-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-allogeneic-hematopoietic-stem-cell-transplantation-in-infant-acute-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-cardiovascular-mortality-in-hodgkin-and-non-hodgkin-lymphoma-a-nationwide-analysis-from-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subtotal-versus-total-splenectomy-in-children-with-sickle-cell-disease-clinical-outcomes-and-spleni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-insights-and-changes-in-survival-of-erdheim-chester-disease-over-time 2026-08-17 monthly 0.7 https://rjrindex.com/articles/automated-multi-source-data-consensus-classification-of-low-frequency-variants-in-hematologic-malign 2026-08-17 monthly 0.7 https://rjrindex.com/articles/csf-1r-macrophages-orchestrate-human-skin-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monocyte-t-cells-crosstalk-orchestrates-early-graft-versus-leukemia-immunity-in-acute-myeloid-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-in-chronic-lymphocytic-leukemia-over-two-decades-a-seer-based-population-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/all-trans-retinoic-acid-and-rarv-agonists-enhance-the-efficacy-of-imid-based-treatments-for-t414 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-genomic-shifts-associated-with-disease-transformation-in-patients-with-polycythemia-ver 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changes-in-complete-blood-count-cbc-and-white-blood-cell-wbc-differential-associated-with-overwe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myc-super-enhancer-dynamics-in-t-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-itd-drives-poor-prognosis-in-npm1-mutated-aml-via-bcat1-dependent-epigenetic-regulation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blood-and-filters-the-intersection-of-myelodysplastic-syndrome-and-renal-failure-in-us-mortality 2026-08-17 monthly 0.7 https://rjrindex.com/articles/personalized-prognostic-model-for-multiple-myeloma-patients-using-continuous-variables 2026-08-17 monthly 0.7 https://rjrindex.com/articles/balancing-efficacy-and-safety-il-15-bcma-car-t-cells-vs-2nd-generation-car-t-in-preclinical-myelom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/s2005-a-phase-ii-randomized-study-comparing-ibrutinib-and-rituximab-ir-vs-venetoclax-and-rituxim 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-serum-h-ferritin-and-its-imbalance-with-l-ferritin-distinguish-hemophagocytic-lymphohistio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-car-t-cell-therapy-versus-bispecific-antibodies-in-patients-with-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-performance-of-clinical-versus-genomic-machine-learning-prognostic-models-in-aml-a-pris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oncofetal-rna-binding-proteins-igf2bp-suppress-innate-immunity-signaling-pathways-in-leukemia-stem-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytokine-medated-expansion-of-clonal-hematopoiesis-after-cart-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/short-term-il-21-and-gsk-3v-inhibition-enriches-stem-like-cd8-t-cells-and-boosts-cd19-car-t-cell-ef 2026-08-17 monthly 0.7 https://rjrindex.com/articles/designing-immune-evasive-ucar-t-cells-to-overcome-allogeneic-barriers-and-advance-off-the-shelf-immu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-epidemiological-trends-in-nodular-lymphocyte-predominant-hodgkin-lymphoma-nlphl-englan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delivery-of-hfe-mrna-by-lipid-nanoparticles-corrects-iron-parameters-and-bmp-responsiveness-in-murin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-asc-demonstrates-continued-improvement-in-patient-reported-outcomes-pros-vs-investigat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ol-101-a-bcmagprc5d-dual-targeting-autologous-car-t-for-relapsed-refractory-multiple-myeloma-rr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/observational-comparison-of-orca-t-to-registry-based-post-transplant-cyclophosphamide-patients-using 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ferritin-reference-ranges-and-improving-diagnosis-of-iron-deficiency-without-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nxt007-prophylaxis-in-people-with-hemophilia-a-with-or-without-fviii-inhibitors-a-global-phase-iii 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-benefit-of-luspatercept-in-erythropoiesis-stimulating-agent-esa-naive-patients-pts-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glp1-receptor-agonists-and-clonal-hematopoiesis-early-human-signals-of-antiinflammatory-clone-mit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-of-iron-deficiency-in-pregnant-women-with-inherited-bleeding-disorders-a-retrospective-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictive-model-based-on-post-car-t-cell-therapy-cytokine-signature-can-help-predict-cytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-new-or-worsening-anemia-and-thrombocytopenia-on-clinical-outcomes-in-jak-inhibitor-naive-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-momelotinib-exposure-and-hemoglobin-improvement-in-patients-with-myelofibrosis-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genome-editing-for-treatment-of-jak2-v617f-driven-myeloproliferative-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-research-on-the-immune-microenvironment-of-patients-with-relapse-or-refractory-diffuse-large-b-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-aml-patients-most-likely-to-benefit-from-venetoclax-using-apoptotic-gene-ratios 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-demonstrates-superior-overall-survival-and-favorable-safety-of-avapritinib-over 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hyper-cvad-versus-hyper-cvad-plus-blinatumomab-for-adult-patients-with-newly-diagnosed-philadelphia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quality-of-life-and-organization-of-care-in-patients-with-chronic-myeloid-leukemia-cml-within-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-test-characteristics-of-mass-spectrometry-monoclonal-protein-monitoring-in-multiple-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tsc-101-eliminates-recipient-hematopoietic-cells-and-demonstrates-potential-for-improved-relapse-fre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-outcomes-including-post-transplant-survival-are-seen-independent-of-baseline-skin-burden-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-post-hoc-safety-analysis-of-fixed-duration-acalabrutinib-venetoclax-combinations-vs-chemoimmunothe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-measurable-residual-disease-mrd-in-light-chain-amyloidosis-the-added-value-of-durabilit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synthetic-lethal-targeting-of-psmc2-dependent-p97-adapted-proteasome-complexes-that-confer-chemoresi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-2-study-of-subcutaneous-isatuximab-plus-bortezomib-lenalidomide-and-dexamethason 2026-08-17 monthly 0.7 https://rjrindex.com/articles/absence-of-circulating-tumor-cells-ctcs-defines-a-subtype-of-multiple-myeloma-mm-patients-pts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/replacing-fish-with-a-comprehensive-integrated-approach-for-tumor-genotyping-and-immune-monitoring-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/three-year-follow-up-of-the-phase-1-first-in-human-study-investigating-surovatamig-a-novel-cd19xcd3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-and-rapid-detection-of-genomic-alterations-in-pediatric-leukemias-using-whole-genome-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-bispecific-t-cell-engagers-in-mm-patients-with-central-nervous-system-cns-involvement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-azacitidine-venetoclax-and-gilteritinib-in-patients-with-newly-diagnosed-fl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nf-kb-is-a-potential-therapeutic-target-for-histone-deacetylase-inhibitor-resistant-cutaneous-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zamtocabtagene-autoleucel-a-tandem-cd20-cd19-directed-car-t-cell-therapy-as-second-line-treatment-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bnp-promotes-platelet-activation-and-thrombosis-via-its-receptor-natriureticpeptide-receptor-a-npra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-risk-integration-for-survival-modeling-prism-in-newly-diagnosed-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-influence-of-age-on-patient-reported-outcomes-pros-endpoints-on-the-s1826-cross-network-phase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/robust-hbf-induction-and-improvement-of-anemia-and-hemolysis-with-base-editing-in-sickle-cell-diseas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-melphalantbi-based-conditioning-regimens-mcactcac-for-autologous-hsct-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-elranatamab-nirogacestat-in-patients-with-relapsed-or-refractory-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analysis-of-cd34-cells-in-myelofibrosis-highlights-their-role-in-extracellular-matri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-data-comparison-of-asciminib-40-mg-twice-daily-vs-80-mg-once-daily-in-chronic-myeloid-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-hypomethylating-agent-failure-in-patients-with-myelodysplastic-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-mantle-cell-lymphoma-frontline-induction-response-assessments-in-the-ecog-acrin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-platelet-autoantibody-prevalence-serology-and-predictive-value-for-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-data-from-the-prioritizing-utilization-and-safety-of-hydroxyurea-using-precision-in-africa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-endothelial-extracellular-vesicles-from-sickle-cell-patients-promote-susceptibility-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypomethylation-agent-improves-late-stage-megakaryocyte-maturation-in-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-outcomes-for-sickle-cell-disease-with-support-staff-driven-interventions-a-scoping-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-immune-and-proteomic-profiling-predicts-response-and-resistance-to-cd19-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/galectin-3-in-host-murine-models-lessens-the-severity-of-graft-versus-host-disease-by-preserving-int 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-angiogenic-proteins-placental-growth-factor-plgf-and-soluble-fms-like-tyrosine-k 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-continuum-of-inherited-telomere-dysfunction-links-tert-rare-variants-to-age-related-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematologic-predictors-of-serious-infection-and-impact-of-serious-infection-on-long-term-mortality-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-mixed-methods-evaluation-of-american-society-of-hematologys-ash-clinical-guidelines 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dyrk1a-interacts-with-ezh2-to-regulate-transcriptionally-active-chromatin-in-myeloid-leukemia-associ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exacerbation-of-anemia-from-hereditary-spherocytosis-during-pregnancy-characterization-of-severity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endothelial-cell-derived-thrombospondin-1-negatively-affects-hematopoietic-function-during-aging 2026-08-17 monthly 0.7 https://rjrindex.com/articles/using-fxia-triggered-thrombin-generation-to-assess-the-risk-of-breakthrough-bleeding-in-patients-rec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-based-risk-score-derived-from-bulk-and-single-cell-transcriptomics-enhances-prognostic-strati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasma-cell-leukemia-a-single-institution-review-of-cases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapy-related-malignancies-in-myeloma-seer-comparison-of-imid-vs-anti-cd38-eras 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-predictors-of-mortality-and-conduction-disease-in-al-cardiac-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nsd2-inhibition-suppresses-t414-gene-expression-and-oncogenic-signaling-to-impair-proliferation-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/recurrent-loss-of-chromosome-y-in-multiple-myeloma-is-linked-to-disease-progression-and-altered-tumo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-burden-of-treatment-with-parenteral-hypomethylating-agents-in-combination-with-venetoclax-among 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-m5c-binding-protein-yb-1-modulates-proteasome-inhibitors-resistance-in-multiple-myeloma-via-epig 2026-08-17 monthly 0.7 https://rjrindex.com/articles/consensus-on-optimal-use-of-fixed-duration-btk-inhibitor-and-venetoclax-therapy-in-cll-a-delphi-stu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-preliminary-safety-and-efficacy-of-mosunetuzumab-plus-ice-or-dhax-salvage-chemotherapy-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-preexisting-mental-health-disorders-and-psychiatric-pharmacotherapy-on-hospital-length-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-outcomes-and-toxicities-of-loncastuximab-tesirine-lonca-in-relapserefractory-rr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anatomical-localization-based-analysis-of-de-novo-secondary-cns-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-therapy-with-fitcy-preparative-regimen-for-patients-above-the-age-of-70-years-with-active 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-diagnostic-hematology-clinic-pilot-program-increasing-access-and-optimizing-resources 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-dynamics-of-flt3-itd-positive-acute-myeloid-leukemia-following-relapse-after-allogeneic-stem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-daratumumab-in-relapserefractory-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-of-hemophilia-and-hemophilia-carriers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-lenalidomide-zanubrutinib-plus-obinutuzumab-in-patients-with-flipi2-high-risk-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-association-of-a-novel-psychosocial-and-mobility-assessment-with-outcomes-of-veterans-with-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-in-leukemia-and-heart-failure-associated-mortality-a-cdc-wonder-database-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-race-and-socioeconomics-on-access-to-t-cell-engaging-therapy-in-us-patients-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-preferences-and-factors-affecting-patient-treatment-decisions-for-chronic-lymphocytic-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-p16ink4a-expression-in-sickle-cell-disease-correlates-with-diminished-social-functioning-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unmasking-hlh-a-bcor-mutation-as-the-hidden-driver-of-immune-dysregulation-and-fulminant-hepatic-fa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytokine-score-for-prognostication-of-newly-diagnosed-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-first-line-selinexor-plus-bortezomib-lenalidomide-and-dexamethasone-xvrd-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-to-evaluate-the-safety-and-efficacy-of-autologous-car-t-cells-with-dual-targeti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/direct-comparison-of-crovalimab-versus-eculizumab-in-paroxysmal-nocturnalhemoglobinuria-a-systemati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-pulmonary-involvement-in-idiopathic-multicentric-castleman-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/testing-for-hereditary-a-tryptasemia-hat-tpsab1-copy-number-analysis-by-droplet-digital-pcr-gen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combined-assessment-of-circulating-tumor-cells-ctcs-and-measurable-residual-disease-mrd-for-dyna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-mortality-attributed-to-agranulocytosis-in-myeloid-leukemia-among-older-adults-in-the-united 2026-08-17 monthly 0.7 https://rjrindex.com/articles/foxp3-and-helios-expressing-cd4-t-conventional-cells-are-a-regulatory-like-subset-that-is-induced-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-mucosal-complications-in-chronic-granulomatous-disease-a-role-of-nox2-oxidase-in-regulating-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-early-toxicities-treatment-modifications-and-outcomes-with-daratumumab-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-t-cell-population-dynamics-of-glofitamab-monotherapy-in-relapsedrefractory-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/remodeling-the-bone-marrow-tumor-microenvironment-with-cart-cell-therapy-to-overcome-resistance-in-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/investigating-belumosudil-in-children-with-refractory-moderate-to-severe-chronic-graft-versus-host-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacologic-drugging-of-bcl-2-during-manufacturing-restores-t-cell-fitness-and-enhances-cart-effic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delayed-pulmonary-embolism-following-oocyte-retrieval-in-invitro-fertilization-a-neglected-risk-fac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-thrombotic-thrombocytopenic-purpura-in-armenia-a-case-series-highlighting-the-role-of-early 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aml-blasts-and-monocytic-myeloid-derived-suppressor-cells-m-mdsc-inhibit-human-mucosal-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/p300cbp-acetyltransferase-inhibition-and-degradation-disrupt-oncogenic-transcriptional-programs-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-differences-in-car-t-cell-therapy-outcomes-based-on-sex-in-patients-with-large-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-cd117-with-engineered-invariant-natural-killer-t-cells-inkt-cells-as-a-novel-approach-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-chimeric-antigen-receptor-car-t-cell-therapy-in-richter-transformation-a-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/akatsuki-third-interim-analysis-safety-of-emicizumab-during-and-after-immune-tolerance-induction-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/silver-nanoparticles-trigger-proteotoxicity-in-multiple-myeloma-cells-via-a-mechanism-distinct-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ras-g12-and-q61-codon-mutations-confer-distinct-disease-characteristics-in-acute-myeloid-leukemia-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-sars-cov-2-infection-covid-19-vaccines-and-immune-thrombocytopenia-in-adults-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-thrombocytopenic-purpura-related-mortality-trends-among-the-united-states-population-a-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-early-dose-escalation-and-treatment-duration-on-hematologic-response-in-ropeginterferon-al 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bilateral-optic-nerve-infiltration-in-pediatric-acute-promyelocytic-leukemia-a-rare-and-aggressive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ptp4a3-a-potential-therapeutic-target-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-heterogeneity-of-acute-myeloid-leukemia-under-nutrient-and-chemotherapy-stress 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combined-biparatopic-nanobody-based-b-cell-maturation-antigen-chimeric-antigen-receptor-t-cell-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-powered-integration-of-global-proteomics-and-ex-vivo-sensitivity-unveils-a-protein 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-tumor-volume-is-an-independent-predictor-of-worse-survival-in-57-elderly-patients-with-dlb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/socioeconomic-inequalities-and-health-related-quality-of-life-profile-of-patients-with-myelodysplast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decisions-about-gene-therapy-do-not-occur-in-isolation-co-development-of-a-website-about-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-blast-and-blast-mol-risk-models-in-chronic-myelomonocytic-leukemia-mayo-humanitas-col 2026-08-17 monthly 0.7 https://rjrindex.com/articles/occurrence-of-immune-mediated-inflammatory-disorders-imids-during-the-course-of-myelodysplastic-sy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-cytoreduction-on-thrombotic-and-bleeding-outcomes-in-patients-with-myeloproliferative-neop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-specific-prognostic-performance-of-eln-2022-eln-2024-and-beat-aml-2024-a-real-world-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/secondary-type-acute-myeloid-leukemia-is-associated-with-a-higher-risk-of-invasive-fungal-infection 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-crs-and-nt-with-bispecific-antibodies-data-from-the-american-bispecifics-and-cart 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transformed-fl-shows-improved-survival-after-car-t-cell-therapy-compared-to-de-novo-lbcl-but-early 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-hematology-education-through-structured-case-based-learning-and-formal-assessment-an-appr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-use-of-complex-innovative-trial-designs-in-hematologic-vs-solid-tumors-a-cross-sectiona 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-assistance-for-drug-cost-sharing-highlighting-the-variability-across-pharmaceutical-manufac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/divergence-in-post-traumatic-stress-disorder-status-between-children-receiving-hematopoietic-stem-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prophylaxis-with-thiotepa-and-high-dose-methotrexate-showed-lower-central-nervous-system-relapse-rat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-strategy-to-circumvent-venetoclax-resistance-in-relapsedrefractory-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cladribine-based-low-intensity-therapy-is-safe-and-effective-in-patients-with-newly-diagnosed-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-plus-mitoxantrone-hydrochloride-liposome-and-azacitidine-as-first-line-treatment-for-adul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-arthroplasty-in-persons-with-hemophilia-a-survey-of-medicare-data 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-cll-type-mbl-and-chip-are-associated-precursor-conditions-insights-from-mayo-clinics-mbl-scree 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-resistance-to-glucocorticoids-in-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/physiologic-oxygen-expansion-of-murine-lineage-negative-bone-marrow-cells-enhances-lymphocyte-recove 2026-08-17 monthly 0.7 https://rjrindex.com/articles/congenital-factor-ii-deficiency-presenting-with-recurrent-thrombosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-clonal-hematopoiesis-and-the-clinical-impact-of-myeloid-somatic-mutations-on-hematolog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/geographic-demographic-and-risk-factor-burden-of-multiple-myeloma-in-the-united-states-insights-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-score-and-survival-outcomes-for-multiple-myeloma-patients-with-disease-refractory-to-bcma-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-feasibility-of-peripheral-blood-based-mrd-monitoring-using-the-miselect-r-aml-mrd-assay-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-potential-drug-to-overcome-the-venetoclax-resistance-challenge-in-aml-mitoxantrone-hydrochloride 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gut-colonization-with-mdr-gram-negative-organisms-and-its-impact-on-bacteremia-and-sepsis-developmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-combination-of-ruxolitinib-and-the-cdk46-inhibitor-abemaciclib-demonstrates-safety-and-efficacy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/large-language-models-mediated-extraction-of-clinical-information-from-bone-marrow-biopsy-pathology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nutrition-needs-assessment-for-sickle-cell-disease-throughout-the-lifespan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-treatment-intensity-and-prognostic-model-performance-in-older-aml-insights-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-novel-post-transplant-cyclophosphamide-ptcy-and-abatacept-aba-graft-versu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cfdna-analysis-for-assessing-spatial-genomic-heterogeneity-in-multiple-myeloma-with-high-metabolic-u 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cladribine-based-salvage-chemotherapy-in-aml-patients-with-persistent-or-recurrent-disease-after-ven 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-11b-dose-escalation-and-expansion-of-cpx-351-in-combination-with-gemtuzumab-ozogamicin-in-new 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-cpx-351-in-younger-patients-amplt60-years-with-newly-diagnosed-second 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-driven-insights-in-sickle-cell-disease-results-from-a-global-survey-informing-public-health 2026-08-17 monthly 0.7 https://rjrindex.com/articles/no-overall-increased-risk-of-death-or-cardiovascular-disease-in-individuals-with-sickle-cell-trait 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-models-improve-survival-prediction-in-dlbcl-analysis-from-the-goya-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-muscle-and-fat-metrics-and-their-association-with-outcomes-following-car-t-cell-therapy-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-nqo1-expression-mediates-proteasome-inhibitor-resistance-and-predicts-adverse-outcomes-in-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-dna-damage-sensing-and-tp53-function-as-modulators-of-sensitivity-to-calicheamicin-based-ant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elucidating-the-chronological-relationship-between-central-venous-line-dysfunction-infection-and-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unravelling-the-biological-and-clinical-features-of-childhood-b-cell-precursor-acute-lymphoblastic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-machine-learning-analysis-for-automatic-recognition-of-b-all-mrd-level-in-flow-cytometry 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reveal-mm-retrospective-evaluation-of-variables-in-early-assessment-and-landmark-trends-in-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-transplant-nutritional-status-and-hospitalization-risk-in-outpatient-hematopoietic-stem-cell-tra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-coagulation-defects-related-mortality-in-adults-in-the-united-states-a-retrospective-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tfh-subsets-in-patients-after-allogenic-transplant-are-dysregulated-prior-to-chronic-gvhd-developmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-car-t-cell-responses-in-lymphoma-through-coadministration-of-vaccine-educated-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/access-to-diagnostics-therapies-and-advanced-care-for-lymphoma-in-latin-america-a-multicenter-su 2026-08-17 monthly 0.7 https://rjrindex.com/articles/scalable-production-and-anti-tumor-efficacy-of-ipsc-derived-immortalized-anti-cd19-car-macrophages 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-of-newly-diagnosed-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-using-hyp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-national-cancer-database-study-of-survival-trends-in-patients-with-classical-hodgkin-lymphoma-imp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiac-complete-response-in-al-amyloidosis-phenotypic-characteristics-functional-recovery-and-su 2026-08-17 monthly 0.7 https://rjrindex.com/articles/two-decades-of-risk-directed-therapy-for-childhood-acute-lymphoblastic-leukemia-in-a-resource-limite 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-clinically-significant-systemic-methotrexate-absorption-following-intratheca 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-teclistamab-in-relapsedrefractory-multiple-myeloma-and-severe-renal-failur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/map2k1-and-map2k2-genes-alterations-in-hairy-cell-leukemia-and-hairy-cell-leukemia-variant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/potential-biomarkers-and-mechanisms-in-central-nervous-system-involvement-of-kmt2a-rearranged-b-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vacarme-analysis-of-humoral-protection-at-baseline-and-after-vaccination-in-patients-with-refracto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/irregulab-automated-interpretation-of-irregular-antibody-panels 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-bone-marrow-biopsy-utility-in-patients-with-unexplained-cytopenias 2026-08-17 monthly 0.7 https://rjrindex.com/articles/community-health-worker-training-for-sickle-cell-disease-education-in-the-consortium-for-newborn-scr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-immune-proteomic-atlas-of-300-million-bone-marrow-cells-reveals-prognostic-cell-states-in-multipl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-dynamic-landscape-of-immune-environment-for-mm-patients-receiving-t-cell-redirectiing-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-improvement-of-renal-function-by-complement-inhibitors-in-patients-with-paroxysmal-nocturnal-hem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intracellular-iron-levels-alter-the-protein-interactome-of-pcbp1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-deep-vein-thrombosis-and-pulmonary-embolism-as-multiple-causes-of-death-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-progressive-kidney-impairment-among-patients-with-polycythemia-vera-pv-are-recapi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-loncastuximab-tesirine-in-heavily-pretreated-and-high-risk-relapsedrefractory-lar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-pre-existing-mental-health-history-and-higher-risk-of-mental-health-outcomes-pos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/laboratory-characteristics-of-monoclonal-gammopathy-of-undetermined-significance-mgus-in-a-diverse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mass-spectrometry-based-screening-for-monoclonal-gammopathy-in-individuals-undergoing-physical-exami 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-fludarabine-exposure-using-pharmacokinetic-modeling-in-pediatric-patients-receiving-tisag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-aml-with-an-idh2-r172k-mutation-have-improved-overall-survival-with-venetoclax-azaci 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-value-of-advanced-genomic-testing-in-adult-philadelphia-negative-b-all-results-from-the-cz 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prok1-locus-variant-identified-as-a-genetic-determinant-of-anthracycline-related-cardiomyopathy-in-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-and-long-term-hematologic-and-neurologic-outcomes-of-igm-related-neuropathy-a-single-cen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/better-renal-response-with-daratumumab-in-patients-with-monoclonal-immunoglobulin-deposition-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-nutrition-and-exercise-to-optimize-muscle-and-adiposity-in-adolescents-and-young 2026-08-17 monthly 0.7 https://rjrindex.com/articles/study-on-the-efficacy-and-safety-of-hdac-inhibitor-combined-with-venetoclax-and-azacitidine-in-the-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-study-on-thrombopoietin-receptor-agonists-combined-with-rituximab-in-the-treatment-of-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iguratimod-plus-low-dose-rituximab-as-second-line-treatment-in-adults-with-primary-immune-thrombocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-growing-burden-of-high-body-mass-index-associated-hematological-cancer-mortality-in-the-united-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-utilization-and-cost-of-molecular-targeted-versus-non-targeted-therapies-in-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-essential-thrombocythemia-on-in-hospital-outcomes-and-thrombotic-complications-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-cost-prediction-in-pediatric-allogeneic-bone-marrow-transplantation-developm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factor-bb-as-a-biomarker-during-breakthrough-hemolysis-in-paroxysmal-nocturnal-hemoglobinuria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-car-t-cell-therapy-versus-bispecific-antibodies-in-patients-with-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-gemox-achieves-durable-ampgt2-year-remissions-in-relapsedrefractory-rr-2l-diff 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glp-1-agonist-use-is-associated-with-reduced-risk-of-multiple-myeloma-in-type-ii-diabetes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-breakthrough-hemolysis-in-patients-with-paroxysmal-nocturnal-hemoglobinuria-treat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-clinical-characteristics-of-patients-with-chronic-lymphocytic-leukemia-cll-from-11-latin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neomorphic-chromatin-engagement-and-epigenetic-reprogramming-by-the-ikzf1-n159y-tandem-duplication-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-incidence-of-impaired-graft-function-after-allogeneic-hsct-for-myelofibrosis-and-successful-ut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-nras-andor-kras-mutations-on-post-transplant-outcomes-in-acute-myeloid-leukemia-a-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/melphalan-weight-based-dosing-in-overweight-and-obese-patients-undergoing-autologous-transplant-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-among-patients-with-newly-diagnosed-npm1-mutated-acute-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-in-post-cbtki-cllsll-final-update-from-the-phase-12-bruin-study-with-more-than-5-ye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimating-incidence-and-prevalence-of-polycythemia-vera-and-associated-eligibility-for-cytoreductiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/locational-patterns-and-ecological-catalysts-of-cutaneous-t-cell-lymphoma-insights-from-a-louisiana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognostic-analysis-of-non-hodgkins-lymphoma-with-paraproteins-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-laboratory-findings-in-adults-with-sickle-cell-disease-which-increase-risk-for-severe-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/experience-with-minor-surgeries-in-people-with-hemophilia-a-or-b-with-and-without-inhibitors-receivi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolution-of-care-and-outcomes-of-kidney-transplantation-in-plasma-cell-dyscrasias-a-single-center 2026-08-17 monthly 0.7 https://rjrindex.com/articles/recruitment-strategies-and-enrollment-for-an-ongoing-virtually-supervised-prehabilitation-exercise-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dysregulation-of-the-complement-system-in-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-safety-and-efficacy-of-pirtobrutinib-in-adults-with-immune-thrombocytopenia-a-phase-12-dose-fi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/poor-neutrophil-recovery-following-cd19-targeted-car-t-cell-therapy-predicts-inferior-outcomes-in-ad 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-two-distinct-human-hematopoietic-stem-cell-subsets-and-their-age-dependent-dynamic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/limitations-of-the-iwg-mrteln-response-criteria-in-defining-post-transplant-remission-and-clinical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/short-course-glofitamab-enables-effective-bridging-to-car-t-therapy-in-b-nhl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/carfilzomib-lenalidomide-and-dexamethasone-krd-versus-bortezomib-lenalidomide-and-dexamethasone 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-iii-open-label-multicenter-dose-escalation-and-expansion-study-of-lbl-03 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-genetic-testing-in-diagnosing-patients-with-severe-congenital-neutropenia-results-from-path 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-ii-study-of-ziftomenib-monotherapy-in-unfit-patients-with-newly-diagnosed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/excellent-long-term-outcomes-after-alemtuzumab-based-hematopoietic-cell-transplantation-hct-for-se 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-multicenter-study-on-stem-cell-mobilization-using-eap-regimen-as-first-line-mobilizat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discovery-of-jak2v617f-mutant-specific-allosteric-inhibitors-for-the-treatment-of-myeloproliferative 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-clinical-benefit-of-glofitamab-plus-gemcitabine-and-oxaliplatin-gemox-versus-rituximab-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-talquetamab-teclistamab-in-patients-with-relapsedrefractory-multiple-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/teclistamab-induced-rapid-and-deep-hematologic-response-in-relapsedrefractory-light-chain-amyloidos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combination-of-mitoxantrone-hydrochloride-liposome-with-chidamide-in-patients-with-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-subcutaneous-mosunetuzumab-continues-to-demonstrate-high-rates-of-durable-responses-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-cd34-cell-mobilizations-collections-and-comparable-safety-profile-with-fixed-dose-versus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-composite-end-points-toxicityprogression-free-survival-tfpfs-and-toxicity-free-complete-rem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vitamin-d-deficiency-as-a-predictive-and-prognostic-tool-in-aggressive-lymphomas-in-peru-a-multicen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-fh-folr1-car-t-for-pediatric-patients-with-folr1cbfa2t3glis2-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-single-agent-subcutaneous-blinatumomab-in-adults-with-relapsedrefractory-rr-b-cell-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-nicotinamide-metabolism-by-the-novel-nampt-inhibitor-ot-82-potentiates-venetoclax-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-gemcitabine-vinorelbine-and-liposomal-doxorubicin-as-second-line-therapy-in-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multimodal-assessment-of-chronic-myelomonocytic-leukemia-with-extramedullary-involvement-reveals-ras 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapcabtagene-autoleucel-ytb323-for-patients-with-first-line-high-risk-large-b-cell-lymphoma-phase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unleashing-intrinsic-inflammation-in-aml-using-therapeutic-cytokines-overcomes-pro-survival-pathways 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selinexor-in-combination-with-venetoclax-and-azacitidine-for-newly-diagnosed-nd-unfit-acute-myeloi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-results-of-a-phase-ib-investigation-of-the-lsd1-inhibitor-iadademsta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tagraxofusp-azacitidine-and-venetoclax-tag-aza-ven-triplet-therapy-shows-efficacy-tolerability 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-infections-after-bispecific-antibodies-targeting-anti-b-cell-maturation-antig 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-prevalence-and-clinical-outcomes-of-myelofibrosis-with-and-without-cytopenia-in-the-unit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-polatuzumab-vedotin-based-regimens-for-elderlyfrail-dlbcl-patients-a-real-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-study-results-of-orelabrutinib-in-combination-with-rituximab-for-treatment-naive-margina 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nonclinical-evaluation-of-apl-4098-a-novel-gcn2-kinase-inhibitor-reveals-potent-anti-leukemic-effe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cumulative-burden-of-myelodysplasia-related-gene-mutations-is-associated-with-poor-leukemia-free-sur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/redefining-the-myeloid-disease-continuum-machine-learning-based-development-and-validation-of-an-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diverse-signaling-and-vulnerabilities-accompany-distinct-btk-mutations-associated-with-clinical-resi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-consolidation-with-cemacabtagene-ansegedleucel-cema-cel-in-patients-with-large-b-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-age-genomic-features-and-treatment-outcomes-in-older-versus-younger-adults-with-acute-myeloi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fat-pad-biopsy-versus-target-organ-biopsy-in-systemic-al-amyloidosis-detection 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-spliceosome-mutant-myelodysplastic-neoplasms-and-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vitro-evidence-supporting-the-use-of-exogenous-il-2-support-for-allogeneic-ucart22-cells-to-treat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gene-regulatory-axes-of-diffuse-large-b-cell-lymphoma-subtypes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-tph-cells-as-prognostic-drivers-of-angioimmunoblastic-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/does-intensive-consolidation-confer-a-clinical-advantage-over-continued-less-intensive-therapy-in-el 2026-08-17 monthly 0.7 https://rjrindex.com/articles/birc5-inhibition-as-a-novel-approach-to-target-ras-mutant-and-drug-resistant-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complete-donor-chimerism-following-deceased-donor-liver-transplant-in-an-adolescent-with-hepatitis-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-seq-a-sensitive-next-generation-sequencing-based-approach-for-measurable-residual-disease-detec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pulmonary-hypertension-on-in-hospital-outcomes-among-patients-hospitalized-with-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-individuals-with-ddx41-germline-predisposition-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/andean-high-altitude-dwellers-with-the-nfkb1-haplotype-rs230511-are-protected-from-acute-mountain 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-outcomes-for-pediatric-patients-with-de-novo-chronic-myeloid-leukemia-in-blast-phase-throug 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-decade-of-progress-a-comparative-analysis-of-real-world-survival-in-chronic-lymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concomitant-use-of-venetoclax-100-mg-and-ketoconazole-a-strong-cyp3a4-inhibitor-is-clinically-equi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sf3b1-mutations-are-associated-with-shorter-time-to-first-treatment-in-chronic-lymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-a-novel-loop-optimized-bcmacd19-bispecific-car-t-therapy-for-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/establishment-and-validation-of-an-optimized-prognostic-model-for-chinese-patients-with-chronic-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mediastinal-myeloid-sarcoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-prolonged-hospitalization-on-outcomes-in-acute-leukemia-a-national-inpatient-sample-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spermine-alleviates-ev71-induced-inflammation-by-inhibiting-gbp5-and-nlrp3-activation-in-macrophages 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-3-multi-regional-open-label-randomized-study-of-tirabrutinib-vs-rituxi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/obesity-is-associated-with-poor-prognosis-in-ph-like-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-for-predicting-transformation-of-monoclonal-gammopathy-of-undetermined-signi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tonsillar-hypertrophy-as-a-rare-presentation-of-chronic-lymphocytic-leukemiasmall-lymphocytic-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloablative-fractionated-busulfan-fludarabine-cladribine-thiotepa-and-venetoclax-cladillac-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-reprogramming-of-megakaryocyte-subpopulations-in-itp-implications-for-tspo-in-predicting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-palliative-care-utilization-across-health-sectors-in-patients-with-aggressive-non-hodgki 2026-08-17 monthly 0.7 https://rjrindex.com/articles/systematic-molecular-profiling-to-identify-determinants-of-response-to-ibrutinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lower-risk-of-incident-dementia-in-males-but-not-females-with-tet2-clonal-hematopoiesis-a-secondar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differential-trends-in-survival-after-allogeneic-transplantation-for-mds-and-mdsmpn-in-a-real-world 2026-08-17 monthly 0.7 https://rjrindex.com/articles/consideration-of-genomic-determinants-improves-the-diagnostic-accuracy-of-oligomonocytic-chronic-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/5-azacytidine-treatment-reshapes-clonal-structure-and-alters-mutation-dependent-splicing-in-mds-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/innovating-rare-disease-care-a-digital-health-network-for-the-remote-management-of-acquired-hemophi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-pdi-atf6-axis-as-a-novel-treatment-target-in-csf3r-driven-chronic-neutrophilic-leukemia-cnl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multimodal-discovery-of-distinct-tumor-ecosystems-for-classic-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-transplant-conversion-rates-with-gemcitabine-dexamethasone-and-carboplatin-gdp-based-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-car-t-access-barriers-in-washington-and-alaska-a-single-center-experience-prior-to-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/years-of-life-lost-to-multiple-myeloma-remains-high-a-targeted-literature-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-analysis-after-3-months-of-aml-patients-treated-with-venetoclax-azacitidine-first-effect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flagven-as-a-frontline-induction-therapy-for-aml-a-multi-centre-experience-of-anthracycline-free 2026-08-17 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-involvement-in-pediatric-acute-myeloid-leukemia-a-comprehensive-report-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-treatment-outcome-and-complications-of-young-patients-less-than-41-years 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-long-term-survival-in-chronic-lymphocytic-leukemiasmall-lymphocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/super-enhancer-mediated-regulation-of-cd38-inducibility-in-multiple-myeloma-via-the-maftrim47rara 2026-08-17 monthly 0.7 https://rjrindex.com/articles/danicopan-add-on-therapy-demonstrates-positive-efficacy-and-safety-outcomes-in-advanced-age-adults-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-utilization-sequencing-and-outcomes-in-mantle-cell-lymphoma-emerging-treatme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploiting-ras-pathway-addiction-as-a-therapeutic-vulnerability-in-myeloid-sarcoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preoperative-platelet-transfusion-in-cancer-surgery-outcomes-across-and-above-guideline-thresholds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-mutational-burden-as-a-novel-biomarker-of-resistance-to-cd19-car-t-cell-therapy-in-large-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extracellular-matrix-targeting-oligonucleotide-reverses-marrow-fibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-open-label-dose-finding-and-dose-expansion-study-to-evaluate-the-safety-expansio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/alphagenome-enabled-analysis-of-non-coding-regulatory-variants-underlying-rhd-expression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-activity-of-gene-therapy-with-aav8-gba1-ly-m001on-type-i-adults-gaucher-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rituximab-dosing-to-prevent-clinical-relapse-in-immune-thrombotic-thrombocytopaenic-purpura 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imaging-flow-cytometry-for-detection-of-red-blood-cell-inclusions-a-quantitative-approach-to-assess 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-cellular-hierarchy-of-multiple-myeloma-uncovers-a-therapeutically-exploitable-ep300 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-regional-and-national-trends-in-the-burden-of-chronic-myeloid-leukemia-from-1990-to-2021-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vorinostat-for-gvhd-prophylaxis-in-children-adolescents-and-young-adults-aya-shows-low-incidence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/good-report-of-secondary-allogeneic-hematopoietic-stem-cell-transplantation-in-patients-with-refract 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-burden-by-ngs-in-bone-marrow-and-peripheral-blood-samples-at-baseline-and-after-frontline-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-profile-of-pola-based-regimen-in-dlbcl-patients-with-high-risk-factors-in-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-effectiveness-of-brentuximab-vedotin-in-chinese-patients-with-cd30-positive-lymphomas-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-paraspinal-extramedullary-hematopoiesis-with-cauda-equina-syndrome-in-a-transfusion-dependent-thal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hospital-admissions-through-the-emergency-department-versus-direct-admissions-for-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-maintenance-with-sorafenib-is-safe-and-effective-in-pediatric-patients-with-har-flt3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/red-lilly-app-a-digital-tool-for-the-evaluation-of-menstrual-bleeding-patterns-to-support-the-early 2026-08-17 monthly 0.7 https://rjrindex.com/articles/persistent-and-emerging-racial-gaps-in-mortality-from-malignant-hematologic-malignancies-2018-2023 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-center-updated-analysis-of-patients-with-relapsedrefractory-peripheral-t-cell-lymphoma-treat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/access-to-innovative-treatment-for-paroxysmal-nocturnal-hemoglobinuria-in-low-and-middle-income-cou 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-blood-transfusion-on-clinical-outcomes-in-patients-hospitalized-with-acute-promyelocytic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-clinical-evaluation-of-surovatamig-azd0486-in-comparison-to-cd20xcd3-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-of-steroid-refractory-acute-graft-versus-host-disease-by-mesenchymal-stromal-cells-the-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-and-efficacy-of-daratumumab-vcd-in-transplant-ineligible-elderly-patients-with-newly-dia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mc210807-phase-1-clinical-trial-assessing-the-safety-and-efficacy-of-onvansertib-a-novel-oral-pl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increasing-guideline-based-anti-emetic-prophylaxis-for-chemotherapy-induced-nauseavomiting-within-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/contact-modality-and-contact-intensity-over-time-among-community-health-workers-in-adult-sickle-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adults-with-therapy-related-acute-lymphoblastic-leukemia-t-all-a-systematic-review-and-meta-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-small-activating-rna-aw1-51-induces-locus-specific-demethylation-and-cebpa-protein-early-upregul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determinants-of-survival-in-primary-cutaneous-cd4-small-to-medium-sized-pleomorphic-t-cell-lymphopr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/new-evidence-indicates-that-the-nlrp3-inflammasome-in-hematopoietic-stem-and-progenitor-cells-hspcs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/why-is-diagnosing-antiphospholipid-syndrome-so-complex-characterization-of-cardiolipin-chemical-fea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-graft-versus-host-disease-prophylaxis-with-modern-strategies-in-matched-sibling-or-unrelat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-seet-01-a-pilot-study-for-diagnosing-crs-and-icans-using-wearable-consumer-devices 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hemorrhage-and-thrombosis-in-adult-patients-with-acute-lymphoblastic-leukemia-a-comparative-analysi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/procedure-triggered-late-onset-congenital-thrombotic-thrombocytopenic-purpura-unmasking-functional 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-alcohol-consumption-epigenetically-reactivates-transposable-elements-in-aged-hematopoietic-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-thrombotic-and-survival-outcomes-with-erythropoiesis-stimulating-agents-in-cancer-related 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-increased-patients-out-of-pocket-costs-for-apixaban-and-oral-anticoagulant-disc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-and-resource-utilization-during-and-after-oral-anticoagulant-related-bleeding-in-chronic-ki 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-chronic-myeloid-leukemia-mortality-in-the-united-states-from-1999 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-n-myristoyltransferase-inhibitor-zelenirstat-for-adults-with-relapsedrefractory-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-novel-allosteric-nek7-inhibitor-ofirnoflast-ht-6184-suppresses-il-8-and-other-pro-inflammatory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-specificity-in-factor-v-leiden-screening-performance-of-the-hemoclot-quanti-v-l-assay 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-extended-reduced-dose-apixaban-versus-full-dose-apixaban-in-cancer-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-associated-with-warm-autoimmune-hemolytic-anemia-among-medicare-beneficiaries 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-discovery-of-crotonoside-as-a-nucleoside-analogue-demonstrates-its-potential-to-inhibit-acute-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1-evaluation-of-the-safety-and-efficacy-of-rapcabtagene-autoleucel-ytb323-in-adult-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-multiomics-identifies-inhibitors-of-apoptosis-iaps-and-death-inducing-signaling-complex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatial-multi-omics-reveal-distinct-immunosuppressive-lipid-laden-macrophages-in-primary-cns-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-value-of-pathogen-metagenomic-next-generation-sequencing-mngs-for-early-bloodstream-inf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-clinical-outcomes-of-hematologic-immune-related-toxicities-in-patients-with-solid-mali 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-tbi-based-vs-non-tbi-reduced-toxicity-conditioning-regimens-in-adult-all-un 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chop-combined-with-linperlisib-or-chidamide-may-decrease-the-risk-of-mortality-of-monomorphic-epithe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-yield-of-recurrent-structural-variants-svs-in-ph-like-b-cell-acute-lymphoblastic-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-diagnosis-and-treatment-at-a-tertiary-center-in-cochabamba-bolivia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-aml-vs-mds-mortality-in-the-united-states-older-adults-from-1999-2023-a-cdc-wonder-databas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-vs-late-plasmapheresis-in-ttp-a-us-national-study-on-in-hospital-mortality 2026-08-17 monthly 0.7 https://rjrindex.com/articles/divergent-immune-programs-in-ebv-pcnsl-a-multiomic-study-of-ar-pcnsl-and-cns-ptld 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-weighted-cytokine-scoring-system-for-immune-status-assessment-follow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-multiple-myeloma-genomes-with-linkprep-assay-enables-sensitive-detection-of-som 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytokine-receptor-armored-car-t-cells-enable-robust-t-cell-expansion-and-function-in-the-absence-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-bispecific-antibodies-in-relapsedrefractory-diffuse-large-b-cell-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-patient-selection-to-decrease-non-relapse-mortality-with-reduced-intensity-conditioning 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-risk-with-thrombopoietin-receptor-agonists-in-immune-thrombocytopenia-real-world-evidenc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-study-of-patient-reported-depression-and-cognitive-and-functional-impairment-and-impac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tca-cycle-turning-is-dispensable-in-vivo-and-its-loss-promotes-stem-cell-function-during-regeneratio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/avatrombopag-beyond-efficacy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-adenovirus-infection-in-allogeneic-hematopoietic-cell-transplant-recipients-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/erythrocyte-aggregability-as-a-hemodynamic-marker-in-paroxysmal-atrial-fibrillation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stepwise-engineering-of-human-germinal-center-b-cells-to-model-dark-zone-high-grade-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comorbid-but-transplantable-favorable-outcomes-with-ric-and-ptcy-in-patients-with-an-hct-ci-score-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissection-of-non-genetic-resistance-mechanisms-by-lineage-tracing-and-single-cell-multiomics-reveal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prophylactic-g-csf-granulocyte-colony-stimulating-factor-in-aml-acute-myeloid-leukemia-induction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-clinical-trials-landscape-in-chronic-lymphocytic-leukemia-a-systematic-review-of-control-arm-ad 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ipsc-derived-epstein-barr-virus-specific-t-cells-with-dual-alpha-t-cell-receptors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-arterial-thromboembolism-in-patients-with-myeloproliferative-neoplasms-treated-with-ant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nup98-rearranged-pediatric-aml-is-sustained-by-a-conserved-leukemia-stem-cell-program-with-spns23-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-nr1i2-gene-polymorphism-and-body-weight-on-asciminib-pharmacokinetics-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-nlp-protein-is-a-novel-regulator-of-g2-m-phase-of-the-cell-cycle-critical-for-proliferation-of-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/p2rx7-in-aml-blasts-orchestrates-myeloid-differentiation-through-t-cell-mediated-visfatin-and-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eln-milestone-driven-tki-switching-improves-deep-molecular-response-rates-in-chronic-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-nae1-dependent-v-catenin-neddylation-as-selective-vulnerability-in-b-cell-malignan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-conditioning-regimen-combining-selinexor-with-melphalan-improves-survival-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-high-risk-relapsedrefractory-multiple-myeloma-rrmm-outcomes-with-belantamab-mafodotin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-daratumumab-plus-carfilzomib-based-inductionconsolidationmaintenance-therap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/different-kinetic-behavior-of-molecular-reduction-by-bcrabl1-transcript-types-in-frontline-treatme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-social-determinants-on-inpatient-outcomes-in-hairy-cell-leukemia-a-national-cohort-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-and-spatial-transcriptomics-analyses-decipher-malignant-b-cell-heterogeneity-and-immunos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/steroid-sparing-use-of-anakinra-for-secondary-hemophagocytic-lymphohistiocytosis-in-sickle-cell-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-hdac-and-ezh2-inhibition-modulates-rfx5-activity-to-increase-the-immunogenicity-of-germinal-cen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-comutational-landscape-of-csf3r-mutations-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ptpn11-copy-number-gain-drives-leukemogenesis-via-mutant-shp2-in-juvenile-myelomonocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multicenter-single-arm-study-of-camrelizumab-combined-with-rituximab-followed-by-r-chop-as-first 2026-08-17 monthly 0.7 https://rjrindex.com/articles/surface-protein-focused-gene-expression-analysis-identifies-prognostic-immunophenotypes-in-newly-dia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/causes-of-death-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-during-the-novel-agent-er 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ldb1-dependent-enhancer-networks-drive-high-risk-transcriptional-programs-in-t-cell-acute-lymphoblas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fludarabine-pharmacokinetic-model-identifies-an-optimal-exposure-associated-with-improved-outcomes-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-risk-of-gastrointestinal-complications-in-older-adults-with-multiple-myeloma-a-propensity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/superior-long-term-outcomes-with-fludarabine-and-melphalan-reduced-intensity-regimen-in-older-amlmd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-ctcs-for-dynamic-risk-assessment-of-patients-pts-with-smoldering-multipl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-survival-outcomes-in-primary-cns-lymphoma-analysis-of-the-nationa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/voriconazole-vcz-therapeutic-drug-monitoring-tdm-for-prophylaxis-and-treatment-of-invasive-funga 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proportion-of-second-hematologic-malignancies-linked-to-radiotherapy-treatment-in-adults-a-cohort-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/resistance-to-imatinib-of-leukemia-growth-in-non-marrow-organs-and-eradication-by-dasatinib-publish 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-gut-microbiome-coalescence-and-ecosystem-fragility-promote-drug-resistant-colonization-and-infe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-profiling-reveals-teclistamab-induced-reshaping-of-nasopharyngeal-immunity-in-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-from-dried-blood-spots-spot-on-cml-results-from-low-and-middle-income 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-based-mutation-profile-in-secondary-compared-to-de-novo-acute-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-detection-model-for-leukemia-cells-in-peripheral-blood-smears-using-yolov11-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maternal-anti-aiib-antibodies-target-fetal-hematopoietic-stem-cells-disrupting-hematopoiesis-and-cau 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-genomic-screens-identify-positive-and-negative-regulators-of-venetoclax-resistance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolution-of-t1114-biology-in-multiple-myeloma-and-its-role-on-outcomes-to-venetoclax-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transient-atm-inhibition-enhances-knock-in-efficiency-and-long-term-engraftment-of-genome-edited-hem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/full-assessment-of-clinical-transfusion-support-facts-a-prospective-study-to-determine-the-burden 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-assessment-of-indirect-treatment-comparison-between-off-label-rituximab-and-novel-treatm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cooperative-activation-of-nf-kb-by-inv3t33-and-nras-mutations-drives-myeloid-leukemogenesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-bcl-6-in-hbv-positive-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/macrophage-cd38-overexpression-drives-primary-platelet-engraftment-failure-via-paracrine-suppression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduced-dose-post-transplant-cytoxan-intermediate-dose-in-combination-with-abatacept-after-matche 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-thiotepa-containing-conditioning-regimens-and-mucositis-burden-in-allogeneic-hsct-for-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inotuzumab-ozogamacin-in-refractory-or-1st-or-greater-relapse-of-pediatric-b-all-as-bridge-to-cure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iron-overload-and-iron-chelation-therapy-in-pnh-patients-on-complement-inhibitors-a-single-centre-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-1v-induced-signaling-modulates-cytokine-release-and-apoptosis-in-idh1-mutant-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-bromodomain-and-extra-terminal-domain-protein-brd4-promotes-both-self-renewal-and-inflammation-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-first-characterization-of-disease-burden-and-healthcare-resource-utilization-for-the-recent-defi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overcoming-barriers-to-clinical-trial-enrollment-among-adolescents-and-young-adults-with-acute-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-chemotherapy-on-survival-in-patients-aged-75-years-and-older-with-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-car-t-cell-membrane-architecture-with-the-proximity-network-assay 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-a-development-restricted-megakaryocyte-primed-population-of-hematopoietic-progeni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/perioperative-anemia-and-transfusion-thresholds-in-vascular-surgery-procedures-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-chronic-pain-in-pediatric-sickle-cell-disease-insights-from-a-retrospective-chart-rev 2026-08-17 monthly 0.7 https://rjrindex.com/articles/signal-rich-and-signal-poor-divergent-detection-of-early-bacterial-sepsis-and-latent-viral-complica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upfront-vs-posttherapy-allogeneic-stem-cell-transplantation-for-high-risk-myelodysplastic-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-venetoclax-in-combination-with-azacitidine-as-maintenance-therapy-for-acute-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/three-decades-of-allogeneic-transplantation-showing-improved-survival-persistent-relapse-and-postr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-relevance-of-mutational-profile-in-secondary-acute-myeloid-leukemia-patients-treated-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/parp-inhibitors-and-the-rising-incidence-of-secondary-myelodysplastic-syndrome-and-acute-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-acquired-platelet-dysfunction-with-eosinophilia-clinical-triad-and-flow-cytometric-signatu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proof-of-concept-study-of-the-cd39-blocking-antibody-js019-in-eosinophilic-associated-disorders 2026-08-17 monthly 0.7 https://rjrindex.com/articles/detection-of-kmt2a-fusion-transcripts-after-induction-chemotherapy-is-strongly-predictive-of-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-flk-independent-pathway-of-megakaryopoiesis-is-differentially-responsive-to-stress-and-can-produce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bach2-regulates-t-cell-lineage-states-to-overcome-dysfunction-driven-by-tonic-car-signaling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/velora-pioneer-phase-12-study-to-evaluate-the-safety-tolerability-pharmacokinetics-pharmacodyna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longterm-survival-and-late-effects-following-hematopoietic-cell-transplantation-for-sickle-cell-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dnmt3a-npm1-and-flt3-itd-triple-mutated-aml-has-a-favorable-prognosis-in-the-era-of-flt3-inhibitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intravenously-administered-lv-169-delivers-a-functional-bcma-car-transgene-to-niche-resident-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-venetoclax-andor-hypomethylating-agent-discontinuation-in-patients-with-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nampt-in-macrophages-promotes-multiple-myeloma-drug-resistance-through-mitochondrial-metabolic-repro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-novel-tmprss6-antisense-inhibitor-sapablursen-for-treatment-of-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crispr-cas12a-gene-editing-of-the-hbg12-promoters-leads-to-sustained-normalization-of-total-hemoglo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-iberdomide-carfilzomib-daratumumab-and-dexamethasone-quadruplet-therapy-for-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-toxicities-in-patients-with-hematologic-malignancies-treated-with-zanubrutinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/astx727-delivers-superior-response-rates-and-associated-survival-benefit-versus-hydroxycarbamidebes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-quintessential-a-phase-2-study-of-arlocabtagene-autoleucel-arlo-cel-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd15-expression-on-leukemic-cells-associates-with-extramedullary-infiltration-and-adverse-outcomes-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/better-outcomes-with-haploidentical-than-matched-sibling-donors-for-adult-aml-patients-allo-transpla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilization-and-outcomes-of-inferior-vena-cava-ivc-filters-in-patients-with-cancer-associated-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-flt3-microclones-on-outcomes-in-patients-with-newly-diagnosed-flt3-itd-negative-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/addition-of-obinutuzumab-after-one-year-of-combined-acalabrutinib-and-venetoclax-is-safer-and-effect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-distance-from-primary-hemophilia-treatment-center-on-annualized-bleeding-rat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-abbreviated-fixed-duration-default-4-cycles-linvoseltamab-immuno-consolidation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-cell-transplantation-in-dyskeratosis-congenita-short-and-long-term-outcom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardinal-a-phase-1-study-of-tern-701-a-novel-investigational-allosteric-bcrabl1-inhibitor-for-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tgrx-678-a-potent-bcrabl1-allosteric-inhibitor-in-cml-cp-and-cml-ap-patients-harbori 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venflubu2-with-ptcytacmmf-ric-transplant-followed-by-venetoclaxazacitidine-maintenance-for-high 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-heights-of-iron-absorption-erythrocytosis-in-patients-with-heterozygous-hfe-mutations-at-altitu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nup98nsd1-fusion-is-associated-with-poor-outcomes-in-acute-myeloid-leukemia-regardless-of-co-occur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-hiv-remission-of-a-perinatally-infected-individual-following-a-hematopoietic-cell-transpl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/newborn-screening-for-sickle-cell-disease-in-a-hospital-setting-in-luanda-angola-local-implementin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-children-and-adolescents-with-acute-myeloid-leukemia-potentially-treatable-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-disease-burden-and-treatment-patterns-among-triple-class-exposed-patients-with-relapsedr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frequency-of-and-finding-risk-factors-for-thromboembolism-and-major-bleeding-in-patients-with-myelod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-car-t-cell-therapy-in-richter-transformation-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-and-treatment-patterns-in-patients-with-essential-thrombocythemia-by-thro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disrupting-the-global-car-t-paradigm-from-the-middle-east-ultra-fast-swift-car-t-and-scalable-point 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-prmt7-enhances-the-anti-aml-immunity-by-regulating-mhc-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissecting-indias-molecular-hematology-landscape-a-1000-patient-genomic-study-identifies-geographi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-relapse-in-acute-promyelocytic-leukemia-in-the-arsenic-era-a-case-series-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-eltrombopag-in-patients-with-low-risk-mds-and-cmml-harboring-tet2-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytotoxic-natural-killer-like-ex-tissue-resident-memory-t-cells-circulate-in-human-chronic-graft-ve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endothelial-dysfunction-and-proinflammatory-state-determine-severe-hematotoxicity-and-adverse-outcom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-interim-assessment-of-bleeding-events-in-a-prospective-natural-history-study-of-hereditary-hemorr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unsupervised-proteomic-and-metabolomic-longitudinal-serum-profiling-of-anti-cd19-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-induced-pluripotent-stem-cell-derived-invariant-natural-killer-t-cell-therapy-a-phase-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/number-needed-to-treat-to-avoid-progression-or-death-zanubrutinib-vs-other-covalent-bruton-tyrosine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-and-quality-of-life-over-time-in-relapsedrefractory-diffuse-b-cell-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-prevalence-of-anemia-among-recently-immigrated-female-south-asian-college-students-a-cros 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-dexamethasone-prophylaxis-after-axicabtagene-ciloleucel-for-non-hodgkin-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pulmonary-hypertension-on-right-heart-catheterization-is-associated-with-worse-progression-free-surv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unsupervised-clustering-of-rna-sequencing-data-identifies-a-novel-xbp1-mutated-subtype-of-b-cell-acu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-time-to-iv-methotrexate-initiation-for-planned-admissions-to-the-inpatient-hematologyonc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chimeric-antigen-receptor-t-cells-in-real-world-care-of-multiple-myeloma-patient-characteristics-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fungal-infections-following-chimeric-antigen-receptor-t-cell-car-t-cell-therapy-a-retrospective-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-355-patients-with-acute-myeloid-leukemia-arising-from-chronic-myelomonocytic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-plus-obinutuzumab-improves-quality-of-life-in-treatment-naive-cll-prospective-real-world 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-obstructive-sleep-apnea-on-hospitalized-patients-with-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/race-related-molecular-differences-in-slamf7-expression-drive-disparities-in-multiple-myeloma-outcom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-accessible-therapies-for-the-management-of-myelodysplastic-syndromes-a-retrospective-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/life-years-and-quality-adjusted-life-years-with-belantamab-mafodotin-bortezomib-and-dexamethasone 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differences-in-outcomes-with-intensive-chemotherapy-in-aml-patients-according-to-mutational-status 2026-08-17 monthly 0.7 https://rjrindex.com/articles/altered-bone-marrow-bm-plasma-amino-acid-aa-composition-reflects-microenvironmental-remodeling-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/piezo1-mediated-mechanosensation-in-bone-marrow-macrophages-promotes-hematopoietic-support-function 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-clinical-experience-with-mesenchymal-stromal-cells-in-autoimmune-hemolytic-anemia-a-cas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-with-acalabrutinib-in-ighv-mutated-setting-and-presence-of-splenomegaly-are-the-main-predi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-profiling-reveals-mdsc-driven-immunosuppressive-remodeling-of-the-tumor-microenvironment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-and-non-overlapping-epigenetic-signatures-differentiate-mpn-subtypes-and-reveal-hydroxyurea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lisocabtagene-maraleucel-liso-cel-demonstrates-superior-efficacy-across-inflammatory-risk-subgroup 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-mantle-cell-lymphoma-in-colombia-a-multicenter-cohort-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-mediastinal-b-cell-lymphoma-survival-trends-and-statistics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-teclistamab-in-relapsed-or-refractory-multiple-myeloma-results-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dysregulated-proteasome-proteostasis-acts-as-a-driver-of-light-chain-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-the-treatment-of-secondary-central-nervous-system-lymphoma-scnsl-with-intensive-systemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-the-biological-function-foxo3-and-its-role-as-a-predictive-biomarker-in-htlv-1-relate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glucose-transporter-5-enhances-car-t-cell-metabolic-function-and-serial-killing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-thromboprophylaxis-use-during-autologous-hematopoietic-stem-cell-transplantat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-car-t-cell-therapy-in-chronic-lymphocytic-leukemia-a-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-first-and-second-generation-flt3-inhibitors-in-newly-diagnosed-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/demystifying-changes-with-upfront-therapy-in-mantle-cell-lymphoma-global-clinician-preparedness-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/apcin-derived-cdc20-inhibitors-synergize-with-microtubule-disruptors-to-induce-mitotic-catastrophe-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-postnatal-loss-of-mature-osteoblasts-creates-an-immunosuppressive-bone-marrow-microenvironme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reprogrammed-regulatory-t-cells-as-cytotoxic-effectors-drive-anti-tumor-immunity-under-bispecific-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ddx3x-facilitates-adaption-to-proteotoxic-stress-by-regulating-the-translation-of-mapkapk2-and-the-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-dose-10-day-decitabine-plus-venetoclax-induced-rapid-mrd-negativity-and-durable-remission-in-de 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-vulnerability-and-mortality-trends-in-acute-myeloid-leukemia-in-the-united-states-adults-201 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-treatment-immune-profiling-by-flow-cytometry-and-single-cell-transcriptomics-identifies-distinct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-investigation-of-somatic-mutations-in-idh-genes-in-peripheral-blood-in-the-all-of-us-research-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-dependent-long-short-term-memory-neural-cox-regression-in-2690-patients-with-myeloid-neoplasia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-of-acute-myeloid-leukemia-with-isocitrate-dehydrogenase-1-idh1-mutation-treated-with-combin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneous-clinical-outcomes-within-contemporary-risk-strata-a-genomic-reappraisal-of-2022-eln-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improvements-in-mental-health-symptoms-are-associated-with-improved-quality-of-life-over-time-in-adu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-derived-secondary-car-t-cell-therapy-for-relapsed-leukemia-following-initial-car-t-bridged-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-autologous-cd30car-t-cells-in-combination-with-nivolumab-in-patients-with-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bridging-the-rural-gap-real-world-teclistamab-outcomes-from-the-us-midwest-myeloma-network 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-multiple-myeloma-mortality-in-the-united-states-a-25-year-analysis-from-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-cd371-shielded-hematopoietic-stem-cell-grafts-for-protection-against-aml-directed-imm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tracking-clonal-dynamics-tolerance-and-adverse-events-after-cd45-adc-conditioned-autologous-hspc-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-multi-center-review-of-the-safety-and-efficacy-of-bispecific-t-cell-engagers-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-crisis-to-cure-thirteen-years-of-real-world-trends-in-acute-promyelocytic-leukemia-outcomes-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasmacytoid-dendritic-cell-associated-acute-myeloid-leukemia-pdc-aml-a-comprehensive-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-iii-study-to-investigate-the-combination-of-lp-118-ponatinib-vincristi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-proteomic-signature-derived-by-ensemble-machine-learning-for-predicting-relapse-in-pediatric-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crosstalk-between-cep72-germline-polymorphism-and-notch1-somatic-mutations-alters-the-sensitivity-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-prophylaxis-with-11-ratio-pdvwffviii-concentrate-vs-recombinant-vwf-in-ty 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-transposon-baff-ligand-directed-chimeric-antigen-receptor-t-cells-lmy-920 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-patients-at-risk-of-prolonged-neutropenia-and-enhanced-risk-of-complications-during-aza 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-cancer-related-mortality-in-hematological-cancers-a-nation-wide-population-based-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-polatuzumab-vedotin-plus-rituximab-cyclophosphamide-doxorubicin-and-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-lung-function-results-for-sleep-disordered-breathing-in-children-with-sickle-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-one-month-mortality-and-bleeding-outcomes-with-caplacizumab-in-thrombotic-thrombocytopeni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vitro-and-in-vivo-foxo3-dependent-induction-of-fetal-hemoglobin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolomic-and-epigenetic-signatures-of-hemin-induced-stress-in-sickle-cell-erythroblasts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-obinutuzumab-plus-chlorambucil-in-treatment-naive-chronic-lymphocytic-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vsa012-a-cfb-targeted-sirna-demonstrates-a-favorable-safety-profile-and-sustained-efficacy-in-pnh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/restarting-etentamig-therapy-after-dosing-delays-or-interruptions-population-pharmacokinetics-popp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-circulating-cd57-cytotoxic-cell-subsets-across-disease-stage-and-aggressiveness-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-a-bulk-higher-incidence-of-venous-thromboembolism-vte-in-patients-with-primary-mediasti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extended-treatment-free-hospitalization-free-time-and-quality-of-life-benefits-with-car-t-cell-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-importance-of-mri-in-diagnostic-workup-of-smoldering-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-practices-in-the-management-of-pediatric-iliofemoral-deep-vein-thrombosis-results-of-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upregulation-of-bcma-expression-by-selinexor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pattern-of-infections-and-impact-on-immunocompetence-of-next-generation-b-cell-depleting-immunothera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/large-b-cell-lymphoma-after-cd19-car-t-failure-updated-real-world-outcomes-prognostic-factors-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-aponermin-kt-decp-in-patientspts-with-relapsedrefractory-multiple-myeloma-and-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rock2-inhibition-attenuates-ctl-mediated-platelet-destruction-by-suppressing-il-6stat3-driven-glyco 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-implementation-of-bispecific-antibody-delivery-in-community-oncology-overcoming-operatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eo2463-eo-peptide-immunotherapy-in-patients-pts-with-newly-diagnosed-asymptomatic-follicular-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyclin-d1-immunostaining-as-a-diagnostic-surrogate-for-the-t1114-translocation-in-al-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-response-and-toxicity-profiles-of-sequential-bispecific-antibody-therapies-in-relapsedre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/is-dual-targeting-of-fxii-and-gas6-a-good-strategy-to-prevent-thrombosis-with-no-risks-of-bleeding 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-preclinical-study-on-the-synergy-between-cd73-inhibitors-and-selinexor-for-managing-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mecapegfilgrastim-for-prophylaxis-of-immunochemotherapy-induced-neutropenia-in-patients-with-diffuse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tocilizumab-prophylaxis-in-patients-receiving-car-t-cell-immunotherapy-for-hematological-malignancie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-open-label-rollover-study-to-assess-the-long-term-safety-of-ixazomib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hiv-1-infected-scd-patients-exhibit-milder-sickle-cell-disease-and-suppressed-antiviral-innate-immun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-89zr-dfo-daratumumab-for-cd38-targeted-imaging-of-multiple-myeloma-the-immunopet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-with-concomitant-chronic-lymphocytic-leukemia-common-or-distinct-clonal-origin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pozelimab-plus-cemdisiran-versus-ravulizumab-in-patients-with-paroxysmal-noct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/psychosocial-well-being-in-patients-undergoing-allogeneic-hematopoietic-stem-cell-transplantation-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/innate-immune-dysregulation-in-monocytes-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-red-blood-cell-functional-biomarkers-following-hematopoietic-cell-transplantation-in-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-mortality-associated-conditions-hospitalizations-and-costsrelated-to-hemophago 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-additional-genetic-variants-in-the-course-of-erdheim-chester-disease-and-their-evolution-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hereditary-alpha-tryptasemia-hat-extends-the-symptom-spectrum-to-cardiovascular-pain-and-neuropsy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelets-enhance-factor-viii-activity-through-protection-from-activated-protein-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-therapy-related-acute-lymphoblastic-leukemia-a-population-based-analysis-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-dose-inotuzumab-ozogamicin-combined-with-vincristine-and-prednisone-regimen-as-induction-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/induction-mortality-in-acute-leukemia-the-hidden-burden-of-infections-in-a-middle-income-country 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-biological-impact-of-plasma-cytokine-levels-in-newly-diagnosed-chronic-lymphocytic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-disparities-in-sickle-cell-disease-among-patients-with-asymptomatic-hiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/persistent-symptom-burden-and-unmet-needs-in-long-term-survivors-of-allogeneic-hematopoietic-cell-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-large-language-model-based-framework-for-automated-phenotypic-characterization-in-myeloproliferati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-npm1-co-mutation-on-outcomes-in-ras-mutated-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mesenchymal-stem-cells-for-treating-gastrointestinal-involved-steroid-refractory-acute-graft-versus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-ciltacabtagene-autoleucel-cilta-cel-versus-belantamab-mafodotin-belamaf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-cyclophosphamide-based-graft-verses-host-disease-gvhd-prophylaxis-is-associated-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-genomic-analysis-of-patients-with-chronic-lymphocytic-leukemia-treated-with-fixed-duration-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rubricbased-comparison-of-code-red-and-specialists-in-managing-cart-related-cytokine-release-syn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/psychometric-evaluation-of-the-self-management-skills-checklist-across-brazil-and-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/craniofacial-involvement-is-associated-with-poor-prognosis-in-extranodal-dlbcl-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-mitapivat-treatment-improves-inflammatory-pro-fibrotic-cardiomyopathy-in-a-murine-model-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-molecular-heterogeneity-and-clonal-evolution-in-chronic-myelomonocytic-leukemia-via-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-stratification-of-relapse-risk-post-allogeneic-hematopoietic-stem-cell-transplantation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-rates-of-deep-molecular-response-dmr-in-patients-pts-with-chronic-myeloid-leukemia-in-chron 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-engaging-bispecific-antibody-shows-potent-mrd-negativity-with-variable-remission-and-survival 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-iron-deficiency-anemia-on-outcomes-in-postpartum-hemorrhage-insights-from-a-national-inpa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/6ploh-as-a-marker-of-immune-mediated-bone-marrow-failure-insights-from-a-large-single-center-experi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-immune-profiles-among-patients-with-primary-effusion-lymphoma-and-other-kaposi-sarcoma-herp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-prognostic-significance-of-myelodysplastic-syndrome-mds-related-features-in-ve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-in-cll-patients-after-btk-inhibitor-progression-identifies-enrichment-of-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-the-international-working-group-iwg-2023-criteria-for-clinical-benefit-in-higher-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-multiproteomic-analysis-reveals-an-inflammatory-phenotype-in-immune-aplastic-anemia-ch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-whole-genome-sequencing-for-genomic-profiling-and-risk-determination-in-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-evaluation-of-the-relationship-between-abnormal-myocardial-perfusion-and-diastolic-dysfunction-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effects-of-bruton-tyrosine-kinase-inhibitors-on-the-waldenstrom-macroglobulinemia-microenvironme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-histopathological-subtyping-of-peripheral-t-cell-lymphoma-ptcl-on-hampe-stai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-predictors-of-cardiovascular-disease-risk-in-mds-patients-results-of-a-pros 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-siltuximab-in-combination-with-standard-induction-chemotherapy-in-patients-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pegylated-interferon-alfa-2b-combined-with-tyrosine-kinase-inhibitors-in-chro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genome-wide-crispr-cas9-screening-identified-gpcr-regulators-ric8a-and-pdcl-as-therapeutic-targets-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-of-nodal-t-cell-non-hodgkin-lymphoma-from-hematology-cancer-consortium-registry-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplant-results-in-t-cell-prolymphocytic-leukemia-t-pll-a-collaborative-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/total-metabolic-tumor-volume-as-a-prognostic-biomarker-in-high-burden-follicular-lymphoma-a-systema 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-driven-prognostication-of-overall-survival-at-6-months-after-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-thrombopoietin-receptor-agonists-for-thrombocytopenia-in-pediatric-malignancies-a-retrospect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/avatrombopag-beyond-the-technical-sheet-a-single-center-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-voxelotor-treatment-in-patients-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-safety-and-therapeutic-efficacy-of-a-novel-humanized-anti-adamts13-antibody-in-acquired-vo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-fcrn-inhibitors-versus-placebo-in-adult-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-combined-with-anti-cd19-car-t-cell-therapy-in-relapsed-and-refractory-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upfront-maintenance-therapy-improves-the-prognosis-of-patients-with-diffuse-large-b-cell-lymphoma-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/consolidation-of-adult-inpatient-sickle-cell-care-to-improve-patients-and-learners-experiences-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-immunotherapy-in-alveolar-soft-part-sarcoma-asps-a-case-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/js203-a-cd20cd3-bispecific-antibody-demonstrated-promising-anti-cancer-activity-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifi16-drives-bortezomib-resistance-in-multiple-myeloma-via-wntv-catenin-pathway-a-novel-therapeuti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/establishment-of-a-prognostic-model-for-diffuse-large-b-cell-lymphoma-based-on-mitochondrial-energy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-of-composite-lymphoma-and-multiple-cancer-diagnoses-in-an-individual-heterozygous-for-fanci-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-survival-analysis-at-a-large-united-states-southern-comprehensive-sickle-cell-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-gender-and-geographic-disparities-in-leukemia-clinical-trials-authorship 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-for-black-persons-with-multiple-myeloma-a-national-retrospective-trend-analysis-from-2015 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zuma-25-preliminary-analysis-a-phase-2-study-of-brexucabtagene-autoleucel-brexu-cel-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-risk-based-scoring-approach-to-individualize-prophylaxis-in-patients-with-hemophilia-a-results-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bms-986458-a-first-in-class-highly-selective-and-potent-ligand-directed-degrader-ldd-of-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-fatigue-on-health-care-resource-utilization-and-costs-in-sickle-cell-disease-in-the-united 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-concentrations-in-cerebrospinal-fluid-in-patients-with-hemophagocytic-lymphohistiocytosi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idiopathic-multicentric-castleman-disease-unresponsive-to-one-il-6-inhibitor-may-respond-to-another 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-neurotoxicity-a-multi-disease-single-cell-atlas-of-cerebrospinal-fluid-reveals-conserved-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-psychosocial-impact-of-myelodysplastic-syndromes-evaluation-by-self-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-eliglustat-for-gaucher-disease-type-1-in-china-a-multicenter-retrospective 2026-08-17 monthly 0.7 https://rjrindex.com/articles/standardizing-lines-of-treatment-lot-in-multiple-myeloma-real-world-validation-of-an-automated-ru 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-a-clinical-trial-communication-training-workshop-on-hematology-oncology-fellows-knowl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/county-level-analysis-reveals-two-high-incidence-regions-and-potential-environmental-contributors-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hetrombopag-for-the-treatment-of-lower-risk-myelodysplastic-syndromes-with-thrombocytopenia-a-prosp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-stratified-prognostic-performance-of-patient-vs-disease-related-ipi-factors-in-large-b-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-high-dose-methotrexate-addition-to-r-chop-chemotherapy-for-prophylaxis-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloproliferative-neoplasms-in-mexico-an-analysis-of-clinical-features-driver-mutations-and-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-burden-of-hemophagocytic-lymphohistiocytosis-in-the-united-states-a-nationwide-analysis-of-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-associated-non-mutational-resistance-in-acute-myeloid-leukemia-is-driven-by-dna-damage-induced-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-in-frame-calreticulin-mutation-induces-activation-of-jak-stat-signaling-and-thrombocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/administration-and-adverse-event-related-costs-among-patients-with-multiple-myeloma-treated-with-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-safety-and-efficacy-of-belumosudil-and-ruxolitinib-combination-in-ruxolitinib-refractory-chronic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-gene-panel-analysis-in-aplastic-anaemia-diagnostic-utility-and-clinical-implications 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-data-from-the-non-transfusion-dependent-dose-confirmation-cohort-a-phase-2a-study-of-luspate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-outcomes-in-hereditary-and-transfusion-associated-hemochromatosis-a-focused-propensity-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/navigating-triple-therapy-in-a-high-risk-cardiac-patient-with-a-covered-stent-and-embolic-stroke-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/n6-methyladenosine-m6a-rna-modification-is-required-to-final-plasma-cell-differentiation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-dynamics-and-clinical-outcomes-in-patients-with-heparin-induced-thrombocytopenia-single-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heparin-induced-thrombocytopenia-after-percutaneous-coronary-intervention-complicated-by-hemothorax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/automated-ai-classification-in-clinical-flow-cytometry-transforming-b-cell-lymphoma-diagnostics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-39il-39r-signaling-drives-acute-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relapse-associated-aberrant-dna-hypermethylation-in-aml-post-allogeneic-stem-cell-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-reprogramming-by-itaconate-haescs-derived-therapy-targets-fibroblast-glud1-to-alleviate-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-satisfaction-with-outpatient-management-of-sickle-cell-pain-crisis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-july-effect-on-sickle-cell-crisis-hospitalizations-a-national-inpatient-sample-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/accelerate-a-platform-protocol-to-investigate-post-transplant-cyclophosphamide-based-graft-versus-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-read-profiling-of-structural-variants-reveals-mechanisms-of-chemo-resistance-and-prognostic-het 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bms-986458-a-first-in-class-bifunctional-cereblon-dependent-ligand-directed-degrader-of-b-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-enhances-41bb-costimulated-cart19-function-and-persistence-through-immune-reprogramming-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-reduces-cardiac-stress-and-improves-cardiac-function-in-a-tet2-deficient-mouse-model-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/triple-base-edited-dual-targeting-cd7033-car-t-cells-to-avoid-cytokine-mediated-resistance-in-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zilovertamab-vedotin-plus-r-chp-versus-polatuzumab-vedotin-plus-r-chp-as-first-line-therapy-in-parti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orca-t-demonstrates-favorable-quality-of-life-and-healthcare-resource-use-compared-to-standard-alloh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frieds-frailty-phenotype-predicts-survival-in-pts-with-relapsedrefractory-lymphoma-or-myeloma-unde 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dars-mediated-m2-polarization-of-tumor-associated-macrophages-drives-mpn-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-death-and-comorbidities-in-v-thalassemia-carriers-identified-by-consecutive-genotyping-a-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-asc-in-chronic-myeloid-leukemia-in-chronic-phase-cml-cp-interim-analysis-ia-efficac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cmv-reactivation-in-multiple-myeloma-patients-receiving-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-with-newly-diagnosed-acute-myeloid-leukemia-with-kmt2a-rearrangement-treated-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/accelerating-access-to-gene-therapy-lessons-from-commercial-implementation-in-sickle-cell-disease-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-center-retrospective-evaluation-of-chop-based-regimens-in-older-patients-with-treatment-naive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lung-infections-and-clinical-outcomes-of-diffuse-large-b-cell-lymphoma-treated-with-polatuzumab-vedo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trium-study-exploring-mrd-guided-triplet-therapy-with-sonrotoclax-zanubrutinib-and-cd20mab-in-unt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-car-t-cell-therapy-using-a-multimodal-approach-to-target-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-epcoritamab-monotherapy-induces-high-response-and-mrd-negativity-rates-in-elderly-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-adverse-events-associated-with-bispecific-antibodies-in-relapsedrefractory-hematolog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imv101-a-novel-cd19-targeted-in-vivo-car-t-therapy-exhibits-potent-efficacy-and-tolerable-safety-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd19-antigen-from-tumor-target-to-safety-switch-able-to-improve-the-safety-profile-of-car-t-cell-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-treatment-cd19-antigen-density-and-multi-antigen-profiling-by-calibrated-quantitative-flow-cytom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-analyses-of-molecular-tumor-burden-are-superior-to-pet-assessed-responses-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spliceosome-mutations-in-aml-prevalence-clinical-features-and-treatment-outcomes-in-a-contemporar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-azd0120-a-bcmacd19-dual-targeting-car-t-cell-therapy-in-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etentamig-plus-pomalidomide-dexamethasone-combination-therapy-in-relapsed-or-refractory-multiple-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prophylactic-tocilizumab-in-relapsedrefractory-multiple-myeloma-patients-treated-with-bispecific-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-transcriptomic-signatures-in-non-hispanic-black-aml-patients-with-npm1-mutations-reveal-pot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allograft-inflammatory-factor-1-is-essential-for-acute-monocytic-leukemia-infiltration 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-the-safety-of-ciltacabtagene-autoleucel-in-relapsed-multiple-myeloma-mm-identification 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mim8-prophylaxis-in-adults-and-adolescents-with-hemophilia-a-52-week-efficacy-and-safety-outcomes-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-outcomes-by-line-of-therapy-in-marginal-zone-lymphoma-real-world-evidence-from-10-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/choice-of-hypomethylating-agent-for-newly-diagnosed-tp53-mutant-acute-myeloid-leukemia-a-command-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/double-hit-alterations-of-tp53-identify-ultra-high-risk-disease-in-previously-treated-myd88-mutated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-limited-pirtobrutinib-venetoclax-and-obinutuzumab-combination-in-first-line-chronic-lymphocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odronextamab-plus-chemotherapy-in-patients-with-previously-untreated-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-gilteritinib-beyond-second-line-therapy-in-relapsedrefractory-flt3-muta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/macrophage-subsets-provide-distinct-niches-for-normal-and-clonal-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd44v6-promotes-anti-apoptotic-phenotypes-in-aml-via-an-spp1-mediated-autocrine-activation-of-the-ma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il18-armored-car-t-cells-in-relapsedrefractory-b-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/embedding-narrative-medicine-into-subspecialty-training-a-novel-clinical-rotation-to-foster-humanis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tdi01-in-the-treatment-of-moderate-to-severe-chronic-graft-versus-host-disease-updated-results-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-autologous-hematopoietic-stem-cell-transplantation-in-nodular-lymphocyte-predominant-hod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subsequent-primary-malignancies-after-car-t-therapy-a-study-from-the-us-multiple-myeloma-immunother 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-dna-profiling-unveils-clonal-evolution-and-identifies-mechanisms-of-therapeutic-resistan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/randomized-comparison-of-ponatinib-versus-imatinib-in-combination-with-chemotherapy-in-patients-55-y 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-breakthrough-hemolysis-on-complement-factor-h-and-factor-i-levels-in-paroxysmal-noctur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-of-co-mutation-of-sf3b1-and-bcrabl1-demonstrating-an-mds-phenotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-viral-pneumonia-on-hospital-outcomes-in-sickle-cell-disease-a-database-review-and-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-cns-ipi-score-is-predictive-of-severe-immune-effector-cell-associated-neurotoxicity-after-axicab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-diagnosis-of-iron-deficiency-among-patients-receiving-a-blood-transfusion-in-the-emerg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trust-and-relationships-between-people-with-sickle-cell-disease-and-healthcare-professionals-region 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hla-b-leader-matching-status-on-prognosis-and-underlying-mechanism-in-patients-with-hemato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementing-patient-centered-proms-in-sickle-cell-disease-care-a-european-consensus-approach 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-initial-flt3-itd-mutated-clone-numbers-on-clinical-outcomes-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-and-sepsis-related-mortality-in-the-united-states-us-older-adults-nation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-development-of-ft839-an-off-the-shelf-cd19xcd38-dual-car-t-cell-for-the-treatment-of-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/late-recurrence-of-transfusion-dependent-thalassemia-30-years-after-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/calcineurin-inhibitors-reduce-risk-of-mgus-progression-to-multiple-myeloma-in-immunosuppressant-user 2026-08-17 monthly 0.7 https://rjrindex.com/articles/specific-environmental-factors-are-associated-with-increased-rates-of-invasive-mucormycosis-infectio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adverse-genetic-alterations-and-their-prognostic-impact-in-chinese-b-all-patients-with-dux4-rearrang 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-bvavd-efficacy-is-influenced-by-interim-pet-age-ecog-performance-status-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-diagnostic-accuracy-of-dermpathgpt01-for-dermatologic-diagnosis-in-post-allogeneic-stem-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-ai-tools-on-diagnostics-and-management-of-hematologic-malignancies-2020-20 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-abatacept-addition-to-post-transplant-cyclophosphamide-based-gvhd-prophylaxys-in-allogene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-dose-anakinra-to-treat-refractory-immune-effector-cell-associated-neurotoxicity-syndrome-in-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-nicotinamide-salvage-pathway-is-a-unique-metabolic-vulnerability-of-high-risk-mds-stem-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/volume-and-nature-of-classical-hematology-outpatient-consults-within-a-national-cancer-institute-des 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-educational-and-resource-needs-of-general-internal-medicine-physicians-in-sickle-cell-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kpg-818-a-novel-cereblon-crbn-modulator-in-patients-with-hematological-malignancies-results-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-cfdna-and-plasma-proteomics-reveal-inflammatory-heterogeneity-in-vaso-occlusive-cris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/founder-effects-and-consanguinity-shape-beta-thalassemia-genetics-a-five-year-hospital-based-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/belumosudil-in-pediatric-patients-with-steroid-refractory-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficient-potent-and-specific-near-universal-base-and-prime-editing-for-elane-mutant-severe-congen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-vitamin-d-is-an-unmodifiable-adverse-prognostic-factor-in-older-dlbcl-patients-results-from-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prkra-associated-with-nf-kb-activation-in-pulmonary-involvement-of-idiopathic-multicentric-castleman 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-recognition-and-optimized-management-of-tafro-syndrome-a-10-year-experience-from-a-single-cen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-the-phase-ii-d-prism-study-daratumumab-in-high-risk-mgus-and-low-risk-smoldering-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifngh-driven-mhc-class-ii-expression-by-intestinal-epithelial-cells-dictates-local-cytolytic-th1-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-united-states-nationwide-analysis-of-sickle-cell-genotype-specific-differences-in-inpatient-outcom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcomes-of-non-transplanted-newly-diagnosed-multiple-myeloma-patients-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-clinical-outcomes-in-multiple-myeloma-patients-treated-with-chimeric-antigen-receptor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-efficacy-to-experience-52-week-patient-reported-outcomes-with-mim8-in-adolescents-and-adults-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hiv-status-on-clinical-outcomes-in-diffuse-large-b-cell-lymphoma-and-burkitt-lymphoma-a-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/finding-ferritin-footprints-in-5-fluorouracil-induced-cardiotoxicity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/academic-advantage-without-survival-benefit-a-national-cancer-database-analysis-of-primary-effusion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-ruxolitinib-on-corticosteroid-treatment-patterns-in-1147-patients-with-chronic-graft-versu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ectopic-ebv-infection-in-t-cells-following-allogeneic-hematopoietic-stem-cell-transplantation-clini 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ivosidenib-combined-with-venetoclax-and-azacitidine-for-the-treatment-of-newly-diagnosed-idh1-mutant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/superior-efficacy-and-persistence-of-orca-t-allogeneic-car1922-versus-autologous-car1922-in-high-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distribution-and-risk-for-bleeding-in-patients-with-cancer-by-anticoagulant-therapy-exposure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baricitinib-reveals-lgals3bp-as-a-novel-pathogenic-factor-and-therapeutic-target-in-immune-thrombocy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-holistic-trial-a-comprehensive-evaluation-of-two-second-line-therapeutic-approaches-for-immune 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gb3226-a-novel-orally-active-first-in-class-small-molecule-inhibitor-of-enl-yeats-and-flt3-kinase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vedolizumab-for-treating-steroid-refractory-lower-gastrointestinal-acute-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-frontline-fixed-duration-chemotherapy-in-mapk-pathway-altered-adult-langerhans-cell-hist 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-b-and-t-cell-lymphomas-with-anti-cxcr5-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-co-occurring-mutations-in-npm1-mutated-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ddx41-related-myeloid-neoplasms-insights-and-treatment-landscape-in-250-patients-managed-at-a-large 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advancing-strategies-to-improve-chemotherapy-adherence-in-young-children-with-all-understanding-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-survival-and-therapy-access-in-aya-acute-lymphoblastic-leukemia-a-real-world-analysi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-of-immune-genes-rearrangements-in-chinese-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-investigator-initiated-trial-of-epcoritamab-lenalidomide-in-treatment-naive-follicular-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-based-therapies-in-patients-with-relapsedrefractory-t-cell-prolymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/performance-of-radiomics-features-in-patients-with-peripheral-t-cell-lymphoma-data-from-internation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-emicizumab-in-patients-with-acquired-hemophilia-a-an-interim-safety-analysis-of-a-large-scal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ai-based-secure-and-privacy-preserving-synthetic-data-generation-platform-in-transfusion-dependent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-ribosomal-readthrough-as-a-precision-medicine-strategy-for-restoring-factor-viii-expressi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilization-and-tolerability-of-r-chop-and-r-mini-chop-in-patients-with-diffuse-large-b-cell-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-pola-r-chp-in-diffuse-large-b-cell-lymphoma-a-single-center-real-world-data-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-pentamidine-for-pneumocystis-jirovecii-prophylaxis-in-allogeneic-hematopoietic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloid-sarcoma-a-population-based-retrospective-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-epitranscriptomic-biomarker-discovery-through-ensemble-analysis-and-multi-omics-integration-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-testing-and-guideline-concordance-in-acute-myeloid-leukemia-across-an-indiana-health-system 2026-08-17 monthly 0.7 https://rjrindex.com/articles/practice-pattern-and-outcomes-in-dlbcl-by-genetic-subtypes-preliminary-results-from-a-large-scale-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polatuzumab-vedotin-in-combination-with-rituximab-cyclophosphamide-doxorubicin-and-prednisone-pol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-intratumoral-cd4-t-cell-abundance-and-frequency-correlates-with-durable-clinical-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypercoagulability-in-clonal-hematopoiesis-a-hidden-contributor-to-thrombosis-in-the-elderly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-high-dimensional-spatiotemporal-single-cell-and-3d-atlas-of-the-bone-marrow-microenvironment-durin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-time-multimodal-ai-outperforms-conventional-scores-for-early-risk-prediction-in-bcma-car-t-trea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/regional-hypometabolism-on-brain-fdg-pet-one-month-after-receiving-chimeric-antigen-receptor-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-6-and-ferritin-levels-predict-the-severity-of-cytopenia-post-car-t-cell-treatment-with-axi-cel-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-thrombocytopenic-purpura-after-allogeneic-hematopoietic-cell-transplantation-a-rare-but 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-and-cardiovascular-outcomes-among-patients-with-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/varnimcabtagene-autoleucel-in-relapsed-refractory-b-cell-malignancies-manufacturing-experience-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/generative-ai-powered-clinical-decision-support-in-germline-predisposition-to-myeloid-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/7-day-venetoclax-combined-with-intensive-chemotherapy-as-induction-treatment-in-high-risk-newly-diag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/knockdown-of-srsf10-enhances-the-sensitivity-of-aml-cells-to-cytosine-arabinoside-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-the-arhgap18pi3kakt-axis-with-vincristine-and-cytarabine-synergistically-suppresses-sene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-second-line-platinum-salvage-and-autologous-stem-cell-transplant-compared-to-cd19-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azeliragon-has-significant-activity-against-acute-myeloid-leukemia-blasts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/automated-subtype-classification-of-acute-leukemia-from-bone-marrow-smears-using-a-cross-platform-de 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-duvelisib-combined-with-chidamide-as-first-line-treatment-for-angioimmunoblas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-prevalence-of-hereditary-thrombophilia-variants-in-an-endogamous-jewish-mexican-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-elderly-patients-with-newly-diagnosed-multiple-myeloma-ndmm-a-retrospective-compariso 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-transplant-ineligible-newly-diagnosed-multiple-myeloma-patients-treated-in-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplant-following-car-t-cell-therapy-in-relapsedrefractory-adult-acute-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/performance-of-molecular-classifiers-relative-to-the-international-prognostic-index-ipi-for-overal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-plasmapheresis-on-mortality-and-length-of-stay-in-hospitalized-patients-with-thrombotic-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/torque-teno-virus-in-pediatric-car-t-recipients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-iib-randomized-clinical-trial-combining-oral-azacitidine-and-vididencel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-tqb3909a-novel-bcl-2-inhibitor-in-combination-with-azacitidine-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-outcomes-with-allo-hsct-in-nup214abl1-positive-acute-leukemia-a-pooled-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lymphodepletion-free-jl-lightning-car-t-targeting-cd19cd22bcma-achieved-100-cr-in-3-relapsedrefr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-interim-pet-in-patients-with-extranodal-natural-killert-cell-lymphoma-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-utilization-with-prophylactic-intravenous-anakinra-following-anti-cd19-car-t-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiplex-detection-of-gastrointestinal-microbiota-using-short-probes-in-graft-vs-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concizumab-efficacy-in-patients-with-hemophilia-ab-without-inhibitors-from-the-phase-3-explorer8-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vga039-as-a-protein-s-targeted-hemostatic-promoting-monoclonal-antibody-promotes-in-vitro-thrombin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-anemia-and-hypertensive-disease-related-mortality-among-adults-aged-65-ye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-radiation-in-limited-stage-diffuse-large-b-cell-lymphoma-in-the-modern-era 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-access-and-role-of-autologous-stem-cell-transplantation-in-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-mogamulizumab-trials-for-mature-t-cell-lymphomas-investigating-differences-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/switching-itp-patients-to-avatrombopag-from-other-tpo-ras-a-real-world-experience-of-the-spanish-it 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imatinib-in-chronic-myeloid-leukemia-a-comparative-assessment-of-patients-in-pivotal-clinical-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-deep-dive-into-the-bone-marrow-plasma-proteome-by-optimized-extracellular-vesicle-enrichment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-therapeutic-vulnerabilities-in-flt3-mutated-aml-through-customized-crispr-screens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-guided-optimization-of-anti-cd70-natural-ligand-based-car-lymphocytes-for-acute-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-efficacy-and-safety-of-romiplostim-n01-in-the-treatment-of-chemotherapy-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cta311-a-universal-anti-cd19-car-t-cell-therapy-with-improved-persistence-for-patients-with-cd19-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-barriers-to-treatment-access-in-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factor-analysis-of-relapse-risk-during-flt3-inhibitor-post-transplant-maintenance-therapy-follo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/underreporting-of-prognostic-factors-in-real-world-studies-for-bispecifics-in-relapsed-or-refractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-development-of-an-off-the-shelf-car-t-cell-therapy-co-targeting-cd19-and-cd38-for-broad-applicat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematologist-based-management-of-ocular-adverse-events-using-the-vra-tool-in-newly-diagnosed-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-patients-with-tp53-aml-treated-with-non-intensive-vidaza-venetoclax-chemotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odyssey-a-first-in-human-study-of-the-aldehyde-dehydrogenase-aldh-inhibitor-abd-3001-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interplay-between-mutant-dnmt3a-and-uba1-worsens-survival-through-altered-inflammatory-and-metabolic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-with-third-line-car-t-therapy-vs-alternative-treatment-in-dlbcl-a-propensity-scor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-cell-dynamics-following-rituximab-and-epcoritamab-as-first-line-therapy-for-patients-with-hig 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-in-the-global-south-mapping-the-unmet-burden-using-global-burden-of-disease-dal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cre-intestinal-colonization-correlates-with-increased-progression-risk-following-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-safety-profile-of-cd20-cd3-bispecific-antibodies-compared-to-immune-checkpoint-inhi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pathogenesis-on-dysregulated-blood-glucose-homeostasis-in-severe-hand-foot-mouth-disease-mouse-model 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impacts-of-ipss-m-and-conditioning-intensity-in-allogeneic-hematopoietic-cell-transplant-for-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-late-mortality-among-allogeneic-blood-or-marrow-transplant-bmt-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-of-luspatercept-and-erythropoiesis-stimulating-agent-esa-hematological-respo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/b-cell-kinetics-on-next-generation-sequencing-after-car-t-cell-therapy-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-stem-cell-transplantation-in-pediatric-and-adolescentyoung-adult-patients-with-trisomy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-avapritinib-on-skin-lesions-in-patients-with-advanced-systemic-mastocytosis-using-a-novel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ferritin-change-and-predictors-of-anemia-response-in-ruxolitinib-intolerant-myelofibrosis-patients-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-bone-marrow-inflammatory-cytokine-network-in-aml-prognosis-and-immune-evasion-a-foc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineering-dual-specificity-ppm1d-inhibitors-to-enhance-therapeutic-response-and-overcome-chemoresi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-associated-healthcare-utilization-in-older-adults-with-aml-a-retrospective-single-center 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-mtor-and-cdk1-regulated-translation-circuits-sustain-flt3-mutated-aml-survival-under-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sociodemographic-determinants-of-survival-in-acute-lymphoblastic-leukemia-a-20-year-seer-based-anal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-canakinumab-in-patient-with-myelofibrosis-results-from-part-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/us-mortality-trends-in-acquired-aplastic-anemia-1999-2021-a-joinpoint-analysis-using-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-landscape-of-extranodal-marginal-zone-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sapport-a-specialty-training-program-for-advanced-practice-providers-to-increase-knowledge-and-acce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-of-pediatric-b-all-bone-marrow-to-determine-mechanisms-of-durable-cd19-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/6-gingerol-ameliorates-murine-gastrointestinal-graft-versus-host-disease-by-inhibiting-pyroptosis-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacogenetic-variants-in-ugt1a1ugt1a3-and-abcc2-associate-with-deferasirox-efficacy-in-transfusi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/n-glycosylation-of-monoclonal-immunoglobulins-across-plasma-cell-dyscrasias-in-routine-care-a-cohor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improvements-in-health-related-quality-of-life-hrqol-in-the-sunmo-study-subcutaneous-sc-mosunet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-lrp1-antibody-that-identifies-upregulation-of-membrane-lrp1-on-activated-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-burden-across-hematologic-and-solid-tumors-a-real-world-comparative-study-in-aml-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monocytosis-as-prognostic-factor-for-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-distributions-of-lymphocyte-subsets-in-myelodysplastic-syndrome-correlate-with-risk-stratif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-sequencing-bispecific-antibodies-bsab-in-patients-with-relapsed-refractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-serious-bleeding-with-concomitant-use-of-apixaban-or-rivaroxaban-with-amiodarone-compared-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tgf-v-regulates-cd123-and-chemotherapy-resistance-in-acute-myeloid-leukemia-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-atrial-fibrillation-and-anemia-related-mortality-in-adults-aged-25-years 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thiopurine-pharmacogenomic-landscape-in-india-tpmt-and-nudt15-allele-frequencies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-genomic-differences-in-hispanic-vs-non-hispanic-patients-with-primary-central-nervous-system-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lessintensive-therapy-in-newly-diagnosed-acute-myeloid-leuekmia-aml-in-india-real-world-adoption 2026-08-17 monthly 0.7 https://rjrindex.com/articles/osteoblasts-differentiated-from-fviii-deficient-mice-exhibit-impaired-mineralization-capacity-and-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/durable-efficacy-of-lenzilumab-plus-azacitidine-in-newly-diagnosed-proliferative-cmml-patients-inte 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-brd4-to-reshape-the-inflammatory-microenvironment-of-senescent-bone-marrow-mesenchymal-ste 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-anti-hlh-and-antitumor-efficacy-of-golidocitinib-in-relapsedrefractory-ptcl-associated-hemopha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilisation-of-machine-learning-algorithms-to-predict-relapse-risk-following-allogeneic-stem-cell-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-autologous-hct-versus-haploidentical-donor-hct-for-ph-b-all-patients-following-tki-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-for-non-invasive-molecular-characterization-and-measurable-residual-disease-analysis-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reproductive-health-across-the-lifespan-in-acute-hepatic-porphyria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sensitive-peripheral-residual-disease-prd-detection-using-clonotypic-mass-spectrometry-easym-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rnabinding-protein-fxr1-stabilizes-receptor-tyrosine-kinase-fgfr1-and-enhances-pi3kakt-signaling-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/y-chromosome-loss-drives-sex-disparities-in-multiple-myeloma-by-reshaping-the-immune-landscape 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-meets-real-world-disparities-a-seer-based-study-of-acute-myeloid-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-patient-reported-value-of-treatment-attributes-in-follicular-lymphoma-insights-from-the-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-allogeneic-bcma-car-expressing-inkt-cells-with-pd1-deletion-demonstrate-superior-tumor-control 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-daratumumab-plus-bortezomib-lenalidomide-and-dexamethasone-d-vrd-vs-borte 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-profiling-of-pediatric-acute-myeloid-leukemia-reveals-distinct-genetic-la 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-associated-cardiotoxicity-a-systematic-review-of-case-reports-observational-studies-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discovering-the-epidemiology-treatment-patterns-and-outcomes-of-chronic-lymphocytic-leukemia-a-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selective-aso-based-jak2-inhibitor-for-the-treatment-of-hematological-malignancies-with-jak2-v617f-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-acute-pain-on-health-care-resource-utilization-and-costs-in-sickle-cell-disease-in-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-first-in-class-oral-clinical-candidate-targeting-mllt1-and-3-degradation-for-the-treatment-of-adva 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ml-driven-analysis-of-iscn-karyotypes-enables-detection-of-novel-prognostic-markers-in-chronic-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-allo-hct-menin-inhibition-enhances-graft-versus-leukemia-effects-by-endogenous-retrovirus-induc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unlocking-new-frontiers-in-leukemia-diagnostics-through-large-language-model-driven-report-generatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-unit-cord-blood-transplantation-reduces-the-risk-of-relapse-and-improves-leukemia-free-surviv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-signatures-mirror-divergent-modalities-of-leukemia-immune-evasion-and-relapse-after-transp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-experience-of-axicabtagene-ciloleucel-car-t-in-refractoryrelapsed-b-cell-lymphoma-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-center-real-world-analysis-of-treatment-outcomes-of-non-covalent-btki-pirtobrutinib-in-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-i-study-evaluating-the-safety-and-preliminary-efficacy-of-amulirafusp-alfa-imm0306-in-comb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-with-novel-agent-combination-therapies-for-the-frontline-treatment-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-invasive-classification-amp-molecular-subtyping-of-mature-lymphoid-neoplasms-by-cell-free-dna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/meteorological-impact-on-ventricular-arrhythmias-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypoxia-driven-complement-activation-expands-circulating-endothelial-cells-in-transplant-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-surfaceome-mapping-in-aml-identifies-cd85d-as-an-immunotherapy-target 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-combined-with-decitabine-intensified-modified-busulfancyclophosphamide-conditioning-reg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/r-propranolol-promotes-lipid-synthesis-via-a-novel-non-adrenergic-pathway-to-treat-sickle-cell-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selective-germline-testing-in-multiple-myeloma-patients-yields-a-six-fold-increase-in-actionable-can 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-elranatamab-a-bcma-bispecific-antibody-for-patients-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifn-gh-drives-long-term-bone-marrow-niche-dysfunction-following-chemotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-mrna-based-cytomegalovirus-vaccine-induces-robust-t-cell-immune-responses-in-cytomegalovirus-sero 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-thromboembolism-related-mortality-among-patients-with-hematologic-malignancies-in-the-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-safety-and-efficacy-in-a-phase-2-study-of-mb-105-a-cd5car-t-therapy-for-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tcr-t-cells-expressing-a-tcr-recognizing-the-mpo-propeptide-derived-mpo132-140hla-a0201-specifica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cell-therapy-related-cytokine-release-syndrome-and-neurotoxicity-real-world-outcomes-from-a-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-real-world-analysis-of-ropeginterferon-alfa-2b-use-in-patients-with-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-open-label-phase-1-study-of-a-novel-cd30-directed-antibody-drug-conjugate-with-a-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-mt-601-in-relapsed-or-refractory-rr-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-metabolic-profiling-of-post-infusion-cd22-and-cd19cd22-car-t-cells-reveals-a-shift-towa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/initial-clinical-data-from-the-phase-1-study-of-dr-01-a-non-fucosylated-anti-cd94-antibody-in-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/addition-of-thiotepa-to-a-busulphan-based-conditioning-regimen-does-not-improve-survival-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biallelic-tp53-aberrations-and-double-tp53-mutations-are-prevalent-in-amlmds-patients-with-del5q 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-and-cause-specific-mortality-of-aml-in-adults-from-chile 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glofitamab-based-combined-therapy-as-bridging-therapy-before-stem-cell-transplants-and-car-t-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effiefficacy-and-safety-of-allogeneic-cd123-car-nk-cell-therapy-in-relapsedrefractory-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mo-trans-update-a-randomized-double-blind-placebo-controlled-multi-center-phase-iii-study-of-moc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-epcoritamab-in-relapsedrefractory-diffuse-large-b-cell-lymphoma-rr-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-epcoritamab-r-chop-in-patients-with-newly-diagnosed-dlbcl-and-high-ipi-scores-3-5 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-treatments-with-food-restrictions-on-adherence-and-quality-of-life-aspects-among-cml-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-germline-and-somatic-mutation-profile-of-diamond-blackfan-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-recovery-and-immunologic-remodeling-after-cd19-directed-chimeric-antigen-receptor-t-cell-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-inaticabtagene-autoleucel-in-adult-b-cell-acute-lymphoblastic-leukemia-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-following-pemivibart-for-covid-19-pre-exposure-prophylaxis-in-immunocompromised 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pomalidomide-salvage-in-t-cell-engager-monotherapy-failures-real-world-experience-with-talquetamab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-recipient-sociodemographic-factors-on-allogeneic-transplant-conditioning-intensity-and-sur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-combined-with-venetoclax-for-pre-emptive-treatment-of-amlmds-after-allogeneic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-spontaneous-hlh-mouse-model-by-engrafting-human-hscs-into-b-ndg-mgmt3-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preservation-of-gonadal-function-following-chemotherapy-protocols-with-acvd-and-acvd-bv-in-adults-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-determinants-of-hepatosplenic-t-cell-lymphoma-hstcl-analysis-of-an-updated-real-world-po 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-characterization-of-platelets-in-immune-thrombocytopenia-indicates-sustained-activati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decitabine-enhances-the-cytotoxic-effect-of-ruxolitinib-in-myeloproliferative-neoplasms-by-targeting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mga-loss-promotes-mitochondrial-structure-changes-and-redox-adaptation-in-richters-transformation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fludarabine-cyclophosphamide-and-melphalan-fcm-preconditioning-in-haploidentical-hematopoietic-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-adherence-to-oral-cll-therapies-in-community-oncology-centers-key-findings-from-a-qualit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-presence-of-sh2b3-mutations-identifies-a-distinct-subtype-of-myelodysplastic-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-activity-and-immune-correlates-of-glofitamab-combined-with-tislelizumab-in-relapsedrefract 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-development-of-an-optimized-manufacturing-crispr-edited-fully-non-viral-1xx-enhanced-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/motixafortide-g-csf-hematopoietic-stem-cell-mobilization-in-patients-with-multiple-myeloma-followi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-genomic-landscape-amp-response-dynamics-of-hiv-associated-lymphomas-identified-by-integra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unveiling-prognostic-subtypes-in-myelofibrosis-through-routine-blood-counts-a-population-based-anal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reviewing-management-of-venous-thromboembolism-in-elderly-lymphoma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zfp36l2-as-a-promising-therapeutic-target-in-acute-graft-versus-host-disease-evidence-from-murine-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyclin-d1-beyond-the-cell-cycle-a-new-role-in-t1114-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-open-label-study-of-ctd402-a-universal-cd7-targeting-car-t-cell-therapy-in-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transgenic-expression-of-enhanced-ascas12a-in-mice-enables-in-vivo-multiplex-genetic-editing-and-dev 2026-08-17 monthly 0.7 https://rjrindex.com/articles/test-characteristics-of-end-of-treatment-pet-scans-in-diffuse-large-b-cell-lymphoma-in-a-population 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-patients-with-hairy-cell-leukemia-treated-with-first-line-cladribine-in-britis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-health-literacy-among-patients-with-thalassemia-results-from-a-global-patient-survey 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blood-board-a-virtual-forum-for-classical-hematology-education-and-care-improvement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myelodysplasticmyeloproliferative-overlap-neoplasms-clinicopathological-features-treatment-strate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/paroxysmal-cold-hemoglobinuria-associated-with-monoclonal-b-cell-lymphocytosis-in-an-elderly-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-analysis-of-allo-hsct-for-relapsed-and-refractory-aggressive-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-arm-meta-analysis-of-melflufen-based-regimens-in-relapsedrefractory-multiple-myeloma-effica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematopoietic-jak2v617f-mutation-increases-susceptibility-to-atrial-fibrillation-via-nlrp3-inflammas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unraveling-the-mysteries-of-platelet-fatigue-in-cold-storage-calcium-release-dynamics-and-energy-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protein-levels-of-isocitrate-dehydrogenase-1-and-2-are-prognostic-and-independent-of-mutation-status 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idh2-r172-mutation-is-associated-with-improved-survival-in-idh-mutated-amlmds-patients-undergoing-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/runx1-mutations-define-a-high-risk-biological-subset-of-chronic-myelomonocytic-leukemia-and-cooperat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-and-integrated-analysis-of-oral-and-stool-microbiome-in-allogeneic-hematopoietic-cell-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abatacept-in-combination-with-post-transplant-cyclophosphamide-and-tacrolimus-may-improve-survival-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upfront-continuous-btk-inhibitor-btki-versus-time-limited-venetoclax-btki-combinations-in-cll-acro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/foreign-antigen-delivered-to-cll-b-cells-via-membrane-igd-leads-to-a-distinct-antigen-processing-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-genomic-analysis-for-the-early-identification-of-complement-abnormalities-in-adults-with-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-ipss-m-a-comorbidity-integrated-model-for-improved-clinical-risk-stratification-in-myelody 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dex-and-il-7-enhance-persistence-of-car-t-cells-to-promote-long-term-remission-in-mouse-models-of-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-t-follicular-helper-cell-lymphoma-a-prognostic-biomarker-and-early-event-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-risk-stratification-in-patients-with-direct-antixa-inhibitors-related-bleedi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcome-of-bridging-therapy-in-chimeric-antigen-receptor-t-cell-treatment-for-relapsedrefractory-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-predictors-of-inpatient-mortality-in-patients-with-aplastic-anemia-a-7-year-national-inp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/translational-potential-in-research-focused-on-hematological-neoplastic-diseases-results-of-automa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/performance-of-different-large-language-models-llms-as-decision-support-tools-across-various-hemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mim8-improves-the-in-vivo-hemostasis-of-select-hemophilia-b-causing-factor-ix-variants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-cohort-analysis-of-treatment-patterns-and-bleeding-outcomes-in-the-korean-bleeding-dis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-from-haven-1-4-to-further-contextualize-injection-site-reactions-among-people-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-normalization-of-platelet-counts-in-patients-with-refractory-thrombocytopenia-associated-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-disease-risk-scores-as-predictors-of-cardiovascular-disease-and-heart-failure-in-allo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-identifies-a-klf5-neutrophil-plasma-cell-axis-driving-immune-suppression-in-poe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-dissociated-and-spatial-single-cell-profiling-reveals-that-hdac-inhibition-restores-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-in-patients-with-sh2b3-mutated-erythrocytosis-a-retrospective 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-influencing-relapse-and-survival-of-childhood-acute-lymphoblastic-leukemia-with-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-of-diffuse-large-b-cell-lymphoma-racial-and-socioeconomic-disparities-in-a-natio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-platelet-variability-index-tool-to-determine-the-likelihood-of-immune-thrombocytopenia-itp-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-variants-in-congenital-fibrinogen-deficiency-by-next-generation-sequencing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aiming-at-immune-fitness-in-cancer-longitudinal-functional-profiling-to-predict-clinical-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golseek-1-a-phase-3-double-blind-randomized-study-of-golcadomide-golca-a-potential-first-in-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/s100a8a9-drives-t-cell-exhaustion-and-compromises-the-therapeutic-efficacy-of-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effects-of-curative-and-disease-modifying-therapies-on-ineffective-erythropoi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-mechanism-of-btk-degrader-nx-5948-in-secondary-hemophagocytic-lymphohistiocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hematopoietic-lineage-specific-deletion-of-cyb5r3-on-steady-state-and-stress-erythropoiesi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aplastic-anemia-mortality-in-the-united-states-1999-2023-trends-disparities-and-public-health-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-venous-and-arterial-thromboembolic-events-following-car-t-therapy-in-relapsed-or-refractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-dual-primary-t-cell-and-b-cell-lymphoid-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/smartphone-app-for-noninvasive-at-home-pediatric-hemoglobin-monitoring-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-enables-automated-quantification-of-hematopoietic-stem-and-progenitor-cells-hspcs-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-trajectory-and-prognosis-of-measurable-residual-disease-mrd-in-t1114-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-bispecific-blind-spot-uncovering-real-world-inequities-in-diffuse-large-b-cell-lymphoma-follic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-related-deaths-among-patients-aged-65-years-with-b-cell-malignancies-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/target-antigen-density-may-impact-clinical-response-in-patients-with-relapsedrefractory-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epithelial-growth-factor-like-7-egfl7-regulates-hematopoiesis-stem-cell-hsc-activation-via-ap-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lower-neutrophil-counts-after-hematopoietic-stem-cell-transplant-for-sickle-cell-disease-patients-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phf19-inhibition-increases-imids-sensitivity-by-epigenetically-regulating-irf4-and-myc-in-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-associated-with-conditioning-regimens-in-patients-with-primary-central-nervous-sys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-car-t-pulmonary-function-test-and-respiratory-comorbidities-have-limited-predictive-value-for-su 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-updated-uk-real-world-analysis-of-factors-affecting-outcome-following-brexucabtagene-autoleucel-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-characteristics-and-outcomes-of-acute-lymphoblastic-leukemia-all-in-adults-with-central-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-for-hemophilia-a-since-the-launch-of-emicizumab-in-the-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abc-highly-active-and-entirely-calcineurin-and-m-tor-inhibitor-free-gvhd-prevention-regimen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oxidative-stress-and-hemoglobin-c-denaturation-drive-hemoglobin-sc-pathophysiology-and-can-be-amelio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-inflammatory-drug-pegtarazimod-rls-0071-demonstrates-clinical-improvement-in-lower-gastrointe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-i-study-of-jak-inhibitor-ruxolitinib-with-and-without-ctla-4-ig-abatacept-for-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-circulating-activated-foxp3-regulatory-t-cell-subset-in-patients-with-advanced-chronic-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanism-of-acquired-resistance-to-histone-deacetylase-inhibitor-romidepsin-in-myeloid-leukemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacological-targeting-of-ctps1-elicits-macrophage-mediated-anti-leukemia-immunity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-chromatin-remodeling-protein-arid1a-is-required-for-mll-af9-leukemogenesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-archetypes-of-clonal-dynamics-underlie-response-and-resistance-to-diverse-cll-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-burdens-associated-with-receiving-car-t-cell-therapy-a-qualitative-study-of-car-t-patients-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sight-sickle-cell-identification-from-general-hematological-testing-a-machine-learning-approach-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-prognostic-modeling-of-venetoclax-enhanced-intensive-chemotherapy-in-fit-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd3cell-dose-is-an-independent-risk-factor-for-grade-ii-iv-agvhd-following-cord-blood-transplantati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-stem-cell-collection-for-patients-with-multiple-myeloma-undergoing-autologous-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-immune-profiling-in-newly-diagnosed-multiple-myeloma-associations-with-mrd-status 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-ameliorates-refractory-chronic-graft-versus-host-disease-through-sh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-a-decade-without-treatment-time-to-first-treatment-in-cll-in-a-chilean-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-challenges-in-adult-hemophagocytic-lymphohistiocytosis-a-case-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sinusoidal-endothelial-cell-derived-fgf23-modulates-hematopoiesis-in-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-drug-response-profiling-predicts-clinical-outcomes-and-shows-utility-for-treatment-strati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-chronic-kidney-disease-on-outcomes-in-patients-admitted-with-acute-promyelocytic-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-medicaid-expansion-on-survival-outcomes-among-individuals-with-chronic-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rxr-agonist-irx4204-enhances-bcma-car-t-cell-efficacy-by-suppressing-ferroptosis-via-chac1-downregul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-reveals-proliferative-immune-evasive-and-bone-marrow-independent-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genotype-guided-comparison-of-ven-hma-versus-intensive-chemotherapy-in-newly-diagnosed-intermediate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-new-deferasirox-derived-compounds-for-the-treatment-of-iron-overload 2026-08-17 monthly 0.7 https://rjrindex.com/articles/study-of-video-electroencephalogram-features-for-predicting-28-day-survival-in-critical-hematologic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-with-intermediate-intensity-pediatric-inspired-regimen-and-allo-hsct-in-adults-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-car-t-idecabtagene-vicleucel-in-advanced-myeloma-plus-iberdomide-or-usual-monit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/duffy-null-phenotyping-reduces-unnecessary-workup-in-asymptomatic-neutropenia-a-quality-initiative 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-hla-loss-clones-are-required-for-hematologic-regeneration-in-immune-aplastic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-bortezomib-thalidomide-and-dexamethasone-improves-renal-outcomes-in-multiple-myeloma-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-impact-of-somatic-mutations-in-patients-with-aplastic-anemia-aa-undergoing-allogene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/castleman-disease-as-a-spectrum-characterization-of-novel-subtypes-using-data-from-the-spanish-gelt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effects-of-golidocitinib-and-gecacitinib-in-mouse-models-of-primary-and-secondary-hemophagocytic-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fraternal-but-not-identical-twins-hlh-and-icans-look-a-lot-alike 2026-08-17 monthly 0.7 https://rjrindex.com/articles/navigating-hematology-and-medical-oncology-fellowship-websites-a-comprehensive-review-and-implicati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/septin6-mutations-in-pediatric-myelodysplastic-syndrome-disrupt-nuclear-actin-organization 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd43-functions-as-a-cd47-independent-dont-eat-me-signal-and-novel-immune-checkpoint-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-targeting-of-focal-adhesion-kinase-fak-modulates-oncogenic-and-immune-pathways-in-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/title-hacs1-is-a-myeloma-immunosuppressor-driving-pro-tumorigenic-myelopoiesis-and-myeloid-cell-dif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-immunophenotyping-reveals-mutation-specific-immune-alterations-in-severe-congenital-neut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-treatment-initiation-and-early-outcomes-among-patients-with-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-high-dose-methotrexate-treatment-regimens-to-improve-exposure-and-mitigate-toxicity-in-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-patients-with-indolent-acute-myeloid-leukemia-long-term-survivors-after-best-supportive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toxicity-efficacy-and-clinical-management-of-bispecific-antibodies-in-routine-clinical-practice-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-serum-tie-2-levels-in-newly-diagnosed-and-untreated-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-cerebral-venous-sinus-thrombosis-in-hematologic-malignancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-bispecific-antibodies-into-community-myeloma-care-challenges-insights-and-educational 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maternal-morbidity-and-predictors-of-adverse-outcomes-in-pregnant-women-with-sickle-cell-disease-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-the-unknown-leveraging-machine-learning-to-predict-adverse-outcomes-in-pregnant-women-with-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extranodal-involvement-of-the-gastrointestinal-tract-in-post-transplant-lymphoproliferative-disorder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-and-tolerability-of-a-cd4-re-directed-chimeric-antigen-receptor-t-cell-therapy-cd4car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-v-thalassemia-mouse-model-by-deleting-hbb-genes-for-therapeutic-evaluation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-morbidities-and-predictors-in-transfusion-dependent-thalassemia-a-cohort-study-over-10 2026-08-17 monthly 0.7 https://rjrindex.com/articles/congenital-dyserythropoietic-anemia-type-i-updated-report-from-the-congenital-dyserythropoietic-ane 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ap-3-targets-the-mrgbptip60myc-axis-to-exert-potent-anti-t-all-effects-in-a-notch1-independent-man 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterisation-of-the-megakaryocyte-proteome-in-patients-with-philadelphia-negative-myeloprolifera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/activating-stim1-mutations-drive-the-development-of-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oxygen-dependency-as-a-critical-regulatory-axis-affecting-hematopoietic-stem-and-progenitor-cell-fun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-management-of-congenital-thrombotic-thrombocytopenic-purpura-in-latin-america-expert-conse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pola-based-therapy-in-molecularly-defined-high-risk-dlbcl-a-retrospective-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intelligent-bispecific-bcma-cd24-car-t-cells-for-precision-navigation-and-elimination-of-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-external-validation-of-an-individuals-machine-learning-clinical-decision-support-prediction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interpretable-deep-learning-predicts-polycythemia-vera-and-identifies-novel-genomic-associations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stepwise-leukemogenesis-and-therapeutic-targets-revealed-in-b-cell-acute-lymphoblastic-leukemia-driv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/split-dose-r-chop-mitigates-toxicity-while-preserving-dose-intensity-and-response-in-frail-elderly-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-epcor-monotherapy-offers-long-term-disease-control-in-large-b-cell-lymphoma-lbcl-nh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/human-hepatocyte-engraftment-in-f8ko-tk-nog-mice-creating-a-novel-hemophilia-a-mouse-model-with-fun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-combined-with-dexamethasone-is-a-promising-prophylaxis-method-for-differentiation-syndro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-prophylaxis-in-people-with-non-severe-hemophilia-in-the-united-states-insights-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-immune-profiling-reveals-t-cell-exhaustion-in-ebv-monomorphic-ptld-vs-immunocompetent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-unified-spatial-amp-molecular-atlas-of-anatomically-restricted-large-b-cell-lymphomas-defines-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ev-mirnas-predict-outcomes-in-pediatric-aml-a-pilot-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-activating-antibodies-to-the-chemokine-platelet-factor-4-in-cerebral-malaria-differ-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oncodif-an-auditable-ai-framework-for-automated-genomic-curation-and-natural-language-clinical-quer 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-immune-reconstitution-dynamics-in-refractory-t-all-treated-with-cd7-car-t-cells-bridgin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-immune-checkpoint-landscapes-in-pcnsl-and-scnsl-revealed-by-single-nucleus-profiling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mapping-out-the-impact-of-map-kinase-in-primary-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-ngs-detection-of-tp53-mutations-in-chronic-phase-primary-myelofibrosis-comparative-analyse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ponatinib-as-a-consolidation-strategy-for-a-second-attempt-at-tki-discontinuation-in-chronic-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-modified-delphi-consensus-on-the-management-of-patients-with-relapsed-or-refractory-flt3-mutated-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-temporal-trends-and-demographic-disparities-in-primary-immunodeficiency-related-mortality-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-parsimonious-clinically-interpretable-logistic-model-for-anemia-in-plwha-feature-selection-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differential-impact-of-clonal-hematopoietic-mutations-on-10-year-atherosclerotic-cardiovascular-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-ctcs-combined-with-frailty-index-offer-an-improved-stratification-system-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liposomal-mitoxantrone-versus-chidamide-in-relapsedrefractory-peripheral-t-cell-lymphoma-final-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combining-mertk-inhibitor-mrx-2843-with-venetoclax-and-5-azacitidine-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tali-cel-is-a-safe-and-effective-therapy-in-patients-with-relapsedrefractory-b-cell-non-hodgkin-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-adolescent-and-young-adult-aya-age-acuity-of-illness-at-diagnosis-and-clinic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/progression-of-disease-within-36-months-pod36-of-starting-first-line-targeted-therapy-independentl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-guided-venetoclax-obinutuzumab-in-cll-final-analysis-of-the-cll2-bag-trial-of-the-gcllsg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiomic-correlates-of-ex-vivo-acd19-chimeric-antigen-receptor-t-cell-cart-cytotoxicity-in-veneto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/demographic-trends-in-acute-myeloid-leukemia-related-mortality-in-the-united-states-a-25-year-natio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-depth-quantitative-characterization-of-important-regulators-and-predictive-biomarkers-for-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/live-imaging-of-human-xenogeneic-cart-cells-in-a-clinical-trial-of-companion-dogs-with-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diffuse-large-b-cell-lymphoma-in-brazil-understanding-the-patient-journey-to-improve-healthcare-ass 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-cardiac-outcomes-after-car-t-in-patients-with-hematologic-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-newly-diagnosed-non-germinal-center-large-b-cell-lymphoma-patients-treated-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-lymphoproliferative-disorders-in-adult-transplant-recipients-preliminary-results-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/space-associated-stem-cell-hallmarks-of-aging-sasha-in-astronauts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chimeric-antigen-receptor-car-t-cell-persistence-at-month-3-predicts-clinical-outcomes-in-adult-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lenalidomide-len-and-anti-cd38-monoclonal-antibodies-mabs-utilization-in-patients-with-newly-dia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyclophosphamide-versus-methotrexate-for-treating-large-granular-lymphocyte-leukemia-real-world-dat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloid-derived-suppressor-cells-are-expanded-in-the-antiphospholipid-antibody-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognosis-of-therapy-related-hematological-neoplasms-a-single-center-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-silico-design-of-degron-tags-for-precise-modulation-of-car-t-cell-activity-using-clinically-utili 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-kinetics-of-circulating-multiple-myeloma-cells-cmmcs-predict-resistance-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disruption-of-nad-and-gshgpx4-axis-via-nampt-inhibition-by-elaiophylin-sensitizes-aml-to-ferroptos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-romiplostim-n01-in-cancer-treatment-induced-thrombocytopenia-results-from-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-economic-burden-of-cytokine-release-syndrome-in-a-nationally-representative-cohort-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlates-of-response-to-combined-checkpoint-and-btk-inhibition-for-treatment-of-richter-transforma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/three-year-efficacy-and-longitudinal-safety-of-lisocabtagene-maraleucel-liso-cel-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatiotemporal-and-genetic-tracking-of-long-term-persisting-car-t-cells-following-ciltacabtagene-aut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gvhd-intel-10-a-scalable-hla-enhanced-machine-learning-model-for-predicting-acute-and-chronic-gvh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-targeted-car-t-cells-for-multi-refractory-primary-immune-thrombocytopenia-a-pilot-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adverse-event-profiles-of-acalabrutinib-and-zanubrutinib-in-chronic-lymphocytic-leukemia-a-real-wor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/xeroderma-pigmentosum-as-a-germline-predisposition-syndrome-for-haematological-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-first-line-luspatercept-in-patients-with-myelodysplast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monoclonal-gammopathy-related-coagulopathies-a-systematic-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-antecedent-clonal-hematopoiesis-ch-mutations-in-lymphoid-and-plasma-cell-neopl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/five-year-interim-analysis-of-multi-institutional-collaborative-study-for-estimating-the-persistence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd90-targeted-multiplex-virus-like-particles-mvps-for-concomitant-in-vivo-gene-editing-transducti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-efficacy-of-zanubrutinib-vs-ibrutinib-for-the-treatment-of-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-tolerability-and-efficacy-of-mesutoclax-to-treat-patients-with-myeloid-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-dose-escalation-and-safety-study-of-cid-103-followed-by-a-randomized-open-label-parallel-arm-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/examining-tp53-mutated-plasma-cell-disorders-across-the-disease-spectrum-using-broad-next-generation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-venetoclax-and-hypomethylating-agents-hma-in-blastic-plasmacytoid-dendritic-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-dna-methylation-based-classification-of-hematological-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-safety-of-oral-administration-of-hbi-002-carbon-monoxide-drug-product-in-healthy-subjects-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-transfusion-is-associated-with-reduced-thrombosis-yet-elevated-mortality-in-consumptive-thr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-phase-1-study-of-incb160058-a-first-in-class-jak2v617f-mutant-selective-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-duffy-genotype-on-progression-free-survival-pfs-with-lenalidomide-bortezomib-and-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hallmarks-of-allogeneic-hematopoietic-cell-transplant-success-a-study-on-immune-signatures-and-pred 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dose-and-btk-occupancy-relationship-in-the-prospective-phase-2-tailor-study-exploratory-end-point-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-prognostic-mutations-on-outcomes-with-fixed-duration-acalabrutinib-venetoclax-combinations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-ct0596-an-allogeneic-car-t-cell-therapy-targeting-bcma-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unravelling-molecular-determinants-of-ruxolitinib-treatment-response-in-myelofibrosis-using-single-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-dual-targeting-bcma-and-cd19-fastcar-t-gc012fazd0120-as-first-line-therapy-for-newly-diagnosed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hetrombopag-for-the-treatment-of-chemotherapy-induced-thrombocytopenia-in-advanced-solid-tumors-a-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hem-ismart-an-international-proof-of-concept-therapeutic-stratification-trial-of-molecular-anomalie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revumenib-for-patients-with-relapsed-or-refractory-rr-kmt2ar-acute-leukemia-outcomes-by-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-generation-of-anti-cd19-car-t-cells-for-the-treatment-of-b-cell-mediated-autoimmune-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crenolanib-plus-salvage-chemotherapy-improves-outcomes-in-flt3-mutant-and-npm1-co-mutated-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emapalumab-induces-rapid-durable-responses-and-reliable-bridging-to-curative-hsct-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-from-the-first-clinical-trial-of-the-selective-glyt1-inhibitor-bitopertin-for-steroid-refrac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-long-term-antigen-spreading-by-novel-cancer-vaccine-with-hyaluronic-acid-nanogel-accelerate-the-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/uric-acid-a-potent-antioxidant-with-protective-and-toxic-affects-on-renal-function 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-first-line-selinexor-plus-r-chop-in-tp53-mutated-diffuse-large-b-cell-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-demographics-of-autoimmune-hemolytic-anemia-in-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-isa-vrd-in-elderly-patients-with-or-without-frailty-criteria-pooled-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-new-prognostic-index-clipi-stratifies-risk-in-advanced-cutaneous-lymphomas-associations-with-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-antithrombin-sirna-fitusiran-as-prophylaxis-in-haemophilia-a-and-b-a-sys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploiting-hla-e-restricted-t-cell-receptors-to-develop-universal-cellular-therapies-for-virus-assoc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-receptors-targeting-mutant-npm1-for-adoptive-cell-therapy-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dosing-patterns-of-ponatinib-in-patients-with-chronic-phase-chronic-myeloid-leukemia-and-effect-on-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-dose-optimization-phase-1b2-study-evaluating-mipletamig-formerly-apvo436-a-novel-bispecific-cd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/altered-osteoblast-populations-dynamics-underlie-myeloma-progression-from-precursors-diseases-in-bon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-erythroid-response-in-the-phase-3-believe-trial-of-luspatercept-in-patients-with-transfus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-update-safety-and-efficacy-of-gprc5d-targeting-car-t-cell-therapy-in-relapsedrefractory-multipl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-genotoxic-conditioning-to-increase-donor-chimerism-levels-in-a-mismatched-murine-transplant-mode 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-and-ppm1d-mutations-in-aml-distinct-frequencies-shared-pathway-and-adverse-prognostic-trends 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-sepsis-related-mortality-among-patients-with-acute-myeloid-leukemia-a-24-year-nationwide 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-transplant-bone-marrow-cellularity-and-fibrosis-on-post-transplant-outcomes-in-sickle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-to-clinical-trial-enrollment-for-children-with-relapsed-or-refractory-hematolog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-subtypes-and-bh3-mimetic-synergy-with-anti-leukemia-agents-in-t-cell-acute-lymphoblastic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-exploratory-analysis-of-health-related-quality-of-life-measures-with-belantamab-mafodotin-in-comb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/usp28-inhibition-upregulates-cd20-via-c-myc-suppression-and-synergizes-with-anti-cd20-immunotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-elranatamab-in-relapsedrefreactor-multiple-myeloma-a-single-center-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-monotherapy-study-assessing-the-safety-and-efficacy-of-gr1803-a-bcmacd3-bispecific-antib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-leukemic-efficacy-of-a-novel-inhibitor-for-kmt2a-rflt3-driven-aml-via-multi-kinase-targeting-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-pathways-of-antibody-dependent-phagocytosis-distinct-kinetics-finite-capacities-and-therapeu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/visualizing-systemic-light-chain-amyloidosis-with-18f-flutemetamol-petct-correlation-with-biomarke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-the-impact-of-chronic-red-blood-cell-transfusion-on-day-to-day-functioning-in-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/point-of-care-musculoskeletal-ultrasound-in-hemophilic-arthropathy-evidence-synthesis-clinical-imp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-second-line-therapies-for-chronic-immune-thrombocytopenia-a-network-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-inactivation-of-duodenal-ferroportin-by-hepcidin-drives-iron-dependent-degradation-of-dmt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-risk-of-thrombosis-in-adults-with-primary-immune-thrombocytopenia-treated-with-eltrombop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-mineral-density-findings-in-patients-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-rearrangement-partner-and-the-presence-of-myc-mutations-determines-outcome-of-patients-with-myc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-roles-of-proton-pump-inhibitors-in-estrogen-induced-venous-thromboembolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-g-csf-in-aml-patients-with-febrile-neutropenia-friend-or-foe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/end-of-study-analysis-of-the-hope-b-trial-confirms-the-durable-efficacy-and-safety-of-etranacogene-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-combined-with-short-course-bendamustine-rituximab-br-for-first-line-treatment-of-chr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mutations-landscape-of-relapsed-refractory-multiple-myeloma-patients-prior-to-anti-bcma-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iberdomide-plus-daratumumab-and-dexamethasone-iberdd-in-patients-with-newly-diagnosed-multiple-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modified-release-formulation-of-decitabine-and-tetrahydrouridine-combination-not-only-increases-expo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/who-needs-second-line-therapy-predictors-of-sustained-response-in-autoimmune-hemolytic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-commercially-available-chimeric-antigen-receptor-car-detection-reagents-for-monitori 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ravulizumab-demonstrates-real-world-effectiveness-in-patients-with-paroxysmal-nocturnal-hemoglobinur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-oncology-a-cross-sectional-analysis-of-chatgpt-and-openevidence-performa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-mass-spectrometry-approach-for-blood-group-antigen-typing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-drives-t-cell-dysregulation-and-immune-remodeling-revealed-by-gwas-based-mendel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pomalidomide-downregulates-fiz1-to-induce-fetal-hemoglobin-in-adult-erythroid-progenitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-multiple-sclerosis-above-age-60-have-neurological-responses-to-autologous-hematopoieti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-following-chimeric-antigen-receptor-t-cell-therapy-in-relapsed-and-refractory-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overcoming-asciminib-resistance-by-targeting-compound-bcrabl1-mutations-in-chronic-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/successful-melphalan-flufenamide-melflufen-therapy-in-patients-with-severe-renal-insufficiency 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-analysis-of-newly-diagnosed-systemic-light-chain-amyloidosis-patients-treated-with-daratu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospecitive-multicenter-study-of-chidamide-in-adult-patients-with-refractory-primary-immune-thro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptional-programming-by-gata3-regulates-cd4-t-cell-gm-csf-production-in-the-gastrointestinal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-levetiracetam-prophylaxis-in-blinatumomab-induced-neuro-toxicities-in-acute-lymphoblasti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-and-recipient-age-related-differences-in-immunological-reconstitution-affect-development-of-ch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-aponermin-based-chemotherapy-as-bridging-therapy-before-car-t-cell-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-dysregulated-lipid-metabolism-is-associated-with-cd8-t-cell-senescence-in-hiv-associated-diffus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-induction-minimal-residual-disease-assessment-by-flow-cytometry-and-molecular-biology-enables-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-events-associated-with-next-generation-bruton-tyrosine-kinase-btk-inhibitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-achieving-complete-response-in-patients-older-than-65-years-diagnosed-with-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-simulated-exposure-of-inotuzumab-ozogamicin-with-and-without-dose-capping-in-overweigh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/number-of-patients-needed-to-treat-to-prevent-one-atrial-fibrillation-event-with-zanubrutinib-versus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-analysis-reveals-impaired-immune-profiles-in-elderly-aml-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimai-20-functional-precision-platform-for-identifying-effective-immunotherapy-combinations-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-mixed-chimerism-with-undetectable-measurable-residual-disease-in-pediatric-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/resolving-the-debate-a-systematic-review-and-network-meta-analysis-of-hydroxyurea-vs-newer-fda-app 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-malignancies-among-cll-survivors-across-treatment-eras-a-seer-based-study-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/which-inflammation-matters-distinct-risk-signatures-before-car-t-cell-therapy-and-the-role-of-infla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/addition-of-venetoclax-to-hypomethylating-agent-offers-limited-incremental-benefit-for-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-hemophagocytic-lymphohistiocytosis-hlh-in-an-urban-population-demographics-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-outcomes-and-unmet-needs-in-patients-with-ph-all-receiving-tyrosine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cva-with-undetectable-adamts13-without-hemolysis-an-atypical-presentation-of-thrombotic-thrombocyto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-essential-link-between-pyrimidine-synthesis-and-ferroptosis-suppression-in-erythroid-differentiat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cdk6-targeting-reverses-leukemia-in-germline-cebpa-q83x-aml-mouse-model-with-cmp-origin-transformati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-voxelotor-on-the-reduction-in-red-blood-cell-transfusions-in-us-patients-with-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-prospective-phase-ii-study-of-decitabine-priming-combined-with-low-dose-idarubicin-cyta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thyroid-hormones-enhance-the-responsiveness-of-t-cell-lymphomas-to-romidepsin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementation-challenges-of-the-learner-clinical-trial-in-pregnant-women-with-sickle-cell-disease-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-large-language-models-in-lymphoma-clinical-scenarios-a-comparative-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-dissection-of-car-t-and-blinatumomab-elicited-t-cell-states-uncovers-therapy-specific-fu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-cytokine-profiles-with-clinical-and-molecular-biomarkers-to-predict-molecular-relapse-af 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparing-the-safety-of-direct-oral-anticoagulants-vs-low-molecular-weight-heparin-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-atra-based-maintenance-therapy-and-prognostic-markers-of-relapse-in-acute-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-future-projections-of-sepsis-mortality-in-leukemia-a-nationwide-analysis-of-dem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multivariable-adjusted-validation-of-iwg23-defined-peripheral-blood-complete-remission-pb-cr-and-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-fixed-duration-chemo-sparing-approach-in-cll-8-year-results-of-the-phase-2-icll-07-filo-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/jagged-1-damage-resistant-myeloid-progenitors-initiate-the-recovery-of-the-bone-marrow-endothelial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-posaconazole-vs-voriconazoleisavuconazole-for-antifungal-prophylaxis-in-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-newly-diagnosed-acute-myeloid-leukemia-with-flt3-tkd-a-multicenter-retrospe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-plus-bendamustine-rituximab-obr-versus-bendamustine-rituximab-br-in-transplant-ine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inpatient-systemic-therapy-for-cllsll-in-the-united-states-2016-2022-trends-disparities-and-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-with-icos-costimulation-lacks-therapeutic-efficacy-in-patient-due-to-strong-trogocytosis-and-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-hematologic-profiles-in-mesoamerican-versus-classical-chronic-kidney-disease-a-focus-on-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pola-r-edch-shows-high-response-rates-in-high-risk-aggressive-b-cell-lymphomas-or-pmbcl-a-phase-2-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-among-patients-treated-with-second-generation-btk-inhibitors-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-polatuzumab-in-combination-with-chemoimmunotherapy-for-richter-transformation-pol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-evolution-in-cml-patients-from-diagnosis-to-tki-failure-an-analysis-of-121-paired-diagnosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/igg2a-formatted-4-1bb-agonism-combined-with-s100a9-inhibition-enhances-t-cell-activation-and-tumor-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-plus-ldac-in-newly-diagnosed-frail-elderly-patients-with-acute-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-function-alterations-in-traf3-drive-btkplcg2-independent-ibrutinib-resistance-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bleeding-disorder-of-unknown-cause-is-there-a-role-for-expanded-platelet-testing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-and-refinement-of-the-new-high-risk-multiple-myeloma-hrmm-criteria-in-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aberrant-clonal-plasma-cells-bypass-the-proteasome-proteostasis-by-endoplasmic-reticulum-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-randomized-placebo-controlled-phase-1-study-of-rpt1g-a-novel-hyperbolic-nampt-inhibi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/co-targeting-menin-and-ras-in-kmt2a-rnpm1c-aml-with-activated-rtkrasmapk-signaling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimal-dosing-of-vobramitamab-duocarmazine-a-cd276-b7-h3-antibody-drug-conjugate-leads-to-durab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extrafollicular-b-cell-expansion-in-covid-19-patients-with-prothrombotic-antibodies-linked-to-inflam 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trans-auricular-vagal-nerve-stimulation-as-an-innovative-approach-to-pain-treatment-in-sickle-cell-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-chimeric-antigen-receptor-t-cell-therapy-in-relapsedrefractory-b-cell-acute-lymphobla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinically-relevant-bleeding-and-heavy-menstrual-bleeding-among-patients-amplt21-years-old-with-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-optimizing-the-serum-ferritin-threshold-for-diagnosis-of-iron-deficiency-a-pre-and-post 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-of-hlh-like-syndromes-across-car-t-cell-products-a-multi-institutional-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-lean-thinking-approach-to-improve-efficiency-in-providing-immune-chemotherapy-injection-in-out-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-anemia-and-chronic-lower-respiratory-diseases-related-mortality-1999-2023-a-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delays-in-hydroxyurea-initiation-for-patients-with-sickle-cell-disease-in-british-columbia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-canadian-national-needs-assessment-for-an-immunology-curriculum-for-hematology-residents 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-quality-improvement-project-to-improve-the-recognition-and-management-of-iron-delivery-in-the-post 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-antiphospholipid-antibody-positivity-in-a-real-world-laboratory-over-two-decades 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tocilizumab-prophylaxis-in-preventing-cytokine-release-syndrome-and-immune-effector-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-versus-late-onset-hematologic-immune-related-adverse-events-following-immune-checkpoint-inhibi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-anti-cd19cd20-bispecific-car-t-cell-therapy-jwcar201-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biology-of-circulating-tumor-cells-ctcs-in-multiple-myeloma-mm-comparative-transcriptomic-profi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-treatment-of-cns-lymphoma-with-zanubrutinib-and-tislelizumab-a-phase-ibii-inves 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolomics-profiling-and-machine-learning-prediction-of-efficacy-and-prolonged-cytopenia-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-3-and-5-year-outcomes-among-first-line-imatinib-dasatinib-and-nilotinib-in-chronic-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interferon-alfa-treatment-of-early-primary-myelofibrosis-is-associated-with-improved-overall-surviva 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-effects-of-tmprss6-suppression-are-negated-by-iron-overload-in-a-mouse-model-of-beta-tha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-lsd1-inhibitor-bomedemstat-in-participants-with-polycythemia-vera-pv-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-use-and-safety-of-peripheral-intravenous-catheters-piv-vs-central-venous-catheters-cvc-for-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-study-of-single-center-pdt-all-2016-regimen-in-the-treatment-of-kmt2a-rearranged-acute-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/filamin-a-expression-in-acute-myeloid-leukemia-a-multi-omic-analysis-of-prognostic-metabolic-and-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-acute-and-chronic-graft-versus-host-disease-after-unrelated-donor-hematopoie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-3-eslim-01-study-final-analysis-of-efficacy-and-safety-of-long-term-treatment-with-sovlepleni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-improves-erythroid-engraftment-in-major-incompatible-abo-group-hematopoietic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-zebrafish-model-of-parn-deficiency-identifies-altered-lipid-metabolism-as-a-novel-therapeutic-targ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discontinuation-of-targeted-therapy-in-histiocytic-neoplasms-with-durable-response-a-multicenter-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-classical-hematology-referrals-development-and-early-evaluation-of-an-enhanced-referral 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-at-diagnosis-shapes-stage-and-survival-in-diffuse-large-b-cell-lymphoma-a-22-year-population-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/menstruation-induced-vaso-occlusive-crisis-in-women-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dietary-fiber-intake-improves-survival-in-allogeneic-hct-patients-and-exhibits-synergistic-effects-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-mutations-in-the-dna-methylation-pathway-on-clinical-outcomes-in-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-pregnancies-in-sickle-cell-patients-treated-with-hydroxyurea-findings-from-the-escort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monoclonal-and-polyclonal-circulating-plasma-cells-cpcs-are-linked-to-disease-spread-in-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-bcma-targeted-therapy-on-car-t-expansion-and-host-t-cell-phenotypes-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modeling-discordant-cardiac-and-renal-recovery-trajectories-in-al-amyloidosis-using-interpretable-ma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-characteristics-treatment-patterns-and-outcomes-of-al-amyloidosis-patients-with-high-risk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heart-failure-readmissions-in-patients-with-iron-deficiency-anemia-a-national-readmission-database 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-infection-frequency-and-incident-clonal-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vancomycin-resistant-enterococci-vre-colonization-is-associated-with-worse-outcomes-post-allogenic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dose-adjusted-treatment-with-venetoclax-for-7-days-and-5-azacitidine-or-decitabine-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-early-discharge-clinic-a-safe-and-efficient-model-for-intensive-outpatient-management-of-hemato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-prognostic-model-for-tp53mutated-myeloid-neoplasms-across-all-myeloid-neoplasm-subtypes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-proteomics-driven-machine-learning-tool-for-distinguishing-et-from-pre-pmf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survey-on-fertility-management-and-outcomes-after-cellular-therapies-on-behalf-of-the-ebmt-cellular 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-fedratinib-and-nivolumab-combination-in-patients-with-myelofibrosis-and-resistan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incb057643-a-bromodomain-and-extra-terminal-protein-inhibitor-in-combination-with-ruxolitinib-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combination-of-cpx-351-and-gemtuzumab-ozogamicin-go-in-relapsedrefractory-rr-acute-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-chronic-lymphocytic-leukemia-cll-specific-biomarker-testing-patterns-and-frontline-trea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-incidence-of-complications-related-to-central-venous-line-placement-in-patients-newly-diagnosed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-outcome-with-azacytidine-aza-tocilizumab-tcz-for-reducing-steroid-dependenc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-incidence-and-outcomes-of-transformed-nodular-lymphocyte-predominant-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcome-of-first-time-acute-chest-syndrome-in-patients-with-preexisting-pulmonary-hypert 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outpatient-palliative-care-utilization-in-adults-with-sickle-cell-disease-a-trinetx-based-national 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-hospitalized-patients-with-hyperferritinemia-and-hematologic-malignancies-a-single-cent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abnormal-metabolic-activation-of-cd8-t-cells-correlates-with-poor-prognosis-in-acute-myeloid-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-premature-mortality-from-hematologic-malignancies-analysis-of-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-events-as-initial-presentation-of-acute-promyelocytic-leukemia-apl-a-literature-based 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-measurable-residual-disease-mrd-testing-patterns-and-associated-outcomes-in-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-trajectory-informed-mendelian-randomization-demonstrates-consistent-causal-protective-effect-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pacritinib-in-patients-with-high-risk-myelofibrosis-outcomes-from-post-hoc-analyses-of-two-phase-3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maps-r-international-consensus-classification-guided-revision-of-the-mayo-alliance-prognostic-syste 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-risk-of-vascular-events-in-patients-with-myeloproliferative-neoplasms-compared-to-the-dan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-measure-genome-atlas-acute-myeloid-leukemia-at-diagnosis-and-complete-remission 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-life-treatments-and-outcomes-of-older-patients-aged-more-than-60-years-with-flt3-mutated-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/target-dose-delivery-comparison-ibrutinib-venetoclax-vs-acalabrutinib-venetoclax-in-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sepsis-induces-plateletactivating-antipf4-antibodies-with-potential-protective-role-against-second 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-study-of-fluoroquinolone-resistance-colonization-in-patients-undergoing-autologous-hemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fibrin-clot-shields-drive-clonal-selection-of-cancer-cells-procoagulant-properties-and-proliferativ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-brutons-tyrosine-kinase-inhibitors-in-adults-with-immune-thrombocytopenic-pu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-insights-from-ctdna-dynamics-monitoring-mrd-and-tracking-divergent-progression-modes-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/droplet-digital-pcr-outperforms-conventional-methods-for-early-relapse-prediction-in-amlmds-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multitarget-kinase-inhibitor-olverembatinib-is-active-and-synergizes-with-btk-inhibitor-acalabrutini 2026-08-17 monthly 0.7 https://rjrindex.com/articles/readability-amp-quality-of-large-language-model-responses-in-car-t-patient-education 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-treatment-patterns-in-primary-and-secondary-plasma-cell-leukemia-a-multicente 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-next-generation-flow-ngf-and-next-generation-sequencing-based-clonoseq-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advantages-of-less-frequent-doing-of-bcma-directed-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mecom-gene-network-drives-chemotherapy-resistance-in-high-risk-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-sutimlimab-in-patients-with-cadcas-a-multinational-multi-center-observation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pembro-core-interim-analysis-of-a-phase-ii-pet-adapted-trial-omitting-high-dose-chemotherapy-with-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcore-fl-2-phase-3-trial-of-epcoritamab-with-rituximab-and-lenalidomide-r2-vs-chemoimmunotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/systematic-analysis-of-gene-mutations-in-chinese-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-characteristics-of-myeloid-neoplasms-in-patients-with-multiple-myeloma-treated-with-no 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-between-crlf2-expression-by-flow-cytometry-and-fish-in-patients-diagnosed-with-b-cell-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-gcc2005-an-allogeneic-cd5-directed-car-nk-therapy-for-patients-with-relapsedrefr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-potent-and-selective-jak2v617f-inhibitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inequity-in-travel-burden-among-patients-receiving-bispecific-antibodies-bsabs-for-diffuse-large-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/apixaban-pharmacokinetics-in-newly-diagnosed-multiple-myeloma-patients-treated-in-the-benefit-and-is 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-life-study-of-ivosidenib-in-either-monotherapy-or-combined-with-azacytidine-for-first-line-muta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-treatment-timing-and-access-to-care-in-chronic-lymphoytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disruption-of-il-10-receptor-signaling-promotes-hematopoietic-stem-cell-exhaustion-and-clonal-expans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golidocitinib-based-therapy-in-relapsedrefractory-mycosis-fungoides-and-sezary-syndrome-a-real-wor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-single-cell-multi-omic-and-functional-profiling-of-human-bone-marrow-regulatory-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orca-t-improves-chronic-graph-versus-host-disease-free-in-patients-with-a-broad-range-of-demographic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-venetoclax-combined-with-metronomic-low-dose-decitabine-and-interferon-for-preventing-post-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-venetoclax-based-therapy-vs-intensive-chemotherapy-in-older-adults-with-newly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hetrombopag-a-novel-thrombopoietin-receptor-agonist-in-children-and-adolesc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-specific-ighv-rearrangements-in-younger-untreated-mantle-cell-lymphoma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-is-associated-with-early-onset-clonal-hematopoiesis-involving-dna-damage-respons 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-in-the-treatment-of-allogeneic-stem-cell-transplant-related-pure-red-cell-aplasia-a-singl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-shortened-venetoclax-course-plus-decitabine-in-newly-diagnosed-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/does-stringent-cytoreduction-improve-survival-in-myeloproliferative-chronic-myelomonocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-monotherapy-versus-active-monitoring-in-patients-with-high-risk-smoldering-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-and-decitabine-in-myeloproliferative-neoplasm-blast-phase-mpn-bp-results-of-enable-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-in-relapsedrefractory-rr-mantle-cell-lymphoma-mcl-final-update-from-the-phase-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-for-newly-diagnosed-chronic-myeloid-leukemia-results-from-a-phase-ii-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gh9d2-t-cell-gh9d2tc-activation-with-ict01-and-azacitidine-venetoclax-aza-ven-induces-high-rates-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/response-adapted-phase-2-study-of-acalabrutinib-window-prior-to-frontline-chemotherapy-in-untreated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rusfertide-or-placebo-plus-current-standard-of-care-therapy-for-polycythemia-vera-durability-of-res 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-2nd-line-treatment-in-cll-after-venetoclax-based-1st-line-treatment-results-from-the-ga 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-peak-car-t-expansion-is-associated-with-delayed-neurotoxicity-following-ciltacabtagene-autoleu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hemoglobin-improvement-with-momelotinib-on-survival-in-patients-with-myelofibrosis-and-ane 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baffr-car-t-cells-pmb-ct01-show-promising-safety-and-anti-leukemia-efficacy-in-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-pola-r-chp-versus-r-chop-in-patients-with-diffuse-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tazemetostat-in-relapsedrefractory-follicular-lymphoma-and-dlbcl-a-systematic-review-of-clinical-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-of-the-bruton-tyrosine-kinase-degrader-bgb-16673-in-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pomalidomide-promotes-activation-induced-cell-death-of-pre-activated-memory-bcma-car-t-cells-in-a-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/qls4131-a-next-generation-gprc5dbcmacd3-trispecific-t-cell-engager-in-patients-with-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selinexor-with-alternating-bortezomib-or-lenalidomide-plus-dexamethasone-in-transplant-ineligible-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adult-acute-myeloid-leukemia-with-nup98-rearrangement-benefits-from-targeted-therapy-and-bone-marrow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/limited-stage-mantle-cell-lymphoma-real-world-outcomes-according-to-nodal-vs-extranodal-presentati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-outcomes-in-angioimmunoblastic-t-cell-lymphoma-linked-to-care-at-academic-cancer-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-adult-patients-diagnosed-with-acute-lymphoblastic-leukemia-in-the-us-between-20 2026-08-17 monthly 0.7 https://rjrindex.com/articles/steroid-toxicity-in-newly-diagnosed-patients-with-multiple-myeloma-treated-with-a-limited-dexamethas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toxicity-of-reduced-dose-versus-standard-dose-pegaspargase-in-adolescents-and-young-adults-with-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-promising-results-in-younger-adult-patients-amplt65-yrs-with-newly-diagnosed-phbcrabl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-anti-cd19-chimeric-antigen-receptor-car-t-cell-therapy-in-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ethnic-racial-and-geographic-disparities-in-idiopathic-thrombocytopenic-purpura-related-mortality 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-prophylactic-intrathecal-chemotherapy-to-prevent-high-grade-immune-effector-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-cardiovascular-outcomes-in-patients-with-lymphoma-who-had-early-post-car-t-cardiovascular 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-treatment-regimens-and-related-health-resource-use-in-managing-patients-with-waiha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-health-care-resource-utilization-clinical-effectiveness-and-safety-of-lis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-the-y-chromosome-defines-a-biologically-distinct-subtype-of-acute-myeloid-leukemia-aml-as 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-coagulation-potential-of-concomitant-factor-viii-administration-in-patients-with-haemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/petct-parameters-as-predictors-of-early-progression-risk-in-newly-diagnosed-multiple-myeloma-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/journey-of-relapsed-or-refractory-multiple-myeloma-rrmm-after-quadruple-class-exposure-qcex-poo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-ao2-prbcthal-trial-on-the-use-of-hemanext-one-for-blood-transfusion-support-transfusion-depen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-ischemic-heart-disease-and-anemia-related-mortality-in-adults-aged-65-ye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-the-aryl-hydrocarbon-receptor-eliminates-leukemia-stem-cells-in-murine-models-of-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevation-of-liver-health-biomarkers-before-and-after-etranacogene-dezaparvovec-gene-therapy-in-hemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-transfusion-associated-circulatory-overload-after-blood-products-transfusion-in-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-profiling-of-natural-killer-t-cell-lymphoma-reveals-stratified-immune-features-and-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vmx-c001-has-no-effect-on-the-anticoagulant-function-of-heparin-in-healthy-subjects 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-absolute-eosinophil-count-and-outcomes-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-reproductive-factors-and-exogenous-hormone-use-with-the-risk-of-multiple-myeloma-in-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tolerability-and-long-term-survival-of-fragile-or-older-patients-with-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combining-next-generation-sequencing-and-optical-genome-mapping-techniques-to-analyze-genomic-abnorm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inositol-hexakisphosphate-kinase-1-ip6k1-driven-tumor-polyphosphate-may-contribute-to-immune-check 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-outcomes-by-age-comorbidity-frailty-and-treatments-prior-to-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eno1-promotes-acute-myeloid-leukemia-progression-through-scd1-mediated-lipid-metabolism-reprogrammin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liposomal-melatonin-targets-mutant-hematopoiesis-and-bone-marrow-remodeling-in-mpn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-architecture-efficientnetb1-excels-in-accurate-diagnosis-and-prognosis-of-acute-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-car-next-generation-sequencing-informs-patient-outcomes-in-children-and-young-adults-with-b-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibitors-of-rad51-as-potential-novel-therapies-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-cart-therapy-in-29-cases-of-relapsed-or-refractory-multiple-myelomaa-retrospective-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-risk-mds-in-the-wke-of-anti-bcma-cart-therapy-in-refractory-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-event-free-survival-in-patients-with-ighv-mutated-high-count-monoclonal-b-cell-lymphocytos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pd-1-expression-on-richter-syndrome-tumor-cells-does-not-provide-a-growth-advantage-in-murine-or-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/continuous-venetoclax-for-relapsed-chronic-lymphocytic-leukemia-cll-characteristics-and-outcomes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-patients-with-non-erythrodermic-mycosis-fungoides-with-high-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimating-the-burden-of-undiagnosed-cmml-prevalence-by-phenotype-and-cytopenia-stratification-in-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-rituximab-high-dose-methotrexate-and-thiotepa-r-mt-as-first-line-inductio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impaired-coordination-between-innate-and-adaptive-immunity-in-hematologic-and-solid-cancer-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-presence-clinical-relevance-of-flt3-itd-length-and-location-in-acute-myeloid-leukemia-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-fever-incidence-following-vincristine-administration-in-pediatric-oncolo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-plasma-proteome-of-multiple-myeloma-and-its-precursor-conditions-and-identif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-steroid-induced-hyperglycemia-in-early-mortality-during-induction-treatment-of-philade 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-for-newly-diagnosed-bcrabl1-negative-b-cell-acute-lymphoblastic-leukemia-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-multi-institution-experience-of-standard-vs-alternative-dosing-of-inotuzumab-ozogamicin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-results-of-ecog-acrin-ea9152-a-multicenter-study-of-liposomal-vincristine-l-vcr-or-vincr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-hydrochloride-liposome-lipo-mit-combined-with-azacitidine-and-chidamide-can-be-an-ef 2026-08-17 monthly 0.7 https://rjrindex.com/articles/condensed-total-skin-electron-beam-therapy-prior-to-allogeneic-stem-cell-transplantation-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/additional-genetic-targets-are-present-in-the-majority-of-aml-patients-with-npm1-kmt2a-or-nup98-abe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hoxa9mettl3bmi1-axis-is-required-for-promoting-anthracycline-resistance-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/descriptive-analysis-of-igm-monoclonal-gammopathy-of-undetermined-significance-progression-events-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/port-77-is-a-potent-inhibitor-of-abcg2-that-reduces-efflux-of-protoporphyrin-ix-from-erythrocytes-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-multiomics-reveals-candidate-cis-regulatory-elements-in-npm1-mutant-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemotherapy-free-treatment-for-children-and-adolescents-with-newly-diagnosed-acute-promyelocytic-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-duffy-null-phenotype-on-neutrophil-counts-in-patients-with-hbsc-hbsv-thalassemia-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/resolvins-modulate-haematopoietic-stem-and-progenitor-cell-dysfunction-and-neutrophil-activation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/regulatory-long-noncoding-rna-of-t-cells-relotlinc00402-impairs-rorght-allogeneic-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-actual-usefulness-of-culturing-apheresis-products-in-hematopoietic-stem-cell-autotransplants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomics-define-neoplastic-transformation-in-multiple-myeloma-precursor-conditions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/i-feel-like-im-being-recognized-as-being-a-part-of-his-treatment-caregiver-perspectives-of-the-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-microenvironment-overlap-between-vexas-and-myelodysplastic-syndrome-demonstrated-by-targ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-chronotherapeutic-approach-to-vip-receptor-antagonist-ant308-in-anti-tumor-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pediatric-idiopathic-multicentric-castleman-disease-is-often-severe-and-responds-to-siltuximab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/automated-grading-of-castleman-disease-histopathology-using-an-attention-based-multiple-instance-lea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-allogeneic-haemopoietic-stem-cell-transplantation-and-cart-cell-therapy-for-tranformed-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-plus-low-dose-dasatinib-maintenance-therapy-for-patients-with-int 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-of-heparin-induced-thrombocytopenia-in-impella-supported-cardiac-surgery-a-comprehensive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-11b-open-label-dose-escalation-first-in-human-study-to-evaluate-the-safety-tolerability 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-sorafenib-combined-with-standard-chemotherapy-in-adult-patients-with-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-center-single-arm-study-evaluating-the-safety-and-efficacy-of-golidocitinib-in-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-impacting-treatment-choice-with-a-cd38-antibody-immunomodulator-proteasome-inhibitor-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-monitoring-of-circulating-plasma-cells-in-multiple-myeloma-a-prospective-multicenter-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mass-spectrometry-demonstrates-very-frequent-multi-clonality-in-familial-waldenstrom-macroglobulinem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determining-the-origin-of-tp53-mutations-in-patients-with-mature-b-cell-neoplasms-is-essential-to-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cutaneous-and-peripheral-t-cell-lymphomas-in-the-us-population-a-25-year-national-review-of-epide 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plitidepsin-in-combination-with-dexamethasone-admyre-trial-versus-an-external-control-arm-of-pomal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etiologic-heterogeneity-in-secondary-hemophagocytic-lymphohistiocytosis-a-retrospective-real-world 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haematological-toxicities-with-targeted-drugs-in-tumors-a-systematic-review-and-network-meta-analys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-malignancies-in-patients-with-chronic-lymphocytic-leukemia-treated-with-zanub 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-immunoproteasome-dependent-v-catenin-degradation-as-a-therapeutic-strategy-in-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-hematologic-response-to-daratumumab-without-cardiac-recovery-in-al-amyloidosis-a-persistent-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-of-flow-cytometry-ogata-score-with-cytogenetic-abnormalities-in-myelodysplastic-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-repeat-car-t-cell-therapy-a-systematic-review-and-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/malignancy-as-a-secondary-cause-of-hemophagocytic-lymphohistiocytosis-outcomes-and-complications-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-enhancement-of-ghd-t-cell-cytotoxicity-against-tumor-spheroids-through-b7h3-car-and-zoled 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-treatment-patterns-and-overall-survival-for-multiple-myeloma-management-in-taiwan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ofirnoflast-a-novel-inflammasome-inhibitor-rewires-transcriptional-programs-and-shows-clinical-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/melatonin-wnt-and-s1p-signaling-regulate-diurnal-bone-marrow-mesenchymal-stem-cell-metabolism-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-multiple-myeloma-and-diabetes-mellitus-in-the-united-states-a-retrospectiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concurrent-viral-infection-as-an-adverse-prognostic-factor-in-diffuse-large-b-cell-lymphoma-not-oth 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pkm2-modulation-regulates-leukemia-cell-survival 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stag2-mutation-preserves-a-stem-cell-phenotype-in-flt3-itd-mediated-mds-to-leukemia-transformation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/khsrp-depletion-selectively-eliminates-aml-cells-that-persist-after-venetoclaxazacitidine-therapy-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-obesity-and-venous-thromboembolism-in-hospitalized-patients-with-multiple-myelom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-y90-ibritumomab-tiuxetan-zevalin-in-low-grade-b-cell-non-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-mace-in-patients-with-chronic-myeloid-leukemia-treated-with-ty 2026-08-17 monthly 0.7 https://rjrindex.com/articles/wm-voice-an-international-discrete-choice-experiment-on-treatment-preferences-in-1455-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombocytosis-in-transient-abnormal-myelopoiesis-association-with-megakaryocytic-skewing-and-gata1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-the-dominant-negative-ikaros-isoform-6-ik6-on-cell-function-and-drug-sensitivity-in-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/computed-tomography-quantification-of-body-adiposity-and-induction-outcomes-in-patients-with-newly-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/romiplostim-n01-enhances-platelet-engraftment-in-asct-using-non-cryopreserved-pbscs-for-plasma-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-and-dna-damage-responses-in-the-intestinal-stroma-of-patients-presenting-with-lower-gastro-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-early-ctdna-kinetics-following-first-cycle-of-r-chop-in-lbcl-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-and-bleeding-rates-in-pregnant-and-postpartum-patients-with-sickle-cell-disea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-acute-chest-syndrome-acs-associated-with-sickle-cell-disease-scd-vaso-occlusive-pain 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-silico-structural-biology-studies-inform-the-identification-of-druggable-pockets-in-previously 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-dimensional-profiling-reveals-predominant-depletion-of-nk-cell-effector-phenotypes-in-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allosteric-inhibition-of-ran-decreases-mir-126-biogenesis-in-endothelial-cells-and-controls-acute-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preemptive-rituximab-in-patients-with-adamts13-relapse-in-thrombotic-thrombocytopenic-purpura-a-sys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ipss-m-outperforms-ipss-r-in-younger-adults-with-myelodysplastic-syndromes-a-retrospective-age-stra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-mammalian-coacervate-based-platform-for-high-efficiency-gene-editing-in-hematopoietic-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-classification-of-chronic-lymphocytic-leukemia-signalotypes-to-allows-biologi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/somatic-asxl1-mutations-in-chronic-myelomonocytic-leukemia-result-in-loss-of-imprinting-control-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-12-year-retrospective-analysis-of-surveillance-strategy-in-young-adults-after-complete-remission-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-the-essential-thrombocythemia-diagnosis-journey-treatment-experience-disease-burden 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tucidinostat-plus-r-chop-in-untreated-mycbcl2-double-expressor-diffuse-large-b-cell-lymphomatopli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-results-from-a-phase-1b-study-of-r289-a-dual-irak-14-inhibitor-in-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/area-deprivation-index-as-a-predictor-of-survival-and-treatment-disparities-in-older-adults-with-acu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-treosulfan-vs-busulfan-based-conditioning-regimens-in-adult-allogeneic-hem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-alterations-and-clonal-hematopoiesis-in-germline-etv6-mutation-carriers-without-hematolo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/celf2-deficient-mutations-promote-b-cell-lymphoma-development-by-inducing-a-germinal-center-b-cell-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eculizumab-vs-control-therapies-in-paroxysmal-nocturnal-hemoglobinuria-a-meta-analysis-of-six-rando 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-changes-in-cll-treatment-patterns-following-collaborative-educational-initiatives-deliver 2026-08-17 monthly 0.7 https://rjrindex.com/articles/belantamab-mafodotin-belamaf-in-combination-with-bortezomib-lenalidomide-and-dexamethasone-vrd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-discrete-choice-experiment-dce-to-determine-preferences-for-relapsed-refractory-follicular-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/representation-of-older-adults-in-registrational-trials-associated-with-therapeutic-approvals-in-fol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/animated-patients-guide-to-acute-myeloid-leukemia-assessing-patient-understanding-shared-decision 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biallelic-tp53-alterations-predict-poorer-survival-in-mantle-cell-lymphoma-insights-from-a-national 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-synuclein-aggregates-inhibit-reticulocyte-maturation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prediction-and-prevalence-of-non-anemic-iron-deficiency-naid-in-early-pregnancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/classical-hematology-education-in-pediatric-hematologyoncology-fellowship-a-national-needs-assessm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-genome-wide-crispr-activation-screen-identifies-novel-gh-globin-regulators 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monocarboxylate-transporter-1-deficient-donor-t-cells-rewire-metabolism-and-ameliorate-agvhd-lethali 2026-08-17 monthly 0.7 https://rjrindex.com/articles/malignancy-associated-internal-jugular-venous-thrombosis-following-chemoradiation-for-oropharyngeal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-acute-myeloid-leukemia-microenvironment-is-defined-by-ineffective-immune-surveillance-despite-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idh2-mutant-hematopoietic-stem-and-progenitor-cells-promote-endothelial-niche-remodeling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-glofitamab-in-combination-with-lenalidomide-in-relapsed-or-refractory-central 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-platelet-count-and-mean-platelet-volume-with-clinical-outcomes-in-pulmonary-embolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetics-of-lymphomas-in-ecuador 2026-08-17 monthly 0.7 https://rjrindex.com/articles/final-results-from-a-prospective-multicenter-non-interventional-study-besremi-pass-on-the-safety 2026-08-17 monthly 0.7 https://rjrindex.com/articles/not-all-that-glitters-is-gold-a-simple-clinical-score-to-unmask-adverse-sf3b1wt-mds-rs-with-low-bla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-of-the-bruton-tyrosine-kinase-degrader-bgb-16673-in-patients-wit-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/specific-targeting-of-hla-genes-generates-hypoimmunogenic-hematopoietic-stem-cells-for-allogeneic-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-blood-based-protein-signature-adds-to-genomic-prognostication-of-survival-in-tp53-mutated-acute-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hemoglobin-uptake-by-liver-endothelium-prevents-von-willebrand-factor-clearance-in-sickle-cell-disea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-circulating-myeloma-cells-accurately-identify-bone-marrow-mrd-positivity-in-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-quality-of-life-and-safety-of-non-clotting-factor-prophylaxis-in-hemophilia-a-and-b-a-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/seasonal-variation-in-chronic-and-acute-pain-in-patients-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-support-and-barriers-to-medication-adherence-among-adolescents-and-young-adults-with-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/symptom-burden-in-patients-with-cancer-and-thromboembolism-a-population-based-matched-cohort-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/major-bleeding-and-stroke-in-patients-with-hemophilia-and-atrial-fibrillation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-result-of-first-line-orelabrutinib-plus-r-chop-in-cd5-positive-diffuse-large-b-cell-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-time-tracking-of-rna-splicing-in-aged-bone-marrow-hematopoietic-stem-and-progenitor-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-idecabtagene-vicleucel-predictors-of-hospitalization-and-impact-on-sur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-ide-cel-and-cilta-cel-in-patients-with-relapsedrefractory-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitochondrial-mass-in-pre-lymphodepletion-t-cells-predicts-early-response-to-car-t-therapy-in-relaps 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-jak2v617f-targeting-lipid-nanoparticle-sirna-as-a-novel-gene-therapy-for-myeloproli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sox11-induced-reprogramming-of-b2-cells-to-a-b1a-like-phenotype-promotes-mantle-cell-lymphoma-in-mic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-palliative-care-improves-pain-management-and-reduces-length-of-stay-in-a-comprehensive-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autoimmune-hemolytic-anemia-an-underrecognized-contributor-to-anemia-and-hemolysis-in-babesiosis-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-the-association-between-antiphospholipid-syndrome-and-non-melanoma-skin-cancers-a-case-co 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-multi-omics-profiling-reveals-distinct-patterns-of-clonal-expansion-and-microenvironment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-randomized-study-of-astx727-with-or-without-iadademstat-in-acceleratedblast-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/establishment-of-differential-diagnostic-model-for-et-and-pre-pmf-based-on-circulating-cd34-cells-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-free-remission-outcomes-in-pediatric-chronic-myeloid-leukemia-second-generation-tkis-vs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changes-in-disease-responses-after-discontinution-of-tyrosine-kinase-inhibitors-tki-for-pregnancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mutant-megakaryocytes-orchestrate-marrow-immune-remodeling-via-inflammatory-and-line1-driven-mechan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/organ-dysfunction-in-pediatric-patients-with-hsct-tma-treated-with-ravulizumab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-cd34-donor-chimerism-and-flow-cytometry-for-measurable-residual-disease-are-complem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-vsvg-variants-for-binderdependent-and-highspecificity-transduction-of-primary-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammatory-and-oxidative-stress-biomarkers-associated-with-cognitive-function-in-patients-with-hod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-in-hospital-outcomes-in-patients-undergoing-bone-marrow-tra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/is-autologous-hematopoietic-stem-cell-transplantation-as-consolidation-therapy-superior-to-chemother 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-relapsed-or-refractory-mature-tnk-cell-lymphomas-in-the-era-of-novel-agents-a-nationwi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-charlson-comorbidity-index-as-a-predictor-of-survival-in-peripheral-t-cell-lymphoma-a-multicent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cellpolaris-a-novel-tool-to-quantify-cell-polarity-reliably-at-scale-in-fixed-and-living-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-branched-chain-amino-acid-rheostat-controls-hematopoietic-stem-cell-replicative-lifespan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vennetoclax-combined-with-decitabine-cytarabine-aclacinomycin-and-granulocyte-colony-stimulating-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/remote-multi-vital-sign-monitoring-allows-earlier-detection-of-cytokine-release-syndrome-after-bispe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-assessment-of-absolute-neutrophil-counts-anc-and-white-blood-cell-counts-wbc-in-heal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-next-generation-sequencing-disease-evaluation-and-pcr-based-car-t-cell-tracking-to-guide 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-profile-of-inaticabtagene-autoleucel-in-chinese-patients-with-b-cell-acute-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-in-high-risk-mantle-cell-lymphoma-a-retrospecti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acquired-factor-v-inhibitor-and-granulomatosis-with-polyangiitis-diagnostic-challenges-and-therapeu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-less-differentiated-car-t-cell-products-in-relapsedrefractory-b-cell-non-hod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/salvage-free-transplantation-free-survival-stfs-in-aml-proposition-for-a-novel-clinical-endpoint 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-associated-with-azacitidine-and-venetoclax-in-myelodysplastic-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-il-10-in-regulating-macrophage-pyroptosis-in-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ponatinib-based-combination-therapies-including-asciminib-and-venetoclax-were-effective-on-patient-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reasons-for-treatment-discontinuation-in-multiple-myeloma-insights-from-the-preamble-registry 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-encorafenib-plus-binimetinib-for-patients-with-braf-v600-mutated-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/us-cost-consequence-and-time-toxicity-model-for-advanced-therapies-in-the-treatment-for-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-fsp1-enhances-venetoclax-induced-cell-death-in-acute-myeloid-leukemia-by-the-ferroptos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-outcomes-in-second-line-2l-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/invisible-wounds-suicide-in-military-service-members-with-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-factor-4-pf4-modulates-endothelial-cell-antimicrobial-activity-to-enhance-bacterial-clear 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-of-anti-bcma-car-t-therapy-in-a-middle-income-country 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hydroxyurea-use-does-not-worsen-age-related-decline-in-blood-counts-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-infusion-adamts13-and-vwf-levels-are-associated-with-clinical-outcomes-of-patients-receiving-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-baseline-fdg-petct-total-metabolic-tumor-volume-and-mycbcl2-double-expression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/projecting-non-hodgkin-lymphoma-mortality-for-young-adults-in-the-united-states2024-2040a-nationa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/budget-impact-analysis-of-rituximab-biosimilar-in-patients-with-haematological-cancers-in-qatar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-effector-cell-associated-enterocolitis-iec-ec-across-car-t-products-in-myeloma-and-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/swog-1318-combination-of-dasatinib-prednisone-and-blinatumomab-for-older-patients-with-philadelph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-assisted-multi-parameter-flow-cytometry-gating-for-minimal-residual-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-a-chemotherapy-free-regimen-of-concomitant-blinatumomab-and-inotuzumab-ozogami 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-venetoclax-therapy-in-al-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lessons-learned-from-the-clinical-trial-portfolio-of-ixazomib-in-multiple-myeloma-a-systematic-revi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/defining-resistance-clinical-outcomes-based-on-varying-definitions-of-heparin-resistance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multilayer-profiling-of-mrd-in-patients-with-relapsedrefractory-cll-treated-with-venetoclax-based-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intein-based-modular-assembly-of-multi-receptor-car-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/searching-for-a-myelodysplastic-syndrome-stem-cells-mds-scs-signature-by-flow-cytometry-toward-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-a-placebo-controlled-study-of-dronabinol-for-adults-with-sickle-cell-disease-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-targeting-of-ror1-and-ror2-with-glycoengineered-antibodies-elicits-potent-and-selective-immunot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-weight-of-stress-allostatic-load-as-a-predictor-of-vaso-occlusive-episodes-in-adults-with-sickl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-bortezomib-maintenance-therapy-in-the-anti-cd38-antibody-era-interim-analysis-results-of-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-of-bleximenib-in-combination-with-venetoclax-in-acute-myeloid-leukemia-with-kmt2a-or 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-phase-1-study-of-the-safety-and-tolerability-of-the-combination-of-revumeni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-outcome-in-adult-patients-with-relapsedrefractory-t-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-talquetamab-teclistamab-in-patients-with-relapsedrefractory-multiple-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-teclistamab-and-talquetamab-for-frail-patients-with-newly-diagnosed-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prophylactic-intravenous-immunoglobulin-in-patients-receiving-bcma-targeted-bispecific-antibody-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimating-and-forecasting-the-incidence-prevalence-and-counts-of-treatment-eligible-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-biomarker-utilization-among-patients-aged-65-years-with-cllsll-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glofitamab-in-combination-with-cd19-car-t-therapy-for-high-risk-relapsedrefractory-large-b-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-phase-1-study-of-sequential-cd7-car-t-cell-therapy-and-haploidentical-hsct-without-gvhd-prop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/higher-baseline-whole-blood-viscosity-is-associated-with-chronic-scd-complications 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ivosidenib-leads-to-durable-responses-in-idh1-mutated-clonal-cytopenias-of-undetermined-significance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-3-study-to-evaluate-the-efficacy-and-safety-of-rilzabrutinib-in-primary-warm-autoimmune-hemoly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-brecadd-protocol-as-frontline-therapy-for-patients-with-advanced-stage-cl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-after-immunotherapy-failure-in-patients-with-nkt-cell-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predicting-genetic-alterations-in-acute-myeloid-leukemia-through-ai-based-analysis-of-bone-marrow-mo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/causes-of-death-in-young-children-with-sickle-cell-disease-and-sickle-trait-in-young-children-invest 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-on-outcomes-of-car-t-cell-therapy-for-hematologic-malignancies-a-real-world-prope 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-class-small-molecule-calmodulin-pathway-modulators-attenuate-excess-p53-activity-and-correc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-duration-of-treatment-and-effect-on-phlebotomy-use-among-2369-patients-with-polycythemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complex-cytogenetics-in-myeloid-malignancies-a-deconstruction-analysis-redefining-complex-karyotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-decitabinecedazuridine-in-combination-with-venetoclax-in-treatment-naive-high-risk-myelodyspla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-toxicity-and-response-after-real-world-administration-of-obecabtagene-auto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-ctdna-for-risk-stratification-across-the-spectrum-of-both-aggressive-and-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-lab-to-field-evaluation-of-a-rapid-low-cost-point-of-care-ferritin-assay-for-detection-of-ir 2026-08-17 monthly 0.7 https://rjrindex.com/articles/persistent-microbiome-dysbiosis-following-hematopoietic-cell-transplantation-gut-gvhd-as-the-most-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gingerol-ameliorates-chronic-graft-versus-host-disease-by-regulating-tregth17-transdifferenciation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vwfadamts13-ratio-is-associated-with-white-matter-hyperintensity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/final-report-of-a-phase-ii-study-of-ibrutinib-and-venetoclax-in-previously-untreated-waldenstrom-mac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-novel-ims-imwg-high-risk-multiple-myeloma-criteria-may-omit-individuals-with-renal-impairment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-as-a-powerful-tool-for-measurable-residual-disease-assessment-in-pediatri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-slim-crab-criteria-on-diagnostic-practices-among-patients-with-mgus-in-the-veteran-health 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-environmental-alterations-underlie-proliferative-clonal-expansion-in-clonal-hematopoiesi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-inequities-in-latin-america-outweigh-the-benefits-of-pediatric-regimens-in-adult-acute-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-iptacopan-in-treatment-of-transplant-associated-thrombotic-microangiopathy-ta-tma-post 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pulmonary-vein-thrombosis-following-bronchoscopic-cryobiopsy-a-case-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/at-211-anti-cd45-radioimmunotherapy-as-conditioning-prior-to-haploidentical-hematopoietic-cell-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mapk-pathway-driven-metabolic-inflammatory-axis-in-al-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shared-immune-features-correspond-to-high-risk-multiple-myeloma-across-multiple-human-subtypes-and-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rethinking-neutropenia-thresholds-ethnicity-specific-distributions-and-mortality-associations-in-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/somatic-mutations-and-clinical-outcomes-in-primary-central-nervous-system-lymphoma-among-hispanic-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatial-single-cell-multiomics-of-the-bone-marrow-microenvironment-in-npm1-mutant-acute-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/magnetic-resonance-imaging-maps-spatiotemporal-changes-in-bone-marrow-composition-of-murine-jakv617f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-profiling-of-t-cell-immune-states-before-and-after-donor-lymphocyte-infusion-in-a-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lysophosphatidylcholine-induced-macrophage-polarization-imbalance-and-functional-dysregulation-in-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-3346-patients-from-the-combined-childrens-oncology-group-aml-studies-further-characteri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/using-electronic-medical-records-to-facilitate-transition-from-pediatric-to-adult-hematology-for-sic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/key-factors-for-the-success-of-autologous-hematopoietic-stem-cell-transplantation-in-hiv-infected-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/labile-heparin-response-in-a-pre-operative-cardiac-surgery-patient-unmasking-predisposition-for-pos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thiotepa-and-busulfan-combined-with-cyclophosphamide-conditioning-regimen-plus-maintenance-therapy-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haploidentical-hematopoietic-stem-cell-transplantation-using-low-dose-alemtuzumab-is-effective-for-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mapping-proteomic-signatures-in-ipsc-derived-neutrophils-modeling-neutropenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brmbrg1-is-a-novel-therapeutic-target-in-znf384-rearranged-mixed-phenotype-acute-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idiotype-mrna-therapeutic-vaccination-in-a-mouse-model-of-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-age-matters-selecting-1010-muds-under-35-enhances-survival-after-ptcy-allo-hct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acquired-regions-of-homozygosity-in-adult-b-cell-acute-lymphoblastic-leukemia-insights-from-a-machi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-clinical-performance-of-metagenomic-next-generation-sequencing-for-diagnosis-of-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/warm-autoimmune-hemolytic-anemia-following-epstein-barr-virus-reactivation-an-uncommon-clinical-ass 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-for-myeloid-malignancies-uncovering-clinical-gaps-in-physician-knowledge 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-oral-pi3kdelta-inhibitor-linperlisib-and-obinutuzumab-as-response-dependent-first-line-regimen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonoseq-mrd-negativity-at-day-90-is-a-strong-predictor-for-progression-free-and-overall-survival-af 2026-08-17 monthly 0.7 https://rjrindex.com/articles/collaborative-outreach-and-education-for-management-of-bi-specific-antibody-treatment-side-effects-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-severe-chemotherapy-associated-nausea-and-vomiting-with-brentuximab-vedotin-and-avd-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/excessive-neutrophil-extracellular-traps-formation-in-sepsis-induced-acute-respiratory-distress-synd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hbc-positive-status-for-hepatis-b-virus-does-not-affect-car-t-cell-outcomes-in-lymphoma-results-fro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lipid-uptake-via-fatp2-enhances-car-t-therapy-resistance-in-b-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-survival-trends-in-smoldering-versus-symptomatic-multiple-myeloma-a-seer-analysis-2012 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comorbidities-and-outcomes-in-patients-with-acute-myeloid-leukemia-with-and-without-type-ii-diabetes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-serum-c3-complement-levels-were-associated-with-poor-prognosis-of-angioimmunoblastic-t-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-long-term-survival-in-adolescents-and-young-adults-with-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-sepsis-and-multiple-myeloma-related-mortality-among-adults-in-the-united-states-from-1999 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-benign-ethnic-neutropenia-using-a-real-world-national-model-evidence-from-national-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-novel-prognostic-models-in-symptomatic-waldenstroms-macroglobulinemia-based-on-real-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aldehyde-dehydrogenase-2-plays-a-dispensable-role-in-hematopoiesis-in-response-to-dna-damage 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-expression-of-tmsb10-in-bone-marrow-in-mds-patients-with-t-cell-large-granular-lymphocytic-proli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-predictive-value-of-mosaic-chromosomal-alterations-for-lymphoid-malignancies-varies-by-monoclona 2026-08-17 monthly 0.7 https://rjrindex.com/articles/refractory-anemia-with-ring-sideroblasts-epidemiological-survival-trends-and-implications-in-a-seer 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-tet2-and-ezh2-serve-as-critical-drivers-of-clonal-malignant-evolution-in-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-during-the-venetoclax-era-trends-in-survival-across-demographic-and-socioeco 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ims-ip-assay-for-the-detection-and-typing-of-monoclonal-immunoglobulins-by-mass-spectr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-bezuclastinib-on-the-pathobiology-of-mastocytosis-changes-in-bm-mast-cells-tryptase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapy-resistance-and-disease-relapse-in-patients-with-mpn-blast-phase-are-associated-with-clonal-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitochondrial-dna-heteroplasmy-and-haplogroup-variation-in-pediatric-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dna-proximal-myb-phosphorylation-is-required-for-oncogenic-transcription-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-transplant-mrd-negativity-predicts-favorable-outcomes-of-car-t-therapy-for-pediatirc-relapsed-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparable-pfs-in-isolated-parenchymal-cns-vs-systemic-relapse-of-dlbcl-results-from-a-large-real-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparable-outcomes-of-haploidentical-sibling-and-unrelated-donor-transplantation-for-adult-t-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-pre-existing-iron-deficiency-anemia-in-hospitalizations-for-cardiogenic-shock 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-patient-characteristics-and-outcomes-of-cbtki-based-therapies-amongs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-implications-of-tp53-mutations-tp53mt-in-patients-pts-with-higher-risk-myelodysplastic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cll-bone-marrow-infiltration-is-associated-with-osteocyte-loss-and-adipose-tissue-fragmentation-a-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-pre-transplant-ipss-m-risk-downstaging-in-myelodysplastic-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delta-opiod-receptor-signaling-modulates-myeloid-suppression-in-myelodysplastic-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-utilization-in-people-with-hemophilia-treated-within-vs-outside-us-hemophilia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/st2-promotes-leukemia-transformation-by-reshaping-the-immune-landscape-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-myelomonocytic-leukemia-clinical-outcomes-from-clinical-trials-submitted-to-the-fda-over-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-elderly-70-acute-myeloid-leukemia-aml-patients-receiving-continued-hypomethylating 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-outcomes-after-crovalimab-exposure-analysis-of-animal-model-and-clinical-trial-data-sugge 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-rituximab-and-thiotepa-ort-in-combination-with-or-without-high-dose-methotrexate-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-of-myeloid-neoplasms-and-pre-neoplasms-with-isolated-zrsr2-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognostic-factors-in-myeloid-blast-phase-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduced-overall-survival-in-tp53-mutated-ccus-is-driven-by-prior-cytotoxic-exposure-and-cytopenia-ra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/insights-into-clonal-and-cbc-changes-at-disease-evolution-among-ccus-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-front-line-metronomic-low-dose-weekly-decitabine-and-venetoclax-in-elderl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eccdna-encoded-lipin1-drives-dgat1-dependent-lipid-droplet-biogenesis-to-promote-acute-myeloid-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-class-dual-btk-malt1-fusion-inhibitors-for-treating-resistant-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-deep-learning-model-to-dynamically-predict-cancer-associated-thrombosis-using-electronic-health-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-patient-related-determinants-of-outcomes-after-unrelated-donor-hematopoietic-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/secondary-malignancies-after-hematopoietic-cell-transplantation-for-sickle-cell-disease-a-single-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-red-cell-deformability-measurements-to-assess-the-impact-of-pyruvate-kinase-activators-on-com 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloma-mortality-trends-in-the-united-states-excluding-puerto-rico-1999-2021-and-future-project 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bortezomib-melphalan-prednisone-vmp-daratumumab-dvmp-vs-lenalidomide-dexamethasone-rd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-t-cell-immunosenescence-profile-of-patients-with-newly-diagnosed-multiple-myeloma-as-an-indicato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-risk-stratification-and-mrd-guided-consolidation-determine-outcomes-in-pediatric-non-down 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lipoproteina-plasma-levels-and-coagulation-biomarkers-results-from-a-comprehensive-laboratory-ass 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-multi-omic-profiling-reveals-two-biologically-distinct-subgroups-of-splenic-marginal-zone 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mass-spectrometry-based-molecular-investigation-identifies-key-proteins-involved-in-synergistic-axl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-ibrutinib-venetoclax-shows-benefit-across-genomic-subgroups-in-patients-with-chronic-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-combined-with-low-dose-chemotherapy-and-tki-as-first-line-induction-for-newly-diagnosed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-facility-type-on-survival-outcomes-in-mantle-cell-lymphoma-a-20-year-ncdb-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-persistent-and-treatment-emergent-cytopenia-in-879-myelofibrosis-patients-treat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/two-decades-of-pregnancy-outcomes-in-women-with-cml-insights-from-a-real-world-single-center-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-fludarabine-exposure-on-post-transplant-outcomes-in-high-risk-v-thalassemia-patients-undergo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-predicts-idh1-mutation-status-in-acute-myeloid-leukemia-from-bone-marrow-smear-images 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-and-overcoming-mechanisms-of-resistance-to-a-vpreb1-directed-antibody-drug-conjugate-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-extranodal-involvement-on-bispecific-antibody-bsab-outcomes-in-patients-with-large-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-treatment-patterns-and-bleeding-in-people-with-hemophilia-a-without-inhibi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-joint-and-bone-health-outcome-in-hemophilia-a-by-protein-s-inhibition 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-population-scale-multiomics-to-define-the-prothrombotic-phenotype-of-protein-c-deficiency 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etoposide-cytarabine-pegfilgrastim-eap-and-disease-specific-chemotherapy-regimens-for-hematopoieti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd7-car-t-cells-in-patients-with-relapsed-or-refractory-cd7-acute-myeloid-leukemia-first-in-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-population-based-study-of-long-term-treatments-and-outcomes-inwaldenstrom-macroglobu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-lysine-acetyltransferases-p300cbp-overcomes-btk-inhibitor-resistance-in-a-xenograft-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-characteristics-of-nup98-rearrangements-and-their-therapeutic-responses-in-6 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hit-antibodies-activate-platelets-by-interacting-with-a-negatively-charged-epitope-on-human-pf4 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dnmt3b-functions-as-tumor-suppressor-in-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-platelet-transfusion-in-heparin-induced-thrombocytopenia-a-five-year-nationa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thromboembolism-and-event-free-survival-in-children-with-extracranial-solid-tumors-a-report-from-cy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-utilization-in-patients-with-sickle-cell-disease-on-buprenorphine-for-chronic-pain 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammatory-remodeling-and-cd4-t-cell-expansion-in-tet2-mutated-myeloid-disorders 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-mutational-evolution-and-transcriptomic-remodeling-on-3rd-generation-tki-therapy-in-tki-resi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-medication-use-is-associated-with-increased-lymphoma-risk-in-autoimmune-diseases-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-derived-sars-cov-2-specific-t-cells-to-prevent-covid-19-early-post-allogeneic-hematopoietic-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-analysis-of-clonal-dynamics-in-patients-with-indolent-systemic-mastocytosis-treated-with-avapriti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd7-negative-t-cell-immune-reconstitution-after-cd7-targted-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-a-population-with-newly-diagnosed-standard-risk-multiple-myeloma-by-the-2025-ims 2026-08-17 monthly 0.7 https://rjrindex.com/articles/parp-inhibition-by-talazoparib-results-in-leukemia-cell-death-via-induction-of-myeloid-differentiati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oligocentric-castleman-disease-clinical-characteristics-and-surgical-outcomes-from-a-single-centre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognostic-analysis-of-52-cases-of-alk-positive-anaplastic-large-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-adult-t-cell-leukemialymphoma-in-academic-and-community-cancer-programs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-patterns-of-clonal-hematopoiesis-exist-in-a-longevity-enriched-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-sole-loss-of-chromosome-y-in-myeloid-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-significance-of-cytoses-in-clonal-hematpoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-dendritic-cell-subtype-alterations-in-polycythemia-vera-clinical-correlations-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/latency-between-detectable-low-level-measurable-residual-disease-mrd-by-next-generation-sequencing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effects-of-zmiz1-mutations-in-newly-defined-early-t-cell-precursor-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-t-large-granular-lymphocytes-lgl-in-chronic-relapsing-remitting-and-refractory-immune-throm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dermatologic-toxicities-associated-with-talquetamab-in-patients-with-relapsedrefractory-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-single-cell-transcriptomic-dissection-analysis-platelet-t-cellmacrophage-crosstalk-and-immune 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-the-menopause-transition-in-sickle-cell-disease-an-analysis-of-the-implementation-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-intensity-and-transplant-independently-predict-survival-in-tp53-mutated-myeloid-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-peripheral-blood-blast-clearance-is-a-prognostic-marker-for-early-treatment-response-and-long 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daunorubicin-and-cytarabine-liposomal-cpx-351-plus-glasdegib-for-newly-diagnosed-secondary-acute-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-stratified-risk-of-second-primary-solid-malignancies-among-follicular-lymphoma-survivors-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-cyclophosphamide-ptcy-versus-other-graft-versus-host-disease-prophylaxis-strategie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/total-marrow-irradiation-based-conditioning-for-allogeneic-hematopoietic-stem-cell-transplantation-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-of-al-amyloidosis-reveals-pathogenic-mechanisms-immune-interactions-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-with-relapsedrefractory-multiple-myeloma-rrmm-in-europe-and-the-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparing-the-efficacy-and-safety-of-the-abc-14-regimen-azacitidine-venetoclax-and-chidamide-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-disease-risk-assessment-in-japanese-adults-with-hemophilia-interim-results-of-a-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-germline-and-somatic-tp53-mutations-on-allogeneic-hsct-outcomes-in-hematologic-malignancie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cognitive-and-physical-disability-after-traumatic-brain-injury-in-patients-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-multicenter-clinical-study-on-the-efficacy-and-safety-of-romiplostim-n01 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-new-hdac12-degrader-increases-hbf-production-in-human-cd34-cells-at-non-cytotoxic-differentiati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-car-t-cell-expansion-and-pd1-expression-in-patients-with-dlbcl-treated-with-axi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-comparative-analysis-of-epigenetic-age-acceleration-across-distinct-hematopoietic-clones-in-hemato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-venous-thromboembolism-on-clinical-outcomes-in-patients-with-brain-cancer-a-national-inpa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/computational-dissection-of-immune-reconstitution-across-diverse-conditioning-regimens-in-adults-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hi-c-ffpe-sequencing-analysis-is-highly-concordant-with-fish-and-detects-additional-variants-informi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-for-non-accidental-trauma-nat-and-bleeding-disorders-in-infants-referred-to-pediatric-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/household-material-hardship-as-a-barrier-to-accessing-sickle-cell-disease-curative-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-human-erythromyeloblastic-islands-embis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-association-between-sglt-2-inhibitor-use-and-progression-from-monoclonal-gammopathy-of-undetermi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-multi-compartmental-immune-pathways-in-antibody-mediated-and-dose-stratified-murine-trali-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-changes-in-cytogenetic-abnormalities-during-treatment-predict-long-term-outcomes-in-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-bcma-car-t-cell-therapy-in-relapsedrefractory-multiple-myeloma-with-extramedullary-disease-co 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extended-validation-of-the-rr6-prognostic-model-at-6-and-12-months-in-primary-and-secondary-myelofib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-reduced-frequency-targeted-combination-regimen-dvd-lite-for-the-treatment-of-newly-diagnosed-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upfront-therapy-with-allogeneic-hematopoietic-stem-cell-transplantation-versus-dna-methyltransferase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stag2-dependent-chromatin-remodeling-enforces-the-erythroid-specific-gata1-cistrome-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-assessment-of-patient-and-caregiver-unmet-needs-in-myeloproliferative-neoplasms-mpns-findi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-high-yield-cgmp-lentiviral-vector-manufacturing-process-using-suspension-culture-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/small-molecule-regulated-bcma-car-expression-switch-enables-precise-control-of-trispecific-bcmacd20 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-with-first-line-venetoclax-therapy-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combined-flt3-and-ezh12-inhibition-reduces-lscs-and-promotes-myeloid-differentiation-in-pdx-models 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tyrosine-phosphorylation-and-allosteric-regulation-of-impdh2-reveals-a-novel-therapeutic-vulnerabili 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-role-for-six1-and-eya2-and-a-novel-eya2-inhibitor-in-myeloid-leukemogenesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/repurposing-of-disulfiram-as-a-novel-therapeutic-agent-to-treat-crebbp-mutant-diffuse-large-b-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-bcrabl1-fusion-alongside-t315i-reveals-mechanism-for-dual-ponatinibasciminib-resistance-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-tumor-microenvironment-profiling-predicts-car-t-efficacy-and-guides-combinatoria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-weight-gain-predicts-nutritional-recovery-in-children-with-sickle-cell-anemia-and-severe-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-brd9-in-kmt2a-rearranged-acute-myeloid-leukemia-to-circumvent-men1-inhibitor-resistance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anthracyclines-induce-epigenetic-changes-in-aldh1a-that-promote-chemoresistance-in-aml-revealing-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/digestive-complications-in-aml-induction-spotlight-on-neutropenic-enterocolitis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-prognostication-in-the-swog-1826-randomized-clinical-trial-of-nivolumab-avd-versus-brentuxi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-registry-of-pediatric-cellular-therapy-patients-at-risk-for-endothelial-dysfunction-sin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-comt-activity-and-development-of-infections-during-therapy-for-pediatric-acute-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemo-immunotherapy-remains-utilized-for-chronic-lymphocytic-lymphoma-in-the-real-world-practice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-sintilimab-and-temozolomide-ost-in-relapsedrefractory-primary-central-nervous-sys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-expressed-srsf1-promotes-lck-exon-8-skipping-to-attenuate-tcr-signaling-and-treg-induction-in-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-improved-survival-with-pola-based-regimen-in-newly-diagnosed-dlbcl-patients-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tissue-factor-pathway-inhibitor-reduced-and-antithrombin-reduced-hemophilia-state-exhibit-different 2026-08-17 monthly 0.7 https://rjrindex.com/articles/no-reduction-in-gvhd-risk-for-aplastic-anemia-patients-to-combined-third-party-unrelated-cord-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fusion-transcript-dynamics-as-predictor-of-optimal-molecular-response-in-core-binding-factor-acute-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-tp53-mutation-on-cd19-chimeric-antigen-receptor-t-cell-therapy-in-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-validation-of-eln2024-and-beat-aml2024-risk-stratification-in-patients-with-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-predictive-model-based-on-nccn-ipi-and-2-pirnas-for-prognostic-risk-stratification-of-diffuse-larg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-1b2a-study-to-evaluate-mezigdomide-in-combination-with-elranatamab-in-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/second-generation-tyrosine-kinase-inhibitors-vs-imatinib-in-adult-ph-all-target-trial-emulation-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-emergency-department-care-for-people-with-bleeding-disorders-a-scoping-review-of-barrier 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-fludarabine-melphalan-versus-fludarabine-busulfan-reduced-intensity-conditio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-tim3-with-hypomethylating-agent-revives-nk-and-cytotoxic-cd4-t-cell-activity-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-rescue-intervention-with-daratumumab-pomalidomide-and-dexamethasone-dpd-in-high-risk-smolde 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utility-of-18f-fdg-petct-for-response-assessment-in-marginal-zone-lymphomas-preliminary-results-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-orelabrutinib-obinutuzumab-and-lenalidomide-in-previously-untreated-margina 2026-08-17 monthly 0.7 https://rjrindex.com/articles/defining-the-clinical-characteristics-and-outcomes-of-adult-patients-pts-with-11q23kmt2a-rearrang 2026-08-17 monthly 0.7 https://rjrindex.com/articles/talquetamab-bridging-therapy-for-b-cell-maturation-antigen-chimeric-antigen-receptor-t-cell-in-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/control-of-gvhd-by-probiotics-with-a-single-strain-of-muribaculaceae-bacterium-through-secretory-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-retreatment-of-real-world-patients-with-chronic-lymphocytic-leukemia-previously-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd7-targeted-car-t-cell-therapy-showed-a-high-efficacy-for-30-patients-with-relapsed-or-refractory-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-in-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-with-pre-transpla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-monotherapy-demonstrates-promising-efficacy-in-patients-with-richter-transformation-rt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-placebo-controlled-trial-of-a-novel-btk-inhibitor-rilzabrutinib-in-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/radiation-free-therapy-for-the-initial-treatment-of-good-prognosis-early-non-bulky-hl-defined-by-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-tisagenlecleucel-in-patients-with-relapsedrefractory-follicular-lymphoma-rr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tcf3hlf-positive-b-all-largest-cohort-study-to-date-reveals-unique-molecular-landscape-and-treatm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-and-clinical-outcomes-in-patients-with-myelofibrosis-and-new-or-worsening-anemia-treated-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-treatment-duration-subcutaneous-mosunetuzumab-monotherapy-in-elderlyunfit-patients-with-previ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crispr-ticaai-a-function-informed-generative-modeling-pipeline-for-prioritizing-drug-discovery-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ultra-low-dose-il-10-expressing-car-t-cells-achieve-high-efficacy-in-rr-dlbcl-an-update-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardio-safe-degrader-ct-03p-degrades-mcl-1-and-overcomes-venetoclax-resistance-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/earlier-use-of-ciltacabtagene-autoleucel-cilta-cel-is-associated-with-better-immune-fitness-and-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-lenalidomide-pre-apheresis-on-markers-of-t-cell-fitness-and-pharmacodynamic-biomarkers-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bleximenib-in-combination-with-intensive-chemotherapy-a-phase-1b-study-in-newly-diagnosed-acute-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-trial-of-azacitidine-and-venetoclax-in-previously-untreated-myelodysplastic-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-outcomes-in-sickle-cell-disease-patients-treated-with-crizanlizumab-with-or-without-hydro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd19-car-t-cell-therapy-is-an-effective-strategy-for-first-cns-relapse-in-pediatric-b-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/radiotherapy-of-extramedullary-acute-myeloid-leukemias-overcomes-resistance-to-checkpoint-blockade-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unifying-the-classification-of-acute-myeloid-leukemia-myelodysplasia-related-a-multi-institutional 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-the-smart-stop-trial-lenalidomide-tafasitamab-rituximab-and-acalabrutinib-al 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haploidentical-donor-regulatory-t-cells-and-memory-t-cells-are-safe-and-effective-in-children-with-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-cost-per-ae-symptom-free-day-of-asciminib-and-second-generation-tyrosine-kinase-inhibitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haploidentical-hematopoietic-stem-cell-transplantation-in-adults-with-severe-sickle-cell-disease-lo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/screening-for-clonal-hematopoiesis-in-patients-with-v-hemoglobinopathies-who-are-candidates-to-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-nivolumabipilimumab-primed-immunotransplant-in-patients-with-relapsedrefrac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trimodal-single-cell-profiling-reveals-principles-of-cell-fate-acquisition-in-human-erythropoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/redefining-early-vs-late-progressive-disease-pd-in-chronic-lymphocytic-leukemia-a-pooled-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mt-601-demonstrates-favorable-safety-and-durable-responses-in-relapsed-or-refractory-rr-non-hodgk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cell-therapy-versus-autologous-hsct-in-patients-with-large-b-cell-lymphoma-in-complete-remissi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-efficacy-and-safety-of-optimized-tandem-cd19cd20-car-t-cell-therapy-in-refractoryrelapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/renal-responses-in-a-phase-12-study-of-at-02-a-novel-pan-amyloid-depleter-ig-fusion-protein-for-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-rna-delivery-by-targeted-lipid-nanoparticles-enable-gene-editing-in-hematopoietic-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overcoming-maturation-deficits-in-ipsc-nk-cells-through-programmable-t-bet-induction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/roginolisib-ioa-244-an-orally-bioavailable-selective-pi3kd-inhibitor-in-combination-with-veneto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-trends-in-vaccination-and-cancer-screening-engagement-among-patients-with-chronic-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-dynamics-in-post-transplant-patients-with-newly-diagnosed-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dasatinib-enhances-potency-of-a-novel-cd123-car-against-aml-by-improving-cell-fitness 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-system-for-delivering-interactive-and-verifiable-guideline-based-clinical-de 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peri-transplant-ruxolitinib-therapy-significantly-improves-gvhd-free-relapse-free-survival-rates-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilization-and-outcomes-of-erythropoietin-stimulating-agents-in-sickle-cell-disease-patient-a-real 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gut-permeability-marker-zonulin-in-sickle-cell-disease-preliminary-associations-with-vaso-occlusive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-relapse-is-uncommon-after-chimeric-antigen-receptor-t-cell-therapy-for-relaps 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptional-profiling-identifies-adgrg1-cd8-t-cells-as-critical-mediators-of-graft 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ornithine-decarboxylase-deficiency-in-donor-t-cells-preserves-strong-gvl-activity-while-attenuating 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-microfluidic-rheology-assay-for-in-vitro-differentiated-red-blood-cells-enhancing-quality-con 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-infusional-chemotherapy-regimens-in-multiple-myeloma-a-retrospective-review-at-a-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-mtor-is-a-regulator-of-sterile-immunothrombosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-second-primary-malignancies-in-patients-with-hematologic-malignancies-treated-with-next 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-pet-response-for-relapse-prediction-in-2nd-or-higher-line-lisocabtagen-maraleucel-in-large-b-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-leukemia-during-pregnancy-a-three-decade-mayo-clinic-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-clonal-hematopoiesis-on-hematologic-recovery-and-outcomes-following-tumor-infiltrating-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-with-dose-adjusted-epoch-feasibility-and-early-efficacy-in-newly-diagnosed-plasmablastic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-trial-of-hetrombopag-tpo-ra-in-the-treatment-of-primary-immune-thrombocytopeni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reactivating-mutant-p53-in-t-cells-enhances-anti-tumor-activity-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-treatment-continuation-of-gecacitinib-in-myelofibrosis-patients-after-ruxolitinib-failure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ropeginterferon-alfa-2b-in-248-patients-with-polycythemia-vera-results-from-the-italian-cohort-of-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-romiplostim-n01-combined-with-immunosuppressive-therapy-in-patients-diagnosed-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-improvements-in-patient-reported-outcomes-after-intravenous-efgartigimod-in-adults-with-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-of-avatrombopag-for-chronic-immune-thrombocytopenia-interim-analysis-of-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcome-after-relapse-in-older-patients-with-philadelphia-chromosome-negative-b-cell-all-treated-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/soluble-factors-in-the-aml-secretome-drive-macrophage-polarization-toward-an-m2-like-state-promoting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-meta-analysis-of-inhibitor-development-in-previously-untreated-patients-with-severe-hemophil 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-and-clonal-evolution-in-minor-versus-major-bcrabl1-chronic-myeloid-leukemia-un 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-stat6-and-pd-l1-expression-in-hodgkinreed-sternberg-hrs-like-cells-in-hodgkin-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combination-of-mitoxantrone-hydrochloride-liposome-with-gemcitabine-cisplatin-and-dexamethasone-mg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-dose-cryopreserved-bone-marrow-from-deceased-donors-may-reduce-relapse-in-hla-mismatched-alloge 2026-08-17 monthly 0.7 https://rjrindex.com/articles/response-dynamics-to-belumosudil-in-chronic-graft-versus-host-disease-characterizing-late-responses 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-geriatric-assessment-to-evaluate-individual-frailty-status-and-quality-of-life-in-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-in-high-altitude-hypoxia-preserves-graft-versus-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/profiling-drug-sensitivity-in-cll-b-cells-after-btk-inhibitor-progression-using-a-novel-drug-panel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ihp-102-compound-decreases-the-adhesion-of-sickle-cell-disease-rbcs-to-acutely-activated-endothelial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/defining-therapeutic-chimerism-thresholds-for-comprehensive-sickle-cell-disease-correction-in-the-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-non-telomeric-role-of-pot1a-in-regulating-hsc-metabolism-via-tin2-localization 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mutational-landscape-of-adult-xanthogranuloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-experience-with-efanesoctocog-alfa-in-patients-with-uncover-needs-on-emicizumab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ai-assisted-diagnosis-of-paroxysmal-nocturnal-hemoglobinuria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-intervention-for-cytokine-release-syndrome-after-chimeric-antigen-receptor-t-cell-therapy-is-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-characteristics-of-brentuximab-vedotin-among-patient-subgroups-insightsfrom-pooled-clinical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-hydroxyurea-for-children-with-sickle-cell-disease-in-sub-saharan-africa-a-dis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pediatric-sickle-cell-outpatient-pain-management-a-quality-improvement-initiative 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-haploidentical-donors-for-pediatric-patients-undergoing-hematopoietic-stem-cell-transp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-multiple-myeloma-patients-autologous-stem-cell-transplants-abrogate-the-difference-of-treating-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-a-novel-surface-antigen-ryk-with-the-antibody-drug-conjugate-slv-404-is-effective-in-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golidocitinib-combination-therapy-as-first-line-treatment-in-ptcl-retrospective-data-from-a-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-immune-dynamics-associated-with-chronic-lymphocytic-leukemia-development-in-mice-with-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-the-immune-microenvironment-in-the-clonal-evolution-of-chronic-lymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombosis-bleeding-and-progression-in-jak2-v617f-clonal-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-spatial-transcriptomics-reveals-age-dependent-cellular-organization-of-mouse-bone-marrow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-of-risk-classification-with-newly-proposed-international-myeloma-working-group-imwg-hi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lymphotoxin-alpha-lta-secretion-correlates-with-gene-expression-and-myeloid-malignancy-disease-sta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-omics-single-cell-spatial-profiling-of-paediatric-and-adult-acute-myeloid-leukaemia-links-spat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/repertoire-of-driver-events-in-coding-and-non-coding-regions-identified-by-whole-genome-sequencing-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-glofitamab-based-regimens-in-relapsedrefractory-aggressive-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-30-day-readmission-following-cart-cell-therapy-a-single-center-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modal-car-t-cells-a-synthetic-cytokine-circuit-to-overcome-tgfv-mediated-immunosuppression-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multimodal-epigenetic-microarray-classifies-aml-mds-and-controls-using-peripheral-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/17p-cytogenetic-changes-in-tp53-mutated-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-uncovers-molecular-subtypes-in-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/redefining-hematology-referral-thresholds-for-eosinophilia-a-10-year-experience-at-an-academic-medi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mapping-skeletal-muscle-mitochondrial-oxidative-phosphorylation-oxphos-in-childhood-acute-lymphobl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-immune-checkpoint-inhibitor-rechallenge-in-patients-with-classical-hodgkin-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pseudo-thrombotic-microangiopathy-secondary-to-severe-vitamin-b12-deficiency-a-case-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-comorbid-mortality-from-disseminated-intravascular-coagulation-and-sepsis-in-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azd4512-a-novel-cd22-directed-antibody-drug-conjugate-for-the-treatment-of-b-cell-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-real-world-uptake-and-patient-characteristics-of-bispecific-antibodies-in-relapsedrefracto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-clot-thickens-diagnosing-aps-in-the-setting-of-multifocal-thrombosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/activated-factor-ix-radua-delivered-via-adeno-associated-virus-enhances-therapeutic-efficacy-in-hemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analysis-identifies-lipid-metabolism-signature-of-defective-erythropoiesis-in-diamond 2026-08-17 monthly 0.7 https://rjrindex.com/articles/humanized-klkb1-provides-a-mouse-model-for-evaluating-the-knockdown-efficacy-of-rnai-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dichotomy-of-tp53-mutant-aml-mrd-microenvironment-spatially-segregated-immunosuppressive-mechanisms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tislelizumab-combined-with-zanubrutinib-and-high-dose-methotrexate-in-newly-diagnosed-primary-centra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lessons-from-the-ielsg45-trial-the-impact-of-patient-fitness-on-dropout-rate-in-primary-central-ner 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-polatuzumab-acalabrutinib-rituximab-and-lenalidomide-pola-ar2-regime 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-results-of-tqb2934-a-novel-21-bcma-cd3-bispecific-antibody-in-patients-with-relapsedre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/murine-reticulated-platelets-generated-during-recovery-from-antibody-induced-thrombocytopenia-are-fu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-the-utility-of-the-charlson-comorbidity-index-in-predicting-outcomes-of-car-t-therapy-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transition-of-care-of-youth-with-bone-marrow-failure-conditions-current-practices-barriers-and-bu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/realworld-matched-comparison-of-talquetamab-versus-teclistamab-in-relapsedrefractory-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-score-settles-it-maybe-not-navigating-postpartum-vte-prophylaxis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-jak12-inhibitor-baricitinib-revealed-unique-immune-biomarkers-in-multirefractory-immune-thrombo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-evaluate-the-safety-tolerability-pharmacokinetics-pharmacodynamics-and-effica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-monitoring-using-ngs-allows-detection-of-abl1-kd-mutations-in-patients-with-chronic-phase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quality-of-life-and-functional-improvements-with-efanesoctocog-alfa-in-patients-with-moderate-to-sev 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-psychiatric-conditions-on-toxicity-and-outcomes-of-patients-after-bcma-direct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-cml-indian-multicentric-data-supporting-safe-pregnancy-and-molecular-control-in-women-with-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/itacitinib-in-combination-with-post-transplant-cyclophosphamide-and-tacrolimus-ict-as-gvhd-prophyl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-of-brief-neurocognitive-assessments-in-adults-and-adolescents-with-sickle-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-of-cyclophosphamide-pomalidomide-dexamethasone-and-daratumumab-cpd-dara-in-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetic-priming-improves-survival-for-pediatric-acute-myeloid-leukemia-results-from-the-multicen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ferroptosis-escape-in-aml-stem-cells-uncovered-by-single-cell-profiling-and-reversed-by-stat3nrf2-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-mouse-model-of-aggressive-atl-associated-with-oncogenic-mutations-and-an-hbz-expressing-hematopoie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/isatuximab-with-bortezomib-cyclophosphamide-and-dexamethasone-followed-by-isatuximab-and-lenalidom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-deep-sequencing-of-myeloma-in-a-multi-institutional-clinical-workflow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-maintenance-strategies-post-autologous-stem-cell-transplant-in-patients-with-newly-diagnos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-dna-sequencing-uncovers-synergistic-co-mutations-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetic-reprogramming-via-ezh12-inhibition-enhances-t-cell-mediated-immunotherapies-against-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antibody-mediated-in-vitro-antigen-removal-from-red-blood-cells-prior-to-transfusion-enhances-surviv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ponatinib-alleviates-car-t-cell-exhaustion-and-remodels-the-immune-microenvironment-a-promising-com 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-hematopoietic-stem-cell-mobilization-for-gene-therapy-using-single-agent-motixafortide-in-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hairy-cell-leukemia-treatment-strategies-a-real-world-multicenter-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-independence-hematological-improvement-and-associated-safety-outcomes-with-bexmarilimab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-agranulocytosis-related-mortality-in-adults-aged-65-yearsin-the-united-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-prospect-of-high-dose-vitamin-c-in-improving-early-survival-in-patients-with-hemophagocytic-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elranatamab-real-world-step-up-dosing-patterns-in-relapsed-refractory-multiple-myeloma-patients-int 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-circulating-tumor-dna-dynamics-during-amp-after-first-line-therapy-in-a-national-coho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-regional-and-national-burden-of-g6pd-deficiency-a-three-decade-analysis-across-204-countri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-zanubrutinib-combined-with-reduced-dose-bendamustine-and-rituximab-for-eldly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-reconstitution-with-the-use-of-bruton-tyrosine-kinase-inhibitor-treatment-for-patients-with-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pulmonary-and-cardiac-comorbidities-on-cytokine-release-syndrome-incidence-in-chimeric-ant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combination-of-golidocitinib-with-chidamide-for-peripheral-t-cell-lymphoma-possible-mechanisms-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lamin-b1-mediates-dynamic-changes-in-heterochromatin-and-regulates-erythropoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-survival-outcomes-in-second-and-third-line-settings-in-large-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-care-kit-as-a-prophylaxis-for-talquetamab-associated-toxicities-in-patients-with-relapsedrefr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-urgent-inpatient-chemotherapy-for-relapsedrefractory-multiple-myeloma-in-the-modern-era 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-levels-of-wilms-tumor-1-wt1-protein-are-prognostically-adverse-and-independent-of-mutation-sta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/qualitative-interviews-exploring-the-patient-experience-of-fatigue-in-individuals-with-sickle-cell-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanism-for-hspc-expansion-in-the-endothelial-cuddling-niche-microenvironment-through-inflammatory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-and-region-specific-targeting-of-scf-and-cxcl12-in-stromal-niche-cells-reveals-local-and-lineag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/onc001-a-first-in-class-adc-targeting-cd64-for-the-treatment-of-monocytic-leukemia-developed-throug 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biomarkers-for-venous-thromboembolism-in-children-with-central-venous-catheters 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictive-performance-of-the-leo-comorbidity-index-in-patients-aged-80-years-with-large-b-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-of-safety-and-outcomes-with-first-line-nivolumab-in-combination-with-doxorubic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiological-survey-of-familial-myelodysplastic-syndromesacute-myeloid-leukemia-in-hawaii 2026-08-17 monthly 0.7 https://rjrindex.com/articles/smarcc1-loss-impairs-differentiation-and-enhances-self-renewal-in-asxl1-mutant-hematopoietic-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-studies-reveal-altered-heterogeneity-in-cd41-enriched-megakaryocytes-afte 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-sickle-cell-disease-related-mortality-in-the-us-mexico-border-region-from-1999-to-202 2026-08-17 monthly 0.7 https://rjrindex.com/articles/setd2-deficiency-in-chronic-myeloid-leukemia-cml-contributes-to-tyrosine-kinase-inhibitor-tki-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-bone-marrow-b-cells-in-patients-with-warm-autoimmune-hemolytic-anemia-by-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-targeted-car-nk-cell-therapy-using-lipid-nanoparticle-mrna-delivery-for-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-and-phenotypic-impact-of-fhd-286-induced-inhibition-of-smarca42-in-patients-with-relapsedr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-in-of-primary-vte-prophylaxis-in-pediatric-patients-in-hospitalized-and-critically-ill-settings 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetically-driven-upregulation-of-immunoproteasome-component-psmb8-characterizes-diffuse-large-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/large-language-models-extract-diverse-manifestations-of-chronic-gvhd-from-unstructured-clinical-docu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kmt2aaf6-fusion-protein-localizes-to-pml-nuclear-bodies-and-undergoes-ato-induced-degradation-a-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-of-chronic-kidney-disease-ckd-in-lymphoma-survivors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-response-to-rupture-evaluating-gi-perforation-after-cd19-cart-in-lbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-the-number-of-bridging-therapy-lines-on-outcomes-after-axi-cel-in-lbcl-a-lysa-study-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-evaluating-nt-i7-efineptakin-alfa-a-long-acting-human-il-7-post-tisagenlecleucel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-antileukemic-activity-of-momelotinib-in-combination-with-venetoclax-and-azacitidine-compare 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-infiltrating-lymphocyte-therapy-in-lung-cancer-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-myocardial-work-indices-and-biomarkers-for-identifying-anthraquinone-induced-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ironregulatory-gene-variants-and-their-association-with-clinical-phenotypes-in-nigerian-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-thalassemia-have-weaker-bones-relative-to-body-size-compared-with-healthy-controls 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hydroxyurea-sequesters-the-histone-methyltransferase-g9a-at-stressed-replication-forks-to-reactivate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-fanconi-anemia-pathway-restrains-mll-rearranged-leukemogenesis-through-suppressing-nhej-mediated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/facility-type-and-survival-outcomes-in-extranodal-nkt-cell-lymphoma-nasal-type-a-national-cancer 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toxicity-profile-of-epcoritamab-and-glofitamab-in-aggressive-b-cell-lymphoma-a-real-world-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-mortality-from-acute-myeloid-leukemia-attributable-to-tobacco-use-in-the-united-states-1999 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-of-high-grade-b-cell-lymphomas-through-bone-marrow-evaluation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-in-patients-aged-80-years-with-lbcl-propensity-score-analysis-reveals-comparabl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd7-chimeric-antigen-receptor-t-cells-for-relapsedrefractory-t-cell-lymphomas-single-arm-open-lab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pegylated-interferon-alfa-2b-in-myeloproliferative-neoplasms-a-multicenter-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/older-donor-age-is-not-associated-with-inferior-survival-in-contemporary-haploidentical-transplantat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/when-growth-hormone-deficiency-isnt-the-answer-a-case-of-gaucher-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-chemotherapy-free-regimen-of-sintilimab-rituximab-and-lenalidomide-polatuzumab-vedotin-in-elde 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proteomic-profiling-of-amyloid-deposits-in-advanced-systemic-light-chain-al-amyloidosis-insights 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-biomarker-dynamics-for-accurate-risk-prediction-in-464-patients-with-asymptomatic-igm-g 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selenocysteine-dependency-renders-central-nervous-system-leukaemia-therapeutically-sensitive-to-ferr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predicting-mortality-in-icu-patients-with-acute-leukemias-a-new-risk-score 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-prognostic-impact-of-bmi-mrd-and-cns-involvement-in-aya-patients-with-philadelphi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fostamatinib-significantly-increases-risk-of-hypertension-in-hematologic-patients-a-meta-analysis-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-perspectives-on-the-burden-of-hypereosinophilic-syndrome-results-from-the-phase-3-natron-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/investigating-patients-experiences-with-dyspnea-associated-with-warm-antibody-hemolytic-anemia-wai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transition-to-ixazomib-based-maintenance-following-daratumumab-based-induction-for-continuous-therap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/associations-between-chronic-kidney-disease-proteinuria-and-thrombotic-risk-in-scd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/self-reported-geriatric-impairments-and-treatment-toxicity-in-older-patients-with-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/using-a-magnetic-column-separator-to-determine-the-magnetophoretic-behavior-and-adhesion-characteris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utility-of-diagnostic-bone-marrow-examinations-for-cytopenias-and-impact-on-clinical-management-a-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/microbiome-and-cytokine-features-are-associated-with-graft-versus-host-disease-incidence-in-allogene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-blood-ebv-dna-in-peripheral-t-cell-lymphoma-not-otherwise-specified-ptcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombophilia-testing-and-thrombotic-risk-evaluation-in-beta-thalassemia-a-cohort-analysis-from-a-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-omics-analysis-identifies-neutrophil-degranulation-as-a-psmd3-regulated-pathway-in-flt3-mutate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/systematic-review-on-the-diagnostic-evaluation-of-pediatric-evans-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-race-on-the-incidence-diagnosis-and-outcomes-of-pregnancy-associated-venous-thromboemboli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-class-immunomodulatory-anti-heat-shock-protein-70-hsp70-antibody-demonstrates-broad-antit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aquired-hemophilla-a-after-covid-19-infection-in-an-5-week-old-infant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-the-therapeutic-potential-of-fenretinide-in-acute-erythroid-and-acute-megakaryoblastic-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tip-20-a-novel-flt3-inhibitor-with-potent-antileukemia-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-midostaurin-in-younger-aml-patients-intensively-treated-with-high-dose-anthracycline 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-the-menin-inhibitor-revumenib-with-the-celmod-mezigdomide-in-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-bendamustine-versus-fludarabine-and-cyclophosphamide-as-lymphodep 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-allogenic-hematopoietic-stem-cell-transplant-allo-hsct-hypomethylating-agent-maintenance-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lp-005-a-bifunctional-c5-antibody-fusion-protein-efficacy-and-safety-in-pnh-patients-with-active-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-relapsedrefractory-flt3mut-acute-myeloid-leukemia-who-resumed-gilteritin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-venetoclax-conundrum-therapeutic-drug-monitoring-of-venetoclax-correlation-with-response-in-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multi-site-break-through-cancer-pilot-study-testing-the-feasibility-and-safety-of-therapeutic-inte 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-evidence-shows-that-intracellular-complement-complosome-expressed-in-hematopoietic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vincristine-induced-neuropathy-long-term-follow-up-of-lymphoma-survivors-treated-with-chop-or-dose 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-of-vitamin-d-deficiency-and-bone-health-risk-factors-in-persons-with-von-willebrand-disease-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-real-world-diagnostic-and-treatment-patterns-risk-of-thromboembolic-events-and-mortalit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-spk-8011qq-an-adeno-associated-virus-gene-therapy-for-people-with-hemophi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/scalable-antibody-free-lipid-nanoparticle-achieves-human-hspc-selective-mrna-delivery-in-vivo-witho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-aki-and-transfusion-burden-following-venetoclax-based-therapy-in-aml-versus-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/geographic-demographic-and-temporal-disparities-in-mortality-from-hematological-cancers-with-renal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cholesterol-and-lipid-associated-transcriptional-signature-in-chronic-myeloid-leukemia-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-complete-response-rates-low-dropout-rate-and-low-grade-toxicities-in-patients-with-relapsedr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metronomic-dose-decitabine-therapy-for-tp53-complex-karyotype-myeloid-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-bone-marrow-blast-reduction-guided-selinexor-based-regimen-therapy-in-relapsedrefractory-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-1-trial-evaluating-the-safety-and-preliminary-efficacy-of-revumenib-as-post-tran 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-cross-sectional-study-to-explore-current-state-of-patient-awareness-of-multiple-myeloma-mm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-infectious-complications-in-patients-with-relapsedrefractory-large-b-cell-lymphoma-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-after-first-relapse-of-pediatric-b-all-differs-by-insurance-type-a-real-world-analysis-fro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-paired-bone-marrow-and-peripheral-blood-measurable-residual-disease-in-pediatric-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-autoimmune-disease-on-outcomes-after-bcma-directed-car-t-cell-therapy-for-patients-with-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/m6a-driven-control-of-t-cell-fitness-via-lrpprc-defines-a-novel-regulatory-axis-to-enhance-adoptive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-prognostic-value-of-ngs-based-measurable-residual-flt3-itd-in-aml-patients-positive-for-flt3-it 2026-08-17 monthly 0.7 https://rjrindex.com/articles/superficial-vein-thrombosis-of-the-upper-extremities-a-retrospective-analysis-of-clot-progression-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/medical-and-perioperative-management-of-acute-and-subacute-heparin-induced-thrombocytopenia-in-adult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-of-tpmt-and-nudt15-diplotypes-in-mexican-children-with-b-cell-acute-lymphoblastic-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-mutations-define-a-high-risk-subgroup-in-pediatric-acute-myeloid-leukemia-with-distinct-molecul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-long-term-outcomes-with-third-party-unrelated-cord-blood-co-infusion-in-a-122-patients-coho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-atoatra-based-regimen-in-apml-steroid-induced-toxicities-are-a-concern-in-lmics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-implementation-of-an-electronic-patient-reported-outcome-system-supporting-self-manag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-vs-low-intensity-chemotherapy-in-aml-survival-and-transplant-outcomes-in-a-brazilian-experien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sonar-ai-discovers-first-comprehensively-described-cases-of-glp-1-receptor-agonist-associated-thromb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-spectrum-of-hereditary-hemorrhagic-telangiectasia-hht-data-from-the-comprehensive-hht-ou 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-approach-identifies-a-transcriptomic-signature-predicting-treatment-free-remissio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-from-the-multicenter-accru-ly-1804caribou-cytarabine-acalabrutinib-and-rituximab-integra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/u2af1s34f-mutant-hspcs-have-a-fitness-advantage-in-aged-and-inflamed-bone-marrow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-molecular-and-translational-analysis-of-tp53-mutated-hr-mds-with-bexmarilimab-and-azacitid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-cilta-cel-dose-and-efficacy-and-toxicity-outcomes-for-patients-with-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-lysosomes-to-overcome-albumin-mediated-proteasome-inhibitor-resistance-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-chip-ccrs-predicts-prolonged-cytopenias-and-inferior-survival-following-anti-bcma-car-t-in-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-guided-therapy-of-sonrotoclax-bgb-11417-obinutuzumab-o-in-patients-with-treatment-naive-cl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/duvelisib-in-patients-with-relapsedrefractory-peripheral-t-cell-lymphoma-final-results-from-the-ph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-mmp-7-as-an-early-and-specific-biomarker-for-hepatic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/setting-the-stage-in-kmt2a-rearranged-acute-myelogenous-leukemia-in-the-era-of-menin-inhibitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tissue-factor-and-extracellular-vesicles-from-pasc-patients-exert-procoagulant-effects-and-mediates 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fedora-preliminary-analysis-of-a-phase-ii-study-evaluating-the-tolerability-safety-and-activity-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-experiential-learning-intervention-with-community-advisory-boards-to-enhance-clinical-trial-liter 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nanopore-sequencing-to-detect-bcrabl1-and-associated-genomic-rearrangements-in-cml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sars-cov-2-nsp10-protein-activates-the-p38-mapk-signaling-pathway-by-downregulating-dusp2-to-trigger 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ivig-prevents-infections-without-affecting-mortality-in-dlbcl-patients-treated-with-car-t-cell-or-bi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-dilemma-intravenous-iv-iron-use-in-iron-deficiency-anemia-during-acute-infections 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-fast-off-rate-of-anito-cels-d-domain-binder-contributes-to-its-distinctive-pharmacology-profile 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-plus-inotuzumab-ozogamicin-for-relapsed-and-refractory-all-results-of-a-phase-i-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-short-course-versus-standard-course-blinatumomab-in-patients-with-relapsedrefractory-or 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-progression-and-clinical-outcomes-after-first-relapse-in-patients-with-primary-plasma-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cart-asct-cart2-sandwich-regimen-as-frontline-therapy-a-phase-ii-trial-in-patients-with-primary-pla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanistic-dissection-of-venetoclax-sensitivity-in-aml-through-single-molecule-bcl2-protein-complex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kp104-a-bifunctional-c5-mab-factor-h-fusion-protein-demonstrates-sustained-long-term-efficacy-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-hematopoietic-stem-cell-hsc-engineering-and-selection-with-cd90-targeted-multiplexed-virus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-tp53-mutation-status-and-variant-allele-frequency-in-myelodysplastic-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improvemf-phase-1b-trial-of-imetelstat-plus-ruxolitinib-in-patients-with-intermediate-2-or-high-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/universal-base-edited-car7-t-cells-for-t-cell-acute-lymphoblastic-leukemia-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-rocbrutinib-a-highly-selective-4th-generation-btk-inhibitor-in-chinese-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/generating-ectopic-subcutaneous-bone-marrow-by-reconstitution-of-endochondral-ossification 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-limitec-a-prospective-trial-of-limited-duration-teclistamab-for-relapsedrefrac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-newly-formulated-intranasal-desmopressin-versus-intranasal-and-subcutaneous-desmopre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subcutaneous-cevostamab-demonstrates-manageable-safety-and-clinically-meaningful-activity-in-relapse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-thrombosis-and-bleeding-in-patients-receiving-car-t-cell-therapy-a-multicentric-retros 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rare-composite-of-rosai-dorfman-destombes-disease-and-nodular-lymphocyte-predominant-b-cell-hodgkin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiology-clinical-features-and-molecular-basis-of-ittmvi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hpa-1a-antibodies-in-fnait-do-not-distinguish-avv3-from-aiibv3-and-bind-inactive-integrins-more-str 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bispecific-antibodies-in-action-the-reality-of-engagement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-pursuit-of-fnait-biomarkers-avv3-specificity-falls-short 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-patients-with-aggressive-b-cell-lymphoma-treated-with-epcoritamab-or-glofitam 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-ketoglutarate-promotes-amino-acid-depletion-and-suppresses-b-cell-lymphoma-growth-and-development 2026-08-17 monthly 0.7 https://rjrindex.com/articles/starving-lymphoma-with-a-kg-supplementation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rexposing-a-weakness-in-tp53-mutant-mds-and-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-resonate-2-study-up-to-10-years-of-follow-up-of-first-line-ibrutinib-treatmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetic-changes-by-ezh2-inhibition-increase-translocations-in-b-cells-with-high-aid-activity-or-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-clinical-guide-to-itp53i-mutations-in-myeloid-neoplas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/making-sense-of-factor-viiis-breakdown 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factor-ixa-and-factor-x-influence-factor-viiia-stability-and-inactivation-mechanisms-in-vitro-and-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/xpo1-drives-resistance-to-eprenetapopt-and-azacitidine-and-can-be-targeted-in-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-far-can-ibrutinib-resonate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/van-oekelen-o-nath-k-mouhieddine-th-et-al-interventions-and-outcomes-of-patients-with-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circfut8-promotes-proplatelet-formation-by-interacting-with-igf2bp2-and-stabilizing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-targeting-in-multiple-myeloma-talquetamab-a-gprc5d-bispecific-antibody-as-a-bridge-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-patients-with-cll-after-prior-treatment-with-a-covalent-btk-inhibitor-and-a-bcl-2-inhibi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-for-imdscs-off-the-shelf-mdscs-to-control-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancer-heterogeneity-in-acute-lymphoblastic-leukemia-drives-differential-gene-expression-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-newcomer-in-allosteric-therapy-for-ph-leukemias 2026-08-17 monthly 0.7 https://rjrindex.com/articles/leukemic-fusion-partners-and-mutations-shape-inup98i-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rgi-2001-for-the-prophylaxis-of-acute-graft-versus-host-disease-after-allogeneic-hct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/designing-a-strong-bridge-to-car-t-cells-with-bispecifics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kshvhhv8-positive-germinotropic-lymphoproliferative-disorder-in-a-patient-with-hiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-inkt-treg-axis-in-gvhd-control 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombopoiesis-comes-full-circle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-characterization-of-tgrx-678-a-brain-penetrant-allosteric-inhibitor-of-bcrabl1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fusion-oncoproteins-and-cooperating-mutations-define-disease-phenotypes-in-inu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-specific-enhancers-in-genetically-uniform-leukemias 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-cause-of-type-1-von-willebrand-disease-impaired-exocytosis-of-weibel-palade-bodies-due-to-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maddlessness-may-cause-von-willebrand-disease-type-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammasome-resistant-ipsc-derived-myeloid-derived-suppressor-cells-ameliorate-xenogeneic-graft-ver 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chilling-controversy-cold-stored-platelets-for-prophylactic-transfusions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shomali-w-an-adaptive-survival-prediction-model-in-cmml-ibloodi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-presentation-management-and-outcome-of-tian-in-cns-lymphoma-treated-with-cd19-car-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd99-promotes-self-renewal-in-hematopoietic-stem-cells-and-leukemia-stem-cells-by-regulating-protein 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-elranatamab-in-patients-with-relapsed-andor-refractory-immunoglobulin-light 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-mimicking-mature-lymphoid-morphology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shaping-individualized-care-for-women-with-hemophilia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd99-tunes-translation-to-sustain-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-becoming-a-new-hope-for-al-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/remestemcel-l-rknd-ryoncil-the-first-approved-cellular-therapy-for-steroid-refractory-acute-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/casein-kinase-1a-essentially-regulates-thrombopoiesis-by-driving-megakaryocyte-maturation-and-cytosk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/locatian-locatian-locatian 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-many-notches-activation-pathways-are-there-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impaired-cytotoxic-function-and-exhausted-phenotype-of-natural-killer-cells-in-vexas-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gene-variants-influence-the-response-to-desmopressin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nk-cell-exhaustion-in-vexas-another-piece-in-the-puzzle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/if8i-gene-variants-influence-the-response-to-desmopressin-in-hemophilia-a-carriers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-noncoding-mutation-in-the-inotch1i-gene-initiates-oncogenic-notch-signaling-via-wild-type-nic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-precision-medicine-approach-to-the-myelodysplastic-syndrome-with-isolated-deletion-5q-50-years-af 2026-08-17 monthly 0.7 https://rjrindex.com/articles/of-mice-men-and-megakaryocytes-ck1a-governs-thrombopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-interleukin-33-receptor-st2-is-a-novel-therapeutic-target-to-attenuate-the-progression-of-hemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/smarter-combos-stronger-t-cells-in-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-of-relapsed-and-refractory-follicular-lymphoma-which-treatment-for-which-patient-for-whic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-large-granular-lymphocytic-leukemia-transformation-to-peripheral-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-and-molecular-mrd-influence-outcomes-in-ikmt2ai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rare-case-of-epithelioid-hemangioendothelioma-involving-bone-marrow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unlocking-myelomas-spatial-world-at-the-micrometer-scale 2026-08-17 monthly 0.7 https://rjrindex.com/articles/end-points-and-outcomes-in-follicular-lymphoma-what-should-we-measure-how-and-why 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-future-of-follicular-lymphoma-management-strategies-on-the-horizon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/profiling-the-spatial-architecture-of-multiple-myeloma-in-human-bone-marrow-trephine-biopsy-specimen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mel200-or-bumel-conditioning-in-myeloma-is-there-a-winner 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-advances-in-glofitamab-combinations-a-new-frontier-for-non-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-dose-busulfan-melphalan-vs-melphalan-and-reinforced-vrd-for-newly-diagnosed-multiple-myeloma-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasminogen-as-a-ribonucleoprotein-regulatory-small-rna-cargo-modulates-fibrinolysis-and-inflammati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frontline-treatment-of-follicular-lymphoma-what-will-it-take-to-change-current-practice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-updated-understanding-of-follicular-lymphoma-transformation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-review-series-on-follicular-lymphoma-solved-or-insoluble-problem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biology-as-vulnerability-in-follicular-lymphoma-genetics-epigenetics-and-immunogenetics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-endothelial-mtorc2-foxo1-axis-serves-as-an-iron-responsive-sensor-governing-systemic-iron-homeos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rebalancing-the-hemophilia-teeter-totter 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-new-prognostic-index-clipi-for-advanced-cutaneous-lymphoma-enables-precise-patient-risk-stratifi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-pediatric-pulmonary-embolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aml-halts-neutrophil-maturation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/remission-conversion-drives-outcomes-after-car-t-cell-therapy-for-multiple-myeloma-a-registry-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/marstacimab-prophylaxis-in-hemophilia-ab-without-inhibitors-results-from-the-phase-3-basis-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/foxo1-unlocks-the-liver-endothelial-code-to-iron-sensing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-skin-deep 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-dli-for-all-but-not-without-lymphodepletion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ipss-m-risk-and-specific-sex-associated-somatic-mutations-predict-response-to-esa-therapy-in-lr-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-acute-myeloid-leukemia-microenvironment-impairs-neutrophil-maturation-and-function-through-nf-kb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-low-risk-myelodysplastic-syndrome-dont-shoot-the-istag2i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/matched-donor-allogeneic-car-t-for-adult-b-all-toxicity-efficacy-repeat-dosing-and-the-importanc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aml-with-mutated-tp53-therapy-related-with-basophilic-differentiation-partial-cd22-and-ring-side 2026-08-17 monthly 0.7 https://rjrindex.com/articles/driving-standard-of-care-car-t-cells-in-real-world-germany 2026-08-17 monthly 0.7 https://rjrindex.com/articles/losing-cd38-in-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/somatic-iirf4i-mutations-and-thymic-tropism-in-primary-mediastinal-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-opsonized-zymosan-induced-phosphorylation-of-p47phox-and-nadph-oxidase-activation-in-hum 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-to-complete-remission-is-an-independent-determinant-of-survival-after-intensive-chemotherapy-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/karpova-d-huerga-encabo-h-donato-e-et-al-clonal-hematopoiesis-landscape-in-frequent-blood-donors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-preleukemic-somatic-igata1i-mutations-in-children-with-down-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombocytopenia-in-myelofibrosis-is-characterized-by-inflammatory-megakaryocytes-with-reduced-g6b-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/new-prognostic-systems-for-multiple-myeloma-in-the-context-of-contemporary-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epstein-barr-virus-sequence-mutations-cause-human-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/silent-tam-keeps-quiet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/g6b-on-the-rise-or-not 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-epstein-barr-virus-genomic-alterations-with-human-pathologies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biallelic-antigen-escape-is-a-mechanism-of-resistance-to-anti-cd38-antibodies-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-dynamics-of-histone-acetylation-and-chromatin-remodeling-in-multiple-myeloma-a-tale 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-review-series-on-the-structural-underpinnings-of-hemostatic-plugs-and-thrombotic-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/all-in-one-place-the-future-of-blood-group-typing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/array-genotyping-of-transfusion-relevant-blood-cell-antigens-in-6946-ancestrally-diverse-study-parti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dangerous-clones-with-complex-ties-to-al-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/structure-and-interactions-of-the-proteins-from-the-contact-system 2026-08-17 monthly 0.7 https://rjrindex.com/articles/structure-based-design-of-therapeutics-to-control-hemostasis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factor-xiii-driving-cross-links-in-hemostasis-thrombosis-and-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-activation-and-signaling-in-thrombus-formation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-dcaf8-impairs-hematopoietic-stem-cell-function-with-cellular-senescence-via-the-dock11-cdc42 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ups-delivers-apolarity-and-senescence-to-hscs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-chop-with-anti-ccr4-antibody-mogamulizumab-for-older-patients-with-adult-t-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-ibap1i-defines-a-unique-subtype-of-itp53i-mutated-de-novo-aml-and-confers-sensitiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-thrombus-niche-lessons-learned-and-potential-therapeutic-opportunities 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibap1tp53i-loss-defines-a-bcl-xl-dependent-erythroleukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diverse-ancestry-genotyping-of-blood-cell-antigens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-and-clonal-analysis-of-al-amyloidosis-plasma-cells-and-their-bone-marrow-microenvironmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-for-vexas-syndrome-a-large-scale-retrospective-study-from-frenve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-as-therapy-for-vexas-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunochemotherapy-for-older-patients-with-atll-a-new-option 2026-08-17 monthly 0.7 https://rjrindex.com/articles/good-flatmates-immature-neutrophils-protect-bone-integrity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-dysfunction-after-cancer-remission-scar-or-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chauhan-d-li-g-hideshima-t-et-al-hsp27-inhibits-release-of-mitochondrial-protein-smac-in-multipl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transposable-elements-as-novel-therapeutic-targets-for-parpi-induced-synthetic-lethality-in-pcg-muta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acalabrutinib-obinutuzumab-improves-survival-vs-chemoimmunotherapy-in-treatment-naive-cll-in-the-6-y 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammatory-memory-of-stem-cells-implications-for-hematologic-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clpp-a-new-achilles-heel-in-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/not-in-the-beginning 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chavez-jc-dickinson-m-munoz-j-et-al-three-year-follow-up-analysis-of-first-line-axicabtagene-cil 2026-08-17 monthly 0.7 https://rjrindex.com/articles/large-b-cell-lymphoma-imprints-a-dysfunctional-immune-phenotype-that-persists-years-after-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mac-man-clearance-of-alloreactive-t-cells-in-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-neutrophil-progenitors-suppress-osteoclast-formation-in-murine-cortical-and-trabecular-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-mitochondrial-protease-clpp-is-a-metabolic-vulnerability-and-an-immunogenic-trigger-against-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasminogen-activation-and-plasmin-activity-are-not-necessary-to-prevent-venous-thrombosisthromboem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/te-parpi-as-a-precision-weapon-against-hematologic-cancers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/augmented-cd47-expression-impairs-alloreactive-t-cell-clearance-after-allo-hct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevate-ing-clinical-trial-reporting-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-genetic-study-of-classic-hodgkin-lymphoma-using-circulating-tumor-dna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-in-vivo-barcoded-crispr-cas9-screen-identifies-incoa4-imediated-ferritinophagy-as-a-dependen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/breaking-ribosomes-to-fight-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-immunodeficiency-in-patients-with-telomere-biology-disorders 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-12-trial-of-anti-cd7-allogeneic-wu-cart-007-for-patients-with-relapsedrefractory-t-cell-mali 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multiomic-analysis-of-waldenstrom-macroglobulinemia-defines-distinct-disease-subtypes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/riding-the-rhoa-rodeo-the-role-of-myo9b-in-neutrophils 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunodeficiency-in-tbds-making-the-lymphocyte-count 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-ferritinophagy-to-iron-out-itet2i-mutant-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-molecular-subtypes-in-waldenstrom-macroglobulinemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/posttranscriptional-depletion-of-ribosome-biogenesis-factors-engenders-therapeutic-vulnerabilities-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cart-007-a-license-to-kill 2026-08-17 monthly 0.7 https://rjrindex.com/articles/classic-hodgkin-lymphoma-the-journey-over-the-destination 2026-08-17 monthly 0.7 https://rjrindex.com/articles/visualizing-amyloidosis-the-role-of-radionuclide-imaging-in-systemic-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rhoa-gap-myo9b-regulates-v2-integrin-activity-and-neutrophil-recruitment-during-murine-acute-kidney 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-the-safety-profiles-of-cd19-targeting-car-t-cell-therapy-in-patients-with-sle-and-b-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/menin-inhibition-with-revumenib-for-inpm1i-mutated-relapsed-or-refractory-acute-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rbm15-mkl1-fusion-protein-promotes-leukemia-via-m6a-methylation-and-wnt-pathway-activation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lrrc8-complexes-are-atp-release-channels-that-regulate-platelet-activation-and-arterial-thrombosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/meddling-with-mettl3-in-acute-megakaryoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/driving-car-ts-safesle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-study-of-modakafusp-alfa-as-a-single-agent-for-patients-with-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hole-in-one-cd137-adc-eliminates-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clone-wars-the-expansion-menace 2026-08-17 monthly 0.7 https://rjrindex.com/articles/npm1-the-ultimate-target-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lrrc8-links-platelet-stretching-to-local-arterial-thrombosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlates-and-consequences-of-clonal-hematopoiesis-expansion-rate-a-16-year-longitudinal-study-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-single-dose-of-a-cd137-antibody-drug-conjugate-protects-rhesus-macaque-allogeneic-hct-recipients-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-alterations-in-myeloma-evolution-and-outcomes-quo-vadis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prasad-r-rehman-a-rehman-l-et-al-antibiotic-induced-loss-of-gut-microbiome-metabolic-output-corr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lineage-switch-from-ikmt2ai-rearranged-congenital-b-all-to-aml-in-an-infant-a-genomic-perspect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-dive-into-shallow-myeloma-cell-pool 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-detection-of-circulating-multiple-myeloma-cells-by-next-generation-flow-after-immunom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-landscape-of-disease-mapping-aplastic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/checkpoint-primed-allo-hct-in-hl-cure-gains-risk-remains 2026-08-17 monthly 0.7 https://rjrindex.com/articles/when-tnfa-is-out-ifn-gh-drives-anemia-of-inflammation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cracking-the-pod24-code-in-follicular-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-burden-too-high-for-car-t-cells-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protecting-the-epithelium-and-taming-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-allogeneic-hct-in-hodgkin-lymphoma-in-the-era-of-checkpoint-inhibitors-a-joint-cibmtr-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-t-follicular-helpert-follicular-helper-regulatory-pathway-in-fviii-immune-responses-in-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/calr-ifying-atf6bcl-xl-activation-by-type-2-calr-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/type-2-calreticulin-mutations-activate-atf6-to-promote-bcl-xl-mediated-survival-in-myeloproliferativ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/challenges-in-gvhd-and-gvl-after-hematopoietic-stem-cell-transplantation-for-myeloid-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tnfa-signaling-restores-steady-state-hematopoiesis-in-a-tnfako-mouse-model-of-anemia-of-inflammation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combined-pet-and-ctdna-response-as-a-predictor-of-pod24-for-follicular-lymphoma-after-first-line-ind 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imaging-mass-cytometry-reveals-the-order-of-events-in-the-pathogenesis-of-immune-mediated-aplastic-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zuma-8-a-phase-1-study-of-brexucabtagene-autoleucel-in-patients-with-relapsedrefractory-chronic-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allo-hct-in-hodgkin-lymphoma-after-cpi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-high-dose-palifermin-for-gvhd-prophylaxis-in-patients-undergoing-hla-matched-unre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-perks-of-er-homeostasis-for-hematopoietic-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd70-car-ts-a-second-wind-for-high-risk-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-adaptive-survival-prediction-model-in-cmml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/precision-under-pressure-tandem-approach-to-hit-diagnosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/linc-ing-rna-isoforms-to-function-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-high-risk-multiple-myeloma-genotypes-with-optimized-anti-cd70-car-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/what-platelets-tell-us-about-cars 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intrasinusoidal-pleomorphic-mantle-cell-lymphoma-mimicking-intravascular-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/perk-signaling-maintains-hematopoietic-stem-cell-pool-integrity-under-endoplasmic-reticulum-stress-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rest-then-rejuvenate-cd19-boost-to-improve-car-persistence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/giving-all-a-smac-down-and-hdac-down-towards-cell-death 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd24-senescent-neutrophils-as-key-players-in-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/defective-neutrophil-clearance-in-ijak2i-iv617fi-myeloproliferative-neop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cracking-trali-targeting-the-membrane-attack-complex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/not-dead-yet-gwas-insights-into-a-common-bleeding-disorder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/counterpoint-the-design-and-interpretation-of-blood-transfusion-randomized-clinical-trials 2026-08-17 monthly 0.7 https://rjrindex.com/articles/keep-your-distance-or-lose-control 2026-08-17 monthly 0.7 https://rjrindex.com/articles/van-laer-c-lavendhomme-r-baert-s-et-al-functional-assessment-of-genetic-variants-in-thrombomodu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimal-mrd-based-end-point-to-support-response-adapted-treatment-cessation-in-newly-diagnosed-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-terminal-complement-complex-formation-alleviates-murine-antibody-mediated-trali 2026-08-17 monthly 0.7 https://rjrindex.com/articles/atypical-cytoplasmic-inclusions-and-erythrophagocytosis-in-acute-myeloid-leukemia-with-ikmt2ai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genome-wide-meta-analysis-of-heavy-menstrual-bleeding-reveals-36-risk-loci 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-mrd-negativity-robust-not-all-powerful 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reactivation-of-developmentally-silenced-globin-genes-through-forced-linear-recruitment-of-remote-en 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-bortezomib-thalidomide-dexamethasone-for-newly-diagnosed-myeloma-cassiopeia-minimal-res 2026-08-17 monthly 0.7 https://rjrindex.com/articles/speeding-up-for-lympho-myeloid-differentiation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloma-a-sky-full-of-mrd-stars 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-acute-lymphoblastic-leukemia-in-the-era-of-immunotherapy-while-revisiting-the-myth-of-se 2026-08-17 monthly 0.7 https://rjrindex.com/articles/coordinated-regulation-of-self-renewal-and-cell-cycle-during-human-lympho-myeloid-lineage-restrictio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hscs-with-the-super-power-to-make-blood-forever 2026-08-17 monthly 0.7 https://rjrindex.com/articles/magrolimab-and-the-tale-of-indigestible-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/two-clones-one-niche-how-ch-shapes-the-mm-microenvironment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-high-potency-multilineage-hematopoietic-stem-cells-and-identification-of-super-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-is-clonally-unrelated-to-multiple-myeloma-and-is-associated-with-specific-micro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-fully-human-bcma-car-t-therapy-for-relapsedrefractory-multiple-myeloma-with-5-ye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-incidence-of-severe-ta-tma-increases-mortality-in-adult-allogeneic-transplant-recipients-a-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/take-five-the-story-of-factor-v-regulation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-tested-safety-fcarh143s-5-year-myeloma-journey 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunoglobulin-containing-vacuoles-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/magrolimab-plus-azacitidine-vs-physicians-choice-for-untreated-itp53i-mutated-acute-myeloid-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multiomics-approach-reveals-novel-regulators-of-plasma-factor-v-levels-highlighting-clec4m-as-a-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modeling-the-hlh-immune-synapse-uncovers-critical-roles-for-is-termination-cytokine-intensity-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/midas-touch-on-ta-tma-golden-gains-through-active-screening 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-enhance-3-study-venetoclax-and-azacitidine-plus-magrolimab-or-placebo-for-untreated-aml-unfit-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-jak-stat-in-macrophage-activation-syndrome-no-mas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ngs-based-igtr-gene-rearrangement-profiling-in-acute-lymphoblastic-leukemia-age-dependence-of-immu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hlh-it-is-all-about-communication 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-targets-jak-stat-signaling-to-modulate-neutrophil-activation-in-refractory-macrophage-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-shapes-the-immunogenetic-fingerprint-of-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/postimmunotherapy-lineage-switch-where-to-from-here 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nkg2d-mediated-cytotoxicity-of-cd4-cytotoxic-t-cells-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relationship-between-immunogenicity-and-protein-structure-at-amino-acid-substitution-sites-of-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differentiation-dependent-ebf1-activity-determines-icd22i-transcription-and-leukemia-sensitivit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predicting-blood-group-antigens-accessible-or-not 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibiting-jak1-lowering-crs-car-stays-on-track 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shear-dependent-platelet-aggregation-by-chadox1-ncov-19-vaccine-a-novel-biophysical-mechanism-for-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytolytic-helper-t-cells-a-new-addition-to-myeloma-immunity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/itacitinib-for-the-prevention-of-iec-therapy-associated-crs-results-from-the-2-part-phase-2-incb-39 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissecting-jak2v617fs-double-life-with-and-without-mpl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/breakthrough-hemolysis-in-paroxysmal-nocturnal-hemoglobinuria-throughout-clinical-trials-from-defin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/project-evolve-an-international-analysis-of-postimmunotherapy-lineage-switch-an-emergent-form-of-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematological-aspects-of-colchicine-poisoning 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delineating-impli-dependent-and-independent-phenotypes-of-ijak2i-v617f-positive-mpns-in-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adenovirus-holds-the-platelet-in-flow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-b-cell-identity-how-ebf1-modulates-ino-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/international-consensus-statement-on-diagnosis-evaluation-and-research-of-richter-transformation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-nlrp6-a-hidden-talent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-phenotype-and-pathophysiological-mechanisms-underlying-qualitative-low-vwf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protaction-against-bcl-xl-in-post-mpn-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/secondary-blastoid-plasma-cell-leukemia-can-an-old-dog-learn-new-tricks 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-unbiased-genomewide-screen-uncovers-7-genes-that-drive-hematopoietic-stem-cell-fate-from-mouse-em 2026-08-17 monthly 0.7 https://rjrindex.com/articles/duployez-n-largeaud-l-duchmann-m-et-al-prognostic-impact-of-iddx41i-germline-mutations-in-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/m6a-meets-t-all-hnrnpc-and-fto-as-new-therapeutic-targets 2026-08-17 monthly 0.7 https://rjrindex.com/articles/type-1-von-willebrand-disease-does-it-need-a-sibling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetic-drug-remedies-for-scd-root-cause-pathophysiology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/weathering-the-hlh-storm-and-redesigning-clinical-trials 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-a-novel-bcl-xl-degrader-dt2216-in-preclinical-models-of-ijak2i-mutated-post-mpn-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/richter-transformation-recommendations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/qualitative-low-vwf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-potent-and-orally-bioavailable-lsd1-inhibitors-induce-fetal-hemoglobin-synthesis-in-a-sickle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-combined-with-dexamethasone-for-adult-patients-with-newly-diagnosed-hemophagocytic-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unusual-suspects-a-surprise-cast-in-making-blood-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hnrnpc-and-m6a-rna-methylation-control-oncogenic-transcription-and-metabolism-in-t-cell-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proteostasis-disruption-in-inherited-bone-marrow-failure-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-nlrp6-protects-against-microvascular-thrombosis-in-sepsis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-adamts13-activity-assays-for-thrombotic-thrombocytopenic-purpura-a-systematic-review-and-meta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iron-overload-impacts-tcr-ghd-cell-immunity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-and-epigenetic-mechanisms-of-gprc5d-loss-after-anti-gprc5d-car-t-cell-therapy-in-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reshaping-the-tme-to-enhance-checkpoint-blockade-in-enktl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/redefining-risk-stratification-in-plch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/when-increased-bone-marrow-blasts-may-not-mean-malignancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-neutrophil-antigen-3ab-polymorphism-in-islc44a2i-unexpectedly-encodes-the-csacsb-red-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/standard-of-care-idecabtagene-vicleucel-for-relapsedrefractory-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-combined-cd38-and-pd-1-inhibition-with-isatuximab-and-cemiplimab-for-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-data-provide-a-carbon-copy-for-ide-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/silence-of-the-myeloma-clones-gprc5d-epigenetic-regulation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrafi-v600e-positive-mononuclear-cells-in-blood-at-diagnosis-portend-treatment-failu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ankrd26-related-thrombocytopenia-2-with-a-baseline-increase-in-blasts-implications-for-clinical-sur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rare-phenotype-of-peripheral-t-cell-lymphoma-nos-coexpression-of-cd15-cd20-and-t-follicular-he 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unveiling-the-truth-different-names-same-antigen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beware-the-zombie-enzyme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ttp-a-disorder-for-all-physicians 2026-08-17 monthly 0.7 https://rjrindex.com/articles/doubling-down-the-new-deal-in-the-clinical-management-of-double-refractory-chronic-lymphocytic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blunted-cd40-responsive-enhancer-activation-in-icrebbpi-mutant-lymphomas-can-be-restored-by-enf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iron-overload-in-hfe-related-hemochromatosis-severely-impairs-vd2-ghd-t-cell-homeostasis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/large-scale-dependency-and-drug-screens-to-characterize-the-therapeutic-vulnerabilities-of-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/check-the-brakes-on-irf4 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interferon-gh-sparks-inflammatory-fire-in-castleman-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/are-we-ready-for-an-mrd-driven-approach-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapy-related-juvenile-myelomonocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/isatuximab-carfilzomib-lenalidomide-and-dexamethasone-induction-in-newly-diagnosed-myeloma-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-wiskott-aldrich-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-mouse-model-of-hemoglobin-sc-disease-reveals-mechanisms-underlying-beneficial-effects-of-hyd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-pathways-in-deep-vein-thrombosis-a-new-frontier-for-therapeutic-intervention 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hbsc-gets-its-mouse-model-75-years-after-discovery 2026-08-17 monthly 0.7 https://rjrindex.com/articles/another-1q-bites-the-dust 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-bcl7a-permits-irf4-transcriptional-activity-and-cellular-growth-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifn-gh-promotes-the-progression-of-imcd-by-activating-inflammatory-monocytes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tracking-iclusterini-expression-in-hematopoietic-stem-cells-reveals-their-heterogeneous-composi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iclusterinig-and-decoding-hsc-aging 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idnmt3ai-mutations-are-unlikely-to-affect-interferon-alfa-treatment-outcomes-in-patients-with-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-autonomous-dysregulation-of-interferon-signaling-drives-clonal-expansion-of-isrsf2i-mutant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/isrsf2i-mutated-mds-bortezomib-stat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-cd38-with-daratumumab-for-platelet-transfusion-refractoriness-in-aplastic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aberrant-single-cell-phenotype-and-clinical-implications-of-genotypically-defined-polyclonal-plasma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genotype-specific-immune-responses-at-the-intestinal-barrier-predispose-to-colitis-in-mouse-models-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/activated-protein-c-takes-a-bite-out-of-factor-va 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cryo-em-structure-of-coagulation-factor-va-bound-to-activated-protein-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-machine-learning-techniques-to-predict-poor-survival-after-hematopoietic-cell-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/it-takes-2-to-inflame-microbiota-and-genotype-shape-cgd-ibd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pathogenesis-of-paroxysmal-nocturnal-hemoglobinuria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/when-the-silence-speaks-t-cell-dysfunction-in-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/b-lymphoblastic-leukemia-with-ikmt2ai-rearrangement-with-mature-b-cell-phenotype-and-surface-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-controlled-trial-for-preventing-priapism-in-sickle-cell-anemia-hydroxyurea-plus-placebo-vs-hydrox 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-evolving-landscape-of-hereditary-stomatocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-myeloma-the-trouble-with-normal-plasma-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expansions-of-circulating-plasmablasts-producing-commensal-reactive-iga-antibodies-are-predictors-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hallmarks-of-t-cell-exhaustion-and-antigen-experience-are-absent-in-multiple-myeloma-from-diagnosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-ai-model-of-transplantation-risk-for-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/no-nitric-oxide-to-priapism-with-hydroxyurea-and-tadalafil 2026-08-17 monthly 0.7 https://rjrindex.com/articles/microbiota-and-chronic-gvhd-a-plasmablast-link 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blood-based-proteomic-profiling-identifies-osmr-as-a-novel-biomarker-of-aml-outcomes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/socioeconomic-factors-and-transplant-access 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disrupting-hit-immune-complexes-as-a-new-treatment-for-hit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-challenges-in-the-hole-puncher 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pi3kgh-in-leukemia-class-ib-pi3-kinase-reemerges-as-a-cancer-intrinsic-target 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-biomarkers-in-mcl-insights-from-the-shine-trial-on-the-impact-of-mcl35-score-and-itp53 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maternal-regulation-of-iron-metabolism-resolved 2026-08-17 monthly 0.7 https://rjrindex.com/articles/precision-pre-hsct-conditioning-by-targeting-cmpl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-bone-marrow-nk-cell-profile-predicts-mrd-negativity-in-patients-with-multiple-myeloma-treated-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/osmr-takes-the-leap-from-nulisa-to-elisa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/destabilization-of-pf4-antigenic-complexes-in-heparin-induced-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/severe-oxidant-hemolysis-in-a-child-with-g6pd-deficiency-and-hb-c-trait 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cmpl-based-purification-and-depletion-of-human-hematopoietic-stem-cells-implications-for-pretranspl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-genotype-challenges-in-predicting-disease-risk-for-carriers-of-biallelic-perforin-variants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-type-1-plasminogen-deficiency 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-natural-head-start-to-mrd-negativity-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/access-to-allotx-for-aml-the-value-of-the-social-phenotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-a-fitusiran-antithrombin-based-dose-regimen-in-people-with-hemophilia-a-or-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maternal-itmprss6i-is-required-for-hepcidin-suppression-and-fetal-health 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-access-to-allogeneic-hematopoietic-cell-transplantation-for-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/approaching-a-therapeutic-inflection-point-for-iflt3i-mutated-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-ibloodi-spotlight-series-on-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/notch1-dimeric-signaling-is-essential-for-t-cell-leukemogenesis-and-leukemia-maintenance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-gvhd-one-more-promising-player-enters-the-arena 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-and-diabetes-mellitus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/connecting-the-dot1l-its-ezh2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diabetes-mellitus-and-iapol1i-genotype-increase-the-risk-for-chronic-kidney-disease-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-fit-older-adult-with-acute-myeloid-leukemia-clinical-challenges-to-providing-evidence-based-fro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-small-b-cell-leukemialymphoma-with-weak-to-negative-expression-of-cd5 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deficiency-of-t-follicular-helper-cell-itet3i-dna-demethylation-inhibits-pathogenic-igg2c-class 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tet3-stirs-up-trouble-via-pathogenic-ig-class-switching 2026-08-17 monthly 0.7 https://rjrindex.com/articles/surface-pta-expression-predicts-lck-activation-and-preclinical-synergy-of-lck-and-jak-coinhibition-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-antitumor-effect-of-combined-ezh2-and-dot1l-inhibition-in-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/itp53i-mutated-acute-myeloid-leukemia-how-can-we-improve-outcomes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predicting-t-all-response-to-pre-tcr-and-il-7r-coinhibition 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-first-in-class-jakrock-inhibitor-rovadicitinib-for-glucocorticoid-refractory-or-dependent-chro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-rilzabrutinib-vs-placebo-in-adults-with-immune-thrombocytopenia-the-phase-3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-cell-transplantation-for-acute-myeloid-leukemia-in-adults-over-70-years-old 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rilzabrutinib-the-first-in-class-btk-inhibitor-for-itp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eliminating-the-need-for-sequential-confirmation-of-response-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunoactinopathies-revisited-understanding-clinical-manifestations-and-biological-pathways 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stat1-mediated-interferon-signatures-are-associated-with-preclinical-jak-inhibitor-sensitivity-in-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/considerations-on-the-dose-and-schedule-of-tyrosine-kinase-inhibitors-for-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-sweet-business-of-vwf-clearance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-10-from-tumoral-b-cells-modulates-the-diffuse-large-b-cell-lymphoma-microenvironment-and-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-panleukemia-signatures-of-hspc-like-blasts-predict-drug-response-and-clinical-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-a2-3-linked-sialylation-determines-the-extended-half-life-of-cho-rvwf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/classic-hodgkin-lymphoma-in-the-cerebellum-a-rare-site-for-a-common-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-murano-study-final-analysis-and-retreatmentcrossover-substudy-results-of-venr-for-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/getting-to-the-root-of-high-risk-leukemias 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploiting-tumor-derived-il-10-activity-in-lymphoma-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-among-adult-recipients-of-car-t-cell-therapy-for-burkitt-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burkitt-lymphoma-click-here-to-add-to-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-regulators-of-gvhd-revealed-through-microbiome-and-metabolome-patterns-across-distinct-intesti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-advent-of-multiomics-in-experimental-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/muranos-final-conclusions-what-weve-learned-whats-next 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-great-mitigator-of-non-icans-neurotoxicities 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyclophosphamide-mitigates-non-icans-neurotoxicities-following-ciltacabtagene-autoleucel-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hitting-the-therapeutic-bullseye-with-targeted-therapy-for-patients-with-chronic-lymphocytic-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/its-high-tim-3-for-armored-car-t-therapy-for-b-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hla-antibodies-delay-platelet-recovery-after-gene-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/histo-blood-group-abo-system-transferase-plasma-levels-and-risk-of-future-venous-thromboembolism-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hla-alloimmunization-in-gene-modified-autologous-stem-cell-transplant-for-transfusion-depe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/guidance-on-the-interpretation-of-crbn-mutations-in-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-allo-hct-in-nonclassical-mpns-and-mdsmpns-recommendations-from-the-phampg-committee-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-and-decitabine-vs-intensive-chemotherapy-as-induction-for-young-patients-with-newly-diagn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ive-got-a-question-how-long-should-we-treat-relapsed-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-abo-vte-connection 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-myelofibrosis-involving-lymph-nodes-with-the-same-mutational-profile-in-bone-marrow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/precision-medicine-for-high-risk-gene-fusions-in-pediatric-aml-a-focus-on-ikmt2ai-inup98i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unveiling-the-enigma-circulating-flowerlike-large-b-lymphoma-cells-in-the-context-of-angioimmunobla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-caseinolytic-mitochondrial-matrix-peptidase-a-novel-contributor-to-the-pathobiology-of-hi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/scotty-we-need-more-power 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-lead-in-followed-by-venetoclax-plus-ibrutinib-for-relapsedrefractory-chronic-lymphocytic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/are-you-ready-for-it-ven-hma-for-younger-patients-with-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-tim-3-fc-decoy-secreted-by-engineered-t-cells-improves-cd19-car-t-cell-therapy-in-b-cell-acute-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/one-hundred-thirty-four-germ-line-pu1-variants-and-the-agammaglobulinemic-patients-carrying-them 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spi-ing-on-human-b-cell-development 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-icrbni-mutations-on-response-to-immunomodulatory-drugs-and-novel-cereb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crispr-cas13d-functional-transcriptomics-reveals-widespread-isoform-selective-cancer-dependencies-on 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-way-for-transglutaminase-2-to-mitigate-liver-damage 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-genomic-analysis-of-dlbcl-identifies-immune-environments-associated-with-bispecific-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammation-conjoins-differentiation-and-resistance-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunotherapy-response-is-it-all-in-the-dlbcl-iqs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-approach-pharmacological-thromboprophylaxis-in-children 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haploidentical-hsct-more-curative-options-for-patients-with-cgd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromatin-dynamics-in-cll-a-matter-of-balance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-landscape-in-frequent-blood-donors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-cebpbil-1vtnf-a-feedback-loop-drives-drug-resistance-to-venetoclax-and-mdm2-inhibitors-in-monocy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lymphoid-malignancies-in-patients-with-shwachman-diamond-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-cross-linking-by-tg2-and-fxiii-generates-hepatoprotective-fibrinogen-deposits-in-injure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advances-in-rna-editing-in-hematopoiesis-and-associated-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/classic-hairy-cell-leukemia-and-concomitant-smoldering-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blitzing-all-with-blinatumomab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hla-haploidentical-stem-cell-transplantation-for-chronic-granulomatous-disease-an-ebmt-iewp-retrosp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/of-donors-and-dynamics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/up-front-blinatumomab-improves-mrd-clearance-and-outcome-in-adult-ph-b-lineage-all-the-gimema-lal2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-biological-role-and-clinical-impact-of-de-novo-chromatin-activation-in-chronic-lymphocytic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-combinations-of-rapid-immunoassays-for-prompt-recognition-of-heparin-induced-thrombocytop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-manage-major-hemorrhage 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-manage-pregnant-patients-who-are-alloimmunized-to-rbc-antigens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-is-genetically-essential-for-itd-mutated-leukemic-stem-cells-but-dispensable-for-human-hematopo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-mrd-negativity-drives-maintenance-stop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-how-i-treat-series-on-transfusion-medicine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-switch-from-plasma-to-recombinant-adamts13-for-patients-with-congenital-ttp-from-japanes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-patients-who-are-refractory-to-platelet-transfusions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-diagnose-and-treat-cardiorespiratory-complications-of-transfusion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adult-t-cell-leukemialymphoma-coexistent-with-immune-dysregulation-associated-ebv-lymphoproliferat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iap-dependency-of-t-cell-prolymphocytic-leukemia-identified-by-high-throughput-drug-screening 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-challenging-transfusion-cases-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/radamts13-in-cttp-a-new-standard-of-care 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-bone-marrow-and-imaging-mrd-negativity-for-3-years-drives-discontinuation-of-maintenance-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expanding-the-universe-of-t-pll-targets 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevention-is-better-than-cure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/n-homocysteinylation-of-v-arrestins-biases-gpcr-signaling-and-promotes-platelet-activation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-rates-of-chronic-graft-versus-host-disease-with-ruxolitinib-maintenance-following-allogeneic-hct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-use-noninvasive-prenatal-testing-for-red-blood-cell-and-platelet-antigens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/right-time-stopping-multiple-myeloma-maintenance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-new-severe-congenital-neutropenia-syndrome-associated-with-autosomal-recessive-icopz1i-mutati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cars-in-pole-position-ready-for-the-race 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trafficking-on-the-road-to-neutropenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/three-year-follow-up-analysis-of-first-line-axicabtagene-ciloleucel-for-high-risk-large-b-cell-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptional-remodeling-shapes-therapeutic-vulnerability-to-necroptosis-in-acute-lymphoblastic-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sting-activation-improves-t-cell-engaging-immunotherapy-for-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetics-based-stratification-in-pediatric-t-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gata-2-much-stemness-and-resistance-in-aml-chemotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-aml-relapse-after-allogeneic-hsct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luskin-mr-murakami-ma-keating-j-et-al-asciminib-plus-dasatinib-and-prednisone-for-philadelphia-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/3d-insights-jak2-461-haplotype-shapes-mpn-development 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cpg-island-methylator-phenotype-classification-improves-risk-assessment-in-pediatric-t-cell-acute-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibabesiai-not-only-is-invasive-but-creates-rbc-inflexibility 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-ghd-t-cell-proliferation-associated-with-ibabesiai-infection-a-rare-and-challenging-diag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sting-activation-enhances-immunotherapy-of-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-prognostication-to-precision-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-ijak2i-461-haplotype-influences-pd-l1-expression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emzl-at-various-sites-learning-from-each-other 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gata2-links-stemness-to-chemotherapy-resistance-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hu-l-shi-y-hsu-j-gera-j-van-ness-b-lichtenstein-a-downstream-effectors-of-oncogenic-ras-in-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lee-hj-ramchandren-r-friedman-j-et-al-brentuximab-vedotin-nivolumab-doxorubicin-and-dacarbazi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/defining-pathogenic-il-17-and-csf-1-gene-expression-signatures-in-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/measurable-residual-disease-and-posttransplantation-gilteritinib-maintenance-for-patients-with-ifl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myelodysplastic-neoplasm-with-biallelic-itp53i-inactivation-in-a-patient-with-plasma-cell-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/seeking-an-escape-door-from-the-maze-of-cgvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/babesiosis-and-sickle-red-blood-cells-loss-of-deformability-altered-osmotic-fragility-and-hyperve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blast-a-globally-applicable-and-molecularly-versatile-survival-model-for-chronic-myelomonocytic-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-higher-risk-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/breathing-life-into-the-hematopoietic-potential-of-the-lung 2026-08-17 monthly 0.7 https://rjrindex.com/articles/is-v2-glycoprotein-i-prothrombotic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nets-persisting-in-vasculature-undergo-self-renewal-with-consequences-for-subsequent-infection-a-mo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/net-self-renewal-vascular-groundhog-day 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-functional-hematopoietic-progenitor-cells-in-the-adult-human-lung 2026-08-17 monthly 0.7 https://rjrindex.com/articles/microbiota-drives-colitis-in-chronic-granulomatous-disorder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-with-single-agent-braf-inhibitor-therapy-in-erdheim-chester-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-regulatory-t-cell-therapy-to-prevent-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mixed-phenotype-acute-leukemia-revisited-omics-lead-the-way 2026-08-17 monthly 0.7 https://rjrindex.com/articles/when-lymphoma-mimics-adenocarcinoma-signet-ring-morphology-in-follicular-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reactive-oxygen-species-regulate-early-development-of-the-intestinal-macrophage-microbiome-interface 2026-08-17 monthly 0.7 https://rjrindex.com/articles/defining-2-biologically-and-clinically-distinct-groups-in-acute-leukemia-with-a-mixed-phenotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protection-of-v2gpi-deficient-mice-from-thrombosis-reflects-a-defect-in-par3-facilitated-platelet-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/class-struggle-in-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dlbiclassi-a-probabilistic-molecular-classifier-to-guide-clinical-investigation-and-practice-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-regulatoryconventional-t-cell-grafts-for-the-gvhd-win 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-genomic-profiling-of-mds-to-inform-allo-hct-recommendations-from-an-international-panel-on 2026-08-17 monthly 0.7 https://rjrindex.com/articles/recycling-is-bad-to-the-bone-in-patients-with-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-v600e-ibrafi-mutations-and-treatment-for-hairy-cell-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/17iri-resolvin-d1-protects-against-sickle-cell-related-inflammatory-cardiomyopathy-in-humaniz 2026-08-17 monthly 0.7 https://rjrindex.com/articles/seeing-is-believing-a-histology-textbooks-dream-case-of-sarcoidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cells-in-autoimmunity-game-changer-or-stepping-stone 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-and-therapeutic-implications-of-measurable-residual-disease-levels-during-remission-induc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emerging-biomarkers-for-cd3cd20-bispecific-antibodies-in-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-ienterobacter-cloacaei-attenuates-osteolysis-by-reducing-ammonium-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/methotrexate-and-glucarpidase-the-emperor-has-new-clothes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/common-hereditary-variants-of-the-iapoei-gene-and-posttransplant-outcome-in-acute-myeloid-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-assessment-of-genetic-variants-in-thrombomodulin-detected-in-patients-with-bleeding-and-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glucarpidase-for-treatment-of-high-dose-methotrexate-toxicity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pstk-inhibition-activates-cgas-sting-precipitating-ferroptotic-cell-death-in-leukemic-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombophilic-thrombomodulin-variants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stinging-leukemia-stem-cells-through-pstk-inhibition 2026-08-17 monthly 0.7 https://rjrindex.com/articles/17iri-resolvin-d1-a-novel-approach-for-scd-cardiomyopathy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-plus-daunorubicin-and-cytarabine-for-newly-diagnosed-acute-myeloid-leukemia-results-of-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-new-variable-to-study-in-transplant-iapoei-variant-status 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-conventional-73-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-icaht-grading-and-prognostic-impact-of-thrombocytopenia-after-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/can-less-differentiation-drive-cars-to-success 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-t-precursor-acute-lymphoblastic-leukemia-with-mature-plasmacytoid-dendritic-cell-proliferation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hsp-car30-with-a-high-proportion-of-less-differentiated-t-cells-promotes-durable-responses-in-refrac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-decline-of-transplant-for-relapsed-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ddavp-response-and-its-determinants-in-bleeding-disorders-a-systematic-review-and-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-targeting-of-ezh2-and-dot1l-in-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/salvage-autologous-transplant-in-relapsed-multiple-myeloma-long-term-follow-up-of-the-phase-3-gmmg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determinants-of-ddavp-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-patients-with-low-risk-polycythemia-vera-who-require-cytoreduction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rare-case-of-nodal-hairy-cell-leukemia-exhibiting-characteristic-morphological-and-immunohistochem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-diagnose-and-treat-systemic-mastocytosis-with-an-associated-hematologic-neoplasm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-how-i-treat-series-on-myeloproliferative-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-diagnose-and-treat-myeloidlymphoid-neoplasms-with-tyrosine-kinase-gene-fusions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-individualize-selection-of-jak-inhibitors-for-patients-with-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-anemia-in-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-approach-the-treatment-of-thrombotic-complications-in-patients-with-myeloproliferative-neoplas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-dot1l-and-ezh2-synergizes-in-breaking-the-germinal-center-identity-of-diffuse-large-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-plat-02-and-plat-03-evaluating-cd19-car-t-cell-therapy-and-cd19-expressing-t-apc-suppor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-daratumumab-in-intermediatehigh-risk-smoldering-multiple-myeloma-final-anal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-plus-gemox-in-transplant-ineligible-relapsedrefractory-dlbcl-results-from-the-epcore-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-a-game-changer-in-early-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/appearances-deceive-unmasking-mantle-cell-lymphoma-with-prolymphocytic-morphology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zhu-h-h-hu-j-lo-coco-f-jin-j-the-simpler-the-better-oral-arsenic-for-acute-promyelocytic-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-cell-surface-vista-expression-on-allospecific-naive-t-cells-promotes-tolerance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/paraspinal-mass-and-lower-extremity-weakness-in-a-patient-with-thalassemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-burden-quantified-by-soluble-b-cell-maturation-antigen-and-metabolic-tumor-volume-determines-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd3cd20-bispecifics-chemotherapy-good-news-for-rr-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/smac-mimetics-in-action-in-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-united-kingdom-infected-blood-inquiry-its-findings-and-lessons-for-the-future-of-transfusion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-1r1-and-il-18-signals-regulate-mesenchymal-stromal-cells-in-an-aged-murine-model-of-myelodysplast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sbcma-and-mtv-prediction-of-outcome-for-cart 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-il-1il-18-mitigates-mds-in-aged-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-throughput-drug-screening-identifies-smac-mimetics-as-enhancers-of-nk-cell-cytotoxicity-in-chro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hitting-the-bullseye-in-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-manage-patients-with-unexplained-cytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-prizloncabtagene-autoleucel-a-cd19cd20-car-t-cell-therapy-for-relapsedrefracto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/x-linked-sideroblastic-anemia-in-females 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incorporation-of-immunotherapy-into-frontline-treatment-for-adults-with-b-cell-precursor-acute-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-review-series-on-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/progressive-chromatin-rewiring-by-eto2glis2-revealed-in-a-genome-edited-human-ipsc-model-of-pediat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-immunotherapy-real-estate-of-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-present-and-future-of-car-t-cell-therapy-for-adult-b-cell-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromoplexy-and-ifndc3biirarbi-fusion-deciphering-a-rare-case-of-ipmliirarai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/giant-cytoplasmic-inclusions-alder-reilly-bodies-in-hurler-syndrome-mucopolysaccharidosis-type-1h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odronextamab-monotherapy-in-rr-dlbcl-after-progression-with-car-t-cell-therapy-primary-analysis-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prizloncabtagene-autoleucel-a-new-car-t-cell-for-b-nhl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-subtypes-of-b-cell-acute-lymphoblastic-leukemia-in-adults 2026-08-17 monthly 0.7 https://rjrindex.com/articles/classification-and-risk-stratification-in-t-lineage-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissection-of-single-cell-landscapes-for-the-development-of-chimeric-antigen-receptor-t-cells-in-hod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/when-im-64-functional-shift-of-aging-platelets 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd44-mediated-metabolic-rewiring-is-a-targetable-dependency-of-idh-mutant-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/two-strikes-base-hit-odronextamab-after-car-t-cells-in-lbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ipscs-unlock-clues-to-pediatric-aml-onset 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aging-platelets-shift-their-hemostatic-properties-to-inflammatory-functions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/warthin-finkeldey-cells-seen-in-a-setting-other-than-measles-chronic-lymphocytic-leukemiasmall-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-trait-does-not-cause-sickle-cell-crisis-leading-to-exertion-related-death-a-systemati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-an-aml-sustaining-metabolic-node 2026-08-17 monthly 0.7 https://rjrindex.com/articles/atypical-chronic-myeloid-leukemia-from-cytology-to-molecular-characterization 2026-08-17 monthly 0.7 https://rjrindex.com/articles/taming-jak-cytokine-release-in-haplo-transplant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reducing-clinical-trial-eligibility-barriers-for-patients-with-mds-an-icmds-position-statement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/two-layered-immune-escape-in-aml-is-overcome-by-fcgh-receptor-activation-and-inhibition-of-pge2-signa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/jumping-barriers-in-clinical-trials-release-the-brake 2026-08-17 monthly 0.7 https://rjrindex.com/articles/itacitinib-for-prevention-of-graft-versus-host-disease-and-cytokine-release-syndrome-in-haploidentic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/two-is-better-than-one-dual-targeting-of-wdr5-in-t-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-new-medications-on-the-treatment-of-immune-ttp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-diagnose-and-treat-acute-infection-associated-purpura-fulminans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pge2-inhibition-to-prevent-aml-escape-from-nk-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-wdr5atad2-signaling-by-the-ck2ikaros-axis-demonstrates-therapeutic-efficacy-in-t-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-ketoglutarate-dehydrogenase-is-a-therapeutic-vulnerability-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-guided-zanubrutinib-venetoclax-and-obinutuzumab-in-relapsed-cll-primary-end-point-analysis-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/math-models-expose-myeloid-bias-mechanisms-in-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-patients-with-aml-using-azacitidine-and-venetoclax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-how-i-treat-series-on-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-acute-myeloid-leukemia-with-differentiation-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/icomplementiing-cd20-antibodies-effector-functions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-secondary-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lss-skin-sclerosis-key-addition-to-cgvhd-assessments 2026-08-17 monthly 0.7 https://rjrindex.com/articles/potentiating-cd20-monoclonal-antibody-therapy-by-targeting-complement-c3-fragments-covalently-deposi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-the-lee-symptom-scale-skin-sclerosis-for-chronic-gvhd-associated-sclerosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/megakaryocyte-mitotic-figures-in-de-novo-aml-myelodysplasia-related-with-stag2-srsf2-and-asxl1-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-use-maintenance-therapy-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/triplets-the-bright-and-the-dark-side-of-the-moon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-venetoclax-and-obinutuzumab-in-rr-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/population-dynamics-modeling-reveals-that-myeloid-bias-involves-both-hsc-differentiation-and-progeni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-chromatin-accessibility-landscape-of-pediatric-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antiaging-for-ph-like-all-targeting-senescence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-venetoclax-plus-azacitidine-for-patients-with-treatment-naive-high-risk-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selenoprotein-mediated-redox-regulation-shapes-the-cell-fate-of-hscs-and-mature-lineages 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-counts-count-after-car-t-for-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heat-insoluble-cryoglobulin-in-peripheral-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-all-hematotox-predicting-post-car-t-cell-hematotoxicity-in-b-cell-acute-lymphoblasti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/why-is-inos-divine-veil-not-protective-against-resistance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/honing-car-t-cells-to-tackle-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-senescent-stemlike-subpopulations-in-philadelphia-chromosome-like-acute-lymphoblastic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-epigenetic-and-clonal-analysis-decodes-disease-progression-in-pediatric-acute-myeloid-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/make-hematopoiesis-great-again-countering-oxidative-stress 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-and-venetoclax-for-hr-mds-election-results-pending 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dntt-mediated-dna-damage-response-drives-inotuzumab-ozogamicin-resistance-in-b-cell-acute-lymphoblas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-adar1-regulated-cytoplasmic-dsrna-sensing-pathway-is-a-novel-mechanism-of-lenalidomide-resistanc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adar1-in-lenalidomide-resistance-still-immunomodulation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-with-irunx1iicbfa2t3i-fusion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cullin-5-controls-the-number-of-megakaryocyte-committed-stem-cells-to-prevent-thrombocytosis-in-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nanobody-based-naturally-selected-cd7-targeted-car-t-therapy-for-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prolymphocytic-progression-of-splenic-marginal-zone-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapy-for-myd88-l265p-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/air-pollution-is-associated-with-increased-risk-of-venous-thromboembolism-the-multi-ethnic-study-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lasalocid-a-selectively-induces-the-degradation-of-myd88-in-lymphomas-harboring-the-myd88-l265p-muta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mutations-in-iambra1i-aggravate-v-thalassemia-by-impairing-autophagy-mediated-clearance-of-free 2026-08-17 monthly 0.7 https://rjrindex.com/articles/childhood-langerhans-cell-histiocytosis-hematological-involvement-severity-associated-with-ibraf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/over-4-decades-french-children-teach-about-lch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-contribution-of-the-monocyte-macrophage-lineage-to-immunotherapy-outcomes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/alk-anaplastic-large-cell-lymphoma-expressing-cd33-and-myeloid-nuclear-differentiation-antigen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cullin-the-herd-cul5-limits-megakaryocyte-biased-hscs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/air-pollution-and-venous-thromboembolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd7-car-t-a-bridge-to-transplant-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ambra1-performs-a-balancing-act-in-v-thalassemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-mechanisms-of-resistance-in-cll-variant-btk-mutations-in-second-generation-and-noncovalent-bt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinctive-morphologic-finding-of-multifocal-perifollicular-concentric-granulomas-in-a-lymph-node-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/methylation-sequencing-enhances-interpretation-of-clonal-hematopoiesis-dynamics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/competition-for-cd19-binding-may-accelerate-car-efficacy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deficiency-of-neutrophil-gelatinase-associated-lipocalin-elicits-a-hemophilia-like-bleeding-and-clot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-interferon-therapy-with-modakafusp-alfa-for-relapsed-or-refractory-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monitoring-ch-time-to-move-beyond-vaf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-treatment-strategies-for-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypercalcemia-in-mgus-keep-the-differential-diagnosis-broad 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ngal-a-new-link-between-thrombosis-and-hemostasis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-series-of-reflections-on-a-quarter-century-of-tkis-for-cml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd19-antibody-cotreatment-enhances-serial-killing-activity-of-anti-cd19-car-t-nk-cells-and-red 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-tyrosine-kinase-inhibitors-in-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-interferon-based-antimyeloma-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/approaching-hypercalcemia-in-monoclonal-gammopathy-of-undetermined-significance-insights-from-the-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-evolution-of-treatment-free-remission 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blastoid-variant-of-double-hit-lymphoma-masquerading-as-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-pathogens-exacerbate-chronic-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blastic-plasmacytoid-dendritic-cell-neoplasm-in-the-absence-of-cutaneous-involvement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammation-driven-nf-kb-signaling-represses-ferroportin-transcription-in-macrophages-via-hdac1-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-belt-and-suspenders-approach-to-pnh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/new-free-light-chain-range-decreases-lc-mgus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brafv600e-induces-key-features-of-lch-in-ipscs-with-cell-type-specific-phenotypes-and-drug-responses 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-quantitative-fibrinogen-disorders 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-free-light-chains-in-a-racially-diverse-population-including-african-americans-and-populations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-inflammation-and-microbiome-dysbiosis-exacerbate-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-danicopan-as-add-on-therapy-to-ravulizumab-or-eculizumab-in-pnh-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antibiotics-bad-bugs-for-car-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antibiotic-induced-loss-of-gut-microbiome-metabolic-output-correlates-with-clinical-responses-to-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fda-approved-therapies-for-chronic-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/appreciating-the-oral-microbiomes-impact-on-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-langerhans-cell-histiocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heme-promotes-venetoclax-resistance-in-multiple-myeloma-through-mek-erk-signaling-and-purine-biosynt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-erythroid-leukemia-or-acute-myeloid-leukemia-with-mutated-itp53i-the-battle-of-phenotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-review-series-on-mantle-cell-lymphoma-sands-shifting-in-the-darkness 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-epigenetic-therapy-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ferroptosis-regulates-hemolysis-in-stored-murine-and-human-red-blood-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mosunetuzumab-next-up-to-bat-is-it-a-home-run 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heme-fuels-venetoclax-resistance-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unraveling-mcl-biology-to-understand-resistance-and-identify-vulnerabilities 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frontline-management-of-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/qtls-unlock-rbc-storage-hemolysis-secrets 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-risk-mcl-recognition-and-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-of-relapsedrefractory-mcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-resistance-to-bet-inhibitors-remodels-compensatory-transcriptional-programs-via-p300-coactivat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-3-year-follow-up-of-mosunetuzumab-in-relapsed-or-refractory-follicular-lymphoma-after-2-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-car-t-cells-to-combat-antigen-escape-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd70-car-t-cells-secreting-an-anti-cd33anti-cd3-dual-targeting-antibody-overcome-antigen-heterogene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-efficacy-of-cdk7-inhibitor-based-combinations-against-myeloproliferative-neoplasms-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-dark-zone-of-cns-relapse-in-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-hepcidin-ferroportin-axis-modulates-liver-endothelial-cell-bmp-expression-to-influence-iron-home 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bmps-and-iron-the-ins-and-outs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/no-exit-targeting-rna-export-in-t-cell-malignancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cns-relapse-in-high-grade-b-cell-lymphoma-with-imyci-and-ibcl2i-rearrangements-and-dark-zo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-gata-3-dependent-transcriptome-and-tumor-microenvironment-are-regulated-by-eif4e-and-xpo1-in-t-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/menin-inhibitors-in-the-treatment-of-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-blastic-plasmacytoid-dendritic-cell-neoplasm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antibodies-to-pf4-in-severe-covid-19-same-but-different 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-plus-dasatinib-and-prednisone-for-philadelphia-chromosome-positive-acute-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-with-ibcl6i-and-ikmt2ai-dual-rearrangements 2026-08-17 monthly 0.7 https://rjrindex.com/articles/v-thalassemia-minor-is-associated-with-high-rates-of-worsening-anemia-in-pregnancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/de-jaking-resistance-with-cdk7-inhibitors-in-post-mpn-saml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-for-ph-all-a-step-forward 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prothrombotic-antibodies-targeting-the-spike-proteins-receptor-binding-domain-in-severe-covid-19 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-to-prioritize-between-oxygen-and-iron 2026-08-17 monthly 0.7 https://rjrindex.com/articles/soluble-b-cell-maturation-antigen-levels-for-disease-monitoring-in-oligosecretory-and-nonsecretory-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-static-measurements-dynamic-frailty-improves-survival-prediction-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-the-amino-acid-modulator-pegcrisantaspase-and-venetoclax-for-relapsed-or-refracto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/woyach-ja-burbano-gp-ruppert-as-et-al-follow-up-from-the-a041202-study-shows-continued-efficacy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-bulge-uridine-in-the-hif2a-ire-allows-irp1-but-not-irp2-to-selectively-regulate-hif2a-expression-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-and-clinical-spectrum-of-samd9-and-samd9l-syndromes-from-variant-interpretation-to-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/for-how-long-has-this-problem-been-there 2026-08-17 monthly 0.7 https://rjrindex.com/articles/c-myc-stain-as-a-potential-minimal-residual-disease-marker-for-acute-myeloid-leukemia-with-inpm1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quantifying-mm-disease-burden-by-bcma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bivalent-cd47-immunotoxin-for-targeted-therapy-of-t-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-therapy-with-a-rational-design-for-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/xu-h-cao-y-yang-x-cai-p-kang-l-zhu-x-luo-h-lu-l-wei-l-bai-x-zhu-y-zhao-b-q-fan-w-adamts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-hyperdiploidy-starts-at-an-early-age-and-takes-a-decade-to-complete 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-cd47-many-misses-hopeful-for-a-hit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-obinutuzumab-and-venetoclax-for-first-line-treatment-of-mantle-cell-lymphoma-with-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-3-pronged-attack-on-itp53i-mutated-mcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imetelstat-a-new-addition-to-the-therapeutic-landscape-of-lower-risk-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd5-positive-high-grade-b-cell-lymphoma-with-imyci-ibcl2i-and-ibcl6i-rearrangements 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-of-iron-overload-lessons-from-transfusion-dependent-hemoglobinopathies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-iron-overload-in-adult-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/montoro-j-eikema-d-j-tuffnell-j-et-al-alternative-donor-transplantation-for-severe-aplastic-anem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cryo-em-structure-of-the-human-native-plasma-coagulation-factor-xiii-complex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pegcetacoplan-treatment-for-cold-agglutinin-disease-and-warm-antibody-autoimm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/another-cryo-em-success-structure-of-fxiii 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ikzf1-born-to-be-the-repressor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/conserved-helical-motifs-in-the-ikzf1-disordered-region-mediate-nurd-interaction-and-transcriptional 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-manage-iron-overload-in-the-hematopoietic-cell-transplantation-setting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammatory-waldenstrom-macroglobulinemia-is-associated-with-clonal-hematopoiesis-a-multicentric-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ex-vivo-venetoclax-sensitivity-predicts-clinical-response-in-acute-myeloid-leukemia-in-the-prospecti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venex-precisely-predicts-ven-aza-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complementing-hemolytic-anemias-whats-next 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-how-i-treat-series-on-iron-overload-in-hematologic-disorders 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hla-i-aberrations-in-cutaneous-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-with-lenalidomide-as-maintenance-after-transplant-in-newly-diagnosed-multiple-myeloma-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-alteration-of-class-i-hla-in-cutaneous-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combined-targeted-modality-in-chl-a-risky-bet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-nivolumab-doxorubicin-and-dacarbazine-for-advanced-stage-classical-hodgkin-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifn-i-promotes-t-cell-independent-immunity-and-rbc-autoantibodies-via-modulation-of-b-1-cell-subsets 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-progression-risk-of-monoclonal-gammopathy-of-undetermined-significance-by-method-of-de 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-for-maintenance-in-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-and-nivolumab-for-chl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/b-1-b-cells-lose-self-control-in-scd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-older-patients-with-relapsedrefractory-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/is-it-time-to-screen-for-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/current-myeloproliferative-neoplasm-scoring-systems-for-clinical-practice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stop-amp-go-discontinuing-tpo-ra-in-chronic-itp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gsi-myeloma-cold-case-closed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-iron-overload-aggravates-and-pharmacological-iron-restriction-improves-mds-pathophysiology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-of-the-multiple-myeloma-microenvironment-after-gh-secretase-inhibition-and-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lower-intensity-therapy-for-good-risk-b-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iron-accelerates-mds-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-the-stopago-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/doubling-down-on-gprc5d-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/forimtamig-a-novel-gprc5d-targeting-t-cell-bispecific-antibody-with-a-21-format-for-the-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-with-ietv6iirunx1i-or-high-hyperdiploid-b-all-treated-in-the-st-ju 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-current-landscape-of-frontline-large-b-cell-lymphoma-trials 2026-08-17 monthly 0.7 https://rjrindex.com/articles/building-the-future-management-of-follicular-lymphoma-with-t-cell-redirecting-strategies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd123-to-the-rescue 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-apl-2-targets-are-better-than-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-promyelocytic-leukemia-long-term-outcomes-from-the-harmony-project 2026-08-17 monthly 0.7 https://rjrindex.com/articles/solvitur-ambulando 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dexamethasone-dose-intensity-does-not-impact-outcomes-in-newly-diagnosed-multiple-myeloma-a-seconda 2026-08-17 monthly 0.7 https://rjrindex.com/articles/down-with-dex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/parvovirus-b19-induced-autoimmune-hemolytic-anemia-in-hereditary-elliptocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-philadelphia-chromosome-like-acute-lymphoblastic-leukemia-in-children-adolescents-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-etp-all-in-children 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-infant-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-older-patients-with-phbcr-abl-negative-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/introduction-to-a-how-i-treat-series-on-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-adult-ph-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-iptacopan-for-paroxysmal-nocturnal-hemoglobinuria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/how-i-treat-postimmunotherapy-relapsed-b-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-erythroid-specific-lentiviral-vector-improves-anemia-and-iron-metabolism-in-a-new-model-of-xlsa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-standard-of-care-ciltacabtagene-autoleucel-for-relapsedrefractory-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/xlsa-breakthrough-gene-therapy-potential 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vitamin-c-deprivation-puts-stem-cells-to-sleep 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ascorbate-deficiency-increases-quiescence-and-self-renewal-in-hematopoietic-stem-cells-and-multipote 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-cost-effectiveness-of-pnh-therapies 2026-08-17 monthly 0.7